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Abstract 
 
The yeast CCR4-NOT (CNOT in mammals) complex is a large (1.0-MDa) and highly conserved 
multifunctional set of proteins. It is involved in many different aspects of mRNA metabolism, 
including repression and activation of mRNA initiation, control of mRNA elongation, and 
deadenylation-dependent mRNA turnover; it also has a role in ubiquitin-protein transferase 
activity and histone methylation. Some studies have suggested that the yeast complex may 
be involved in the recognition and repair of DNA damage. To investigate whether similar 
properties are attributable to the mammalian complex we have examined the effects of 
inactivation of the complex on various aspects of the DNA damage response. Inactivation was 
achieved by depletion of CNOT1, the largest of the CNOT proteins, which forms a scaffold to 
the complex. Ablation of CNOT1 expression disrupts cell cycle progression through S and 
G2/M phases, which subsequently arrests the cell cycle in G1, with markedly elevated levels 
of cyclin E, p27 and p21. At later times, the cells appear to senesce and /or undergo 
autophagy. As expected, depletion of CNOT1 affects global transcription and can lead to 
transcription-dependent replication stress and R-loop formation. CNOT1 depletion can also 
affect DNA replication by reducing dNTP synthesis. Activity of the RNase H2 complex 
decreases following loss of CNOT1, which increases the sensitivity of genomic DNA to alkaline 
lysis due to an increase in embedded ribonucleotides.  In addition, depletion of CNOT1 results 
in DNA damage as seen by comet assay, and formation of micronuclei. This is accompanied 
by activation of Chk2 in the absence of extraneous DNA damage. In this study, we have 
demonstrated that the CNOT complex contributes to the maintenance of genome stability 
and to the response to DNA damage. 
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1 INTRODUCTION 
 
1.1 The CCR4-NOT complex 
The yeast Ccr4-Not, carbon catabolite repression 4 (Ccr4)–negative on TATA-less (Not) 
complex is a large (1.0-MDa) and highly conserved multifunctional set of proteins (Kumagai 
and Dunphy 1999, Nasertorabi, Batisse et al. 2011). It is involved in different aspects of mRNA 
metabolism, including repression and activation of mRNA initiation, control of mRNA 
elongation, deadenylation-dependent mRNA turnover, and in ubiquitin-protein transferase 
activity and histone methylation (Kruk, Dutta et al. 2011). Most studies have investigated the 
Ccr4-Not complex in S. cerevisiae, thus much of our understanding of the complex function is 
a yeast-based model (Denis and Chen 2003, Morita, Suzuki et al. 2007). In S. cerevisiae the 
multi-subunit CCR4-NOT complex comprises nine core subunits, including the Ccr4 (Carbon 
Catabolite Repression), Caf proteins (Ccr4 associated factor) (Caf1, Caf40, Caf130) and Not 
proteins (Not1, Not2, Not3, Not4, and Not5) as well as several less well characterised 
components (Collart 2003). The Ccr4-Caf1 mRNA deadenylase complex contains a 3’ 
exoribonuclease motif which is involved in removing poly (A) tails from mRNA (Tucker, 
Valencia-Sanchez et al. 2001). More evidence in support of the Ccr4-Not complex’s role in co-
transcriptional RNA processing has been already reported (Lee, Wyrick et al. 1998). Genetic 
approaches in yeast have identified four Not genes (Not1-4) that can globally repress RNA 
polymerase II activity. Mutation of these genes increase basal expression of many genes in 
yeast (Collart and Struhl 1994). 
Complexes of a similar size, containing the human orthologues CNOT1–CNOT9 with three 
extra subunits of CNOT10, Tab182 (Tankyrase 1-binding protein1, TNKS1BP1) and C2ORF29 
(CNOT11), have been identified in mammals (Table 1.1).  
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Yeast Protein  Human Orthologue Function 
NOT1/CDC39 CNOT1 Scaﬀold 
NOT2/CDC36 CNOT2 Unknown 
NOT3/NOT5 CNOT3 Unknown 
NOT4/MOT2/SIG1 CNOT4 E3ligase activity 
CCR4α CNOT6 Deadenylase 
CCR4β CNOT6L Deadenylase 
CAF1α CNOT7 Deadenylase 
CAF1β/P0P2 CNOT8 Deadenylase 
RCD1/CAF40 CNOT9 (RQCD1) 
Transcriptional 
cofactor 
 Not present CNOT10 Unknown 
 Not present CNOT11 (C2orf29) Unknown 
CAF130 Unknown Unknown 
 Not present 
TNKS1BP1 
(Tab182) Multifunctional 
 
Table 1.1 Classification of human-yeast orthologues of CNOT complex subunits 
The yeast Ccr4-Not complex subunits and their human orthologues are listed, together with 
their function if known. 
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Four deadenylase subunits CNOT7/CNOT6, CNOT7/CNOT6L, CNOT8/CNOT6 and 
CNOT8/CNOT6L are expressed in mammalian cells; however, deadenylation is mediated by 
only one complex (Ccr4/Caf1 subunits) in yeast. In mammalian cells, that the complex 
contains either CNOT7 or CNOT8 (not both as in yeast), suggesting they compete for binding 
to CNOT1 (Lau, Kolkman et al. 2009).  While the E3 ubiquitin ligase Not4 is consistently present 
in the yeast complex, CNOT4 is not stably associated with the other subunits in mammalian 
cells (Lau, Kolkman et al. 2009). No orthologues of CNOT10, CNOT11 or Tab182 have been 
identified in yeast (Mauxion, Prève et al. 2013). The CNOT3 subunit which is not reported to 
have an enzymatic activity is orthologous to two yeast subunits, Not3 and Not5. Every 
individual subunit appears to have a unique role with a slight overlap between some proteins 
(Panepinto, Heinz et al. 2013). The evidence in support of this includes the observation that 
mutations and deletions of the different subunits are responsible for different phenotypes in 
yeast (Azzouz, Panasenko et al. 2009). Mammalian CNOT1 is the largest component of the 
CCR4-NOT complex with a molecular weight of 267 kDa. It is a scaffold protein and its 
depletion destabilises the whole complex’s integrity, leading to a reduction in the level of 
other subunits (Bawankar, Loh et al. 2013). In addition, CNOT1 has no enzymatic function; 
however, it guarantees the enzymatic activities of the complex. It has been shown that in 
CNOT1-depleted HeLa cells the level of CHOP mRNA increased and the cells undergo caspase-
4 activation causing ER stress-mediated apoptosis, suggesting CNOT1 is essential for viability 
and cell proliferation (Ito, Takahashi et al. 2011). CNOT1 is the focal point of the complex and 
interacts with CNOT11 and CNOT10 at its N-terminal region although the function of this is 
not evident at present (Bawankar, Loh et al. 2013). CNOT7 or CNOT8 bind to MIF4G, the 
middle domain of CNOT1, forming a bridge between CNOT1 and CNOT6 or CNOT6 (Petit, 
Wohlbold et al. 2012). CNOT9 binds in close proximity to a domain of uncharacterised 
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function DUF3819, the remaining residues of the middle part of CNOT1. At the C-terminus of 
CNOT1, it interacts with the heterodimer CNOT2/CNOT3. Although the function of these 
latter two CNOT proteins is still not clear they appear to regulate the stability of the complex 
(Bawankar, Loh et al. 2013) (Figure 1.1) and (Figure 1.2). The location of Tankyrase1 binding 
protein 1 (TNKS1BP1, also known as Tab182), which is a novel subunit we have studied 
previously, in the complex, is still undetermined (Hagkarim, Ryan et al. 2018).  
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Figure 1.1 Architecture of the yeast Ccr4-Not complex structure. 
An L-shape configuration of the CNOT complex was confirmed using electron microscopy. The 
complex is composed of a pair of arms of 180Å and 190Å. NOT1 is described as the scaffold 
protein, to which all the other subunits bind , obtained from (Collart, Panasenko et al. 2013). 
Permission is obtained from publisher (Elsevier) through RightLinks under the licence number 
4691371252345 on October 17, 2019.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2 Architecture of the mammalian CCR4-NOT complex structure.  
Electron microscopy analysis has established that the multi-subunit CCR4-NOT complex 
consists of a scaffold protein CNOT1 and deadenylase subunits CNO6/CNOT6L and 
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CNOT7/CNOT8. The E3 ubiquitin ligase component CNOT4 is not stably associated with the 
CNOT complex. TAB182 is a novel integral component of the CCR4-NOT complex. Adapted 
from (Ryan 2016).  
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1.1.1 CNOT1 
CNOT1 is the largest subunit (an amino acid length of 2376 and a mass of 266.9 kDa in Homo 
sapiens) and the scaffolding component of the complex (Shirai, Suzuki et al. 2014). Three 
domains have been delineated for CNOT1, N-terminal, MIF4G (middle domain of eukaryotic 
initiation factor 4G) and C-terminal domains. CNOT1 interacts with CNOT11, which is required 
for the association of CNOT10 with the NOT complex, through its N-terminal domain 
(Bawankar, Loh et al. 2013, Mauxion, Prève et al. 2013). CNOT1 directly associates with the 
deadenylase module through its middle region MIF4G region (Petit, Wohlbold et al. 2012, 
Bawankar, Loh et al. 2013). CNOT7 / CNOT8 function as an adaptor between CNOT1 and 
CNOT6 / CNOT6L. The remaining residues of the middle domain of CNOT1, named domain of 
unknown function (DUF3819) associates with CNOT9 (Bawankar, Loh et al. 2013, Chen, 
Boland et al. 2014). CNOT3 via CNOT2 binds to the C-terminal region of CNOT1 (Bawankar, 
Loh et al. 2013, Boland, Chen et al. 2013) (Figure 1.3).  
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Figure 1.3 CNOT1 interaction regions with the other CNOT subunits. 
Interaction map obtained from  negative-stain electron microscopy showing the interaction 
sites between CNOT1 as a scaffolding platform and the other CNOT subunits, adapted from 
(Nasertorabi, Batisse et al. 2011). Different colours represent the different regions as shown 
above. The TAB182 interacting site has not been mapped.  This article published by Frontiers 
in Genetics is under an open access license (published material can be re-used without 
obtaining permission as long as a correct citation to the original publication is given). 
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CNOT1 scaffolding function, through these interactions, provides a platform for complex 
formation. Therefore, depletion of CNOT1 would result in the destabilization of the whole 
complex and degradation of the other subunits such as CNOT2, CNOT6L, CNOT7, and CNOT9, 
but not CNOT3, in HeLa cells (Ito, Takahashi et al. 2011). Although, CNOT1 has no enzymatic 
activity, as far as is known, the importance of its scaffolding function for the deadenylase 
activities of the CNOT complex cannot be overstated.  
 
The specificity of deadenylase activity to the selected mRNA 3'UTRs has been determined by 
RNA-binding proteins (RBP) through their interaction with CNOT1. For example, 
Tristetraprolin (TTP; zinc-finger protein ZFP36) has an effect on tumour necrosis factor-α 
(TNF-α) mRNA turnover (Sandler, Kreth et al. 2011). It has been reported that Nanos2, which 
is a sequence-specific RNA-binding protein, degrades specific mRNAs, such as Stra8 and plays 
a key role in  murine male germ cell development (Suzuki, Saba et al. 2012). CNOT1 also plays 
an important role in miRNA-mediated gene silencing. Human GW182 (TNRC6), which is a core 
component of the miRNA-repression complex provides a platform for CCR4–NOT and PAN2–
PAN3 to promote degradation of miRNA–target mRNAs (Braun, Huntzinger et al. 2011). 
CNOT1, through its MIF4G domain, binds to the C-terminal RecA domain of the DEAD-box 
protein DDX6, a central component of translational repression, and stimulates the DDX6 RNA 
helicase ATPase and its recruitment to miRNA-targeted mRNAs (Chen, Boland et al. 2014).  
The failure of cell differentiation in planaria can occur due to elevated stem cell specific-
mRNAs with elongated poly (A) tails following depletion of CNOT1 (Solana, Gamberi et al. 
2013).  Similarly, lethality in Saccharomyces cerevisiae can be promoted following a single 
deletion of only the NOT1 gene. Double deletion of the CCR4 and CAF1 genes, however, does 
not lead to lethality, suggesting that CNOT1 is essential not only for integrity of the CNOT 
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complex but is also involved in other functions that are crucial for homeostasis (Maillet, Tu et 
al. 2000).  
Several studies have implicated CNOT1 in transcription regulation. (Lee, Wyrick et al. 1998) 
have reported Not1p to be a negative TBP-associated regulator of RNA polymerase II in yeast. 
CNOT1 supresses the ligand-dependent transcriptional activation of oestrogen receptor 
α (ERα). This is achieved by a conserved LXXXLL motif on CNOT1 which mediates interaction 
with ERα in MCF-7 human breast cancer cells (Winkler, Mulder et al. 2006). The other nuclear 
receptor that CNOT1 is able to interact with retinoid X receptor α (RXRα); this association 
suppresses RXR-mediated transcription in a ligand-dependent manner (Winkler, Mulder et al. 
2006). Among those proteins involved in controlling major histocompatibility complex class II 
(MHC-II) transcription and transport, CNOT1 and CNOT2 were identified using a genome-wide 
RNAi screen (Paul, van den Hoorn et al. 2011). Single nucleotide polymorphisms (SNPs) within 
the CNOT1 and CNOT6 genes are associated with B-cell paediatric lymphoblastic leukaemia 
(B-ALL) (Gutierrez-Camino, Lopez-Lopez et al. 2014). (Cheng, Li et al. 2017) have proposed a 
role for CNOT1 as an oncogene in osteosarcoma progression; depletion of CNOT1 inhibits 
osteosarcoma cell proliferation through inhibition of the Hedgehog signalling pathway. 
 
1.1.2 Deadenylation of mRNAs and the CNOT complex 
In response to different cellular conditions, transcription patterns of messenger RNA (mRNA) 
are rapidly adjusted through, among other factors, polyadenylation and deadenylation. Poly 
(A) tail length determines mRNA fate. Poly (A) tails of species-specific length (∼70 nucleotide 
in yeast and ∼250 nucleotides in mammals) are added to the 3′ end of newly synthesised 
mRNA in the nucleus to help with mRNA translation and stability (Brown and Sachs 1998). The 
poly(A) tail is bound by poly(A)-binding protein (PABP) which increases the stability of the 
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mRNA and stimulates its translation in the  cytoplasm (Svitkin and Sonenberg 2006). The 
protein level produced during mRNA translation is controlled by deadenylation which is 
determined by the rates of mRNA synthesis (Wada and Becskei 2017). 
The rate of deadenylation varies between different mRNAs and determines their half-lives. 
Deadenylation-dependent mRNA decay plays an important role in eukaryotic fine-tuning of 
gene expression and this is achieved by monitoring mRNA translation and initiating 
degradation under appropriate circumstances (Chen, Ezzeddine et al. 2008). Pan2-Pan3 
deadenylation complex initiates the mRNA turnover by removing long poly (A) tails of above 
150 nt. A subsequent step is carried out by CCR4–NOT which can remove the PABPC-bound A 
tails. Following deadenylation, the removal of the 5′ 7-methylguanosine cap is performed by 
the decapping complex DCP1/2 following the binding of the Lsm1–7 complex to the 
oligoadenylated 3′ end. Finally, 5’ to 3’ exonucleolytic degradation is carried out by XRN1 (Du, 
Liu et al. 2018) (Figure 1.4). In an alternate pathway after poly (A) tail removal, the cytoplasmic 
exosome complex is entirely responsible for degradation of mRNA in the 3’ > 5’direction 
(Siwaszek, Ukleja et al. 2014) (Figure 1.4).  Several studies have reported deadenylase 
involvement in different cellular processes, including the DDR (Morita, Suzuki et al. 2007) 
(Traven, Hammet et al. 2005) , cell cycle regulation (Morel, Sentis et al. 2003) and cell 
proliferation (Ito, Takahashi et al. 2011). In particular, the balance between polyadenylation 
and deadenylation is thought to underlie this involvement, but the exact mechanism is 
unknown.  
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Figure 1.4 The mRNA decay pathway. 
Initial Poly (A) degradation is carried out by the A) Pan2-Pan3 (n> 150 nt) followed by a further 
degradation by B) CCR4-NOT complex. Subsequent to this, two general pathways of mRNA 
decay have been identified. C & D) The first involves the decapping of the mRNA 5’ cap by the 
DCP1-DCP2 enzymatic complex following the binding of the Lsm1–7 complex. E) This allows 
XRN1 to act on the mRNA body and complete the degradation process. F) In the other 
pathway, 3’ to 5’ degradation is entirely performed by the cytoplasmic exosome, obtained 
from (Du, Liu et al. 2018). This article published by MDPI is under an open access license 
(published material can be re-used without obtaining permission as long as a correct citation 
to the original publication is given). 
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1.1.3 Transcription initiation and the CNOT complex  
The CNOT complex appears to be crucial for regulation of gene expression homeostasis in 
eukaryotes (Collart 2016). The Not proteins were previously reported in yeast to be a part of 
a transcription pre-initiation complex. Using co-immunoprecipitation (Kruk, Dutta et al. 2011) 
showed that the CCR4-NOT complex assembles at promoters, in yeast, through an interaction 
with RNA polymerase II (RNA Pol II) and binds to nascent RNA transcripts during elongation. 
The five Not 1-5 subunits were originally described as negative regulators of transcription 
initiation by impeding the access of TBP (TFIID)  to TATA-less genes which are mostly involved 
in energy metabolism and the inflammatory response (Lee, Wyrick et al. 1998). It was also 
suggested that they could act  by inhibiting the interaction between TBP and DNA, possibly 
through interactions of Not5 and Not2 with TFIID (Badarinarayana, Chiang et al. 2000). The 
Not-Box domain, present in Not2 and hCNOT3 orthologues, has been found to be an active 
repressor of transcription upon promoter targeting. This Not-Box-mediated suppression is 
sensitive to the histone deacetylase inhibitor TSA, suggesting the involvement of histone 
deacetylases in the process (Zwartjes, Jayne et al. 2004). Significantly, CNOT3 was identified 
among those genes whose function contribute to the formation of a unique module in the 
transcriptional network required for self-renewal in mouse ES cells (Hu, Kim et al. 2009). More 
evidence in support of the Ccr4-Not complex’s role in transcription initiation has been 
presented by (Lee, Wyrick et al. 1998).  These authors showed that Not1 has the ability to 
bind to TBP in the TFIID and SAGA transcription factors at promoters, which is essential for 
the presence of  RNA polymerase II at transcription start sites. TFIID is typically found on 
promoters of constitutive housekeeping genes that are required for the maintenance of basic 
cellular functions, while SAGA is mainly present at highly inducible gene promoters (Figure 
1.5). Ccr4-Not subunit crosslinking is enriched at SAGA‐dependent genes and genome‐wide 
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gene expression analyses of Ccr4-Not mutants have confirmed that SAGA‐responsive genes 
are largely affected (Cui, Ramnarain et al. 2008). The other regulators that are biased towards 
the SAGA-pathway are Spt6, a replication-independent histone chaperone, and COMPASS, a 
histone H3 lysine 4 (H3K4) methylase (Venters, Wachi et al. 2011). Interaction between Spt6 
and RNA Pol II promotes the recruitment of deadenylation activity, by the Ccr4-Not complex, 
at the site of transcription in order to facilitate the degradation of mRNAs required for cell-
cycle progression (Dronamraju, Hepperla et al. 2018). Saccharomyces cerevisiae H3K4 
methylation is catalysed by Set1/COMPASS and removed by Jhd2 demethylase. The yeast E3 
ligase Not44 regulates the level of H3K4me3 through proteasomal degradation of Jhd2 
demethylase (Mersman, Du et al. 2009) and Not4Δ cells show a significant reduction in the 
level of H3K4me3 (Mulder, Brenkman et al. 2007).  ATP‐dependent chromatin remodelling 
factors such as histone methylase (HMT) and histone acetyltransferase (HAT) increase the 
accessibility of DNA to RNA Pol II. Yeast cells lacking Not4 or Not5, histones H3 and H4 are 
mostly hypoacetylated (Peng, Togawa et al. 2008). 
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Figure 1.5 The Ccer4-Not complex interacts with transcription machinery in yeast.  
A schematic diagram showing the contribution of the CNOT complex to the transcription 
machinery, Top panel presents the interactions of CNOT complex with components required 
for transcription initiation.  Bottom panel shows the interactions of CNOT complex with 
components likely to recruit the complex to the transcription machinery. TF (transcription 
factor); TFB (transcription factor binding site); Ubi, (ubiquitination); Ac (acetylation); Me3, 
(trimethylation); SAGA (Spt–Ada–Gcn5 acetyltransferase). Obtained from (Collart 2016). This 
article published by Wiley Interdiscip Rev RNA is under an open access license (published 
material can be re-used without obtaining permission as long as a correct citation to the 
original publication is given).  
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1.1.4 Transcription elongation and the CNOT complex 
A number of sites on DNA, for example those containing A/T-rich regions (hairpin structures), 
DNA binding proteins and DNA lesions, as well as a low concentration of ribonucleotides  all 
cause disruption of mRNA-DNA-RNA polymerase ternary elongation complexes (TECs); this 
results in a situation generally referred to as transcription stress (Fish and Kane 2002). Stalled 
transcribing RNA Poll can also be problematic for replisomes, causing a conflict between the 
replisome and the transcription machinery leading to an interruption of DNA replication and 
loss of genome stability (Hawkins, Dimude et al. 2019). Therefore, efficient RNA polymerase 
II transcription elongation through template-encoded pausing sites is necessary for normal 
cell viability. Although the CNOT complex appears to have no effect on the transcription rate 
of an active elongating RNA polymerase II, it contributes to transcription elongation by 
regulation of histone H3 K4 methylation through Jhd2. This, in turn, will result in forward 
translocation of a stalled RNA Pol II (Reese 2013); this requires the association between the 
Rpb4/7 module of the polymerase RNA Pol II and both Not3 and Not5 in Saccharomyces 
cerevisiae (Babbarwal, Fu et al. 2014) (Figure 1.6). It seems that the length of the transcript is an 
important determinant in this rescue operation by the CNOT complex, suggesting that an 
association of the complex with nascent RNA also contributes to the promotion of 
transcription elongation (Collart 2016). Transcription factor S-II (TFIIS) is another factor that 
directly induces resumption of elongation and helps RNA Pol II to pass through trapping sites 
by increasing the intrinsic nuclease activity of RNA Pol II and displacing transcripts. The 
ribonuclease activity of the CNOT complex does not appear to contribute to this mechanism; 
however, the CNOT complex improves the recruitment of TFIIS to elongation complexes and 
this is mediated by an interaction between the complex and the N terminus of TFIIS (Wind 
and Reines 2000) (Figure 1.6). Following nascent mRNA removal an increased time is spent 
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stalled at that site by RNA Pol II;  there is also a decreased stability of the transcription 
machinery which targets the destruction of RNA Pol II, returning the DNA template to its initial 
state (von Hippel 1998). 
Similar to the DNA trapping sites, increased global transcription activity can also lead to 
elevated transcription stress and genome instability (Saponaro, Kantidakis et al. 2014, 
Kotsantis, Silva et al. 2016). Although RNA Pol II transcript elongation rate is fast, the 
transcribing RNA Pol II is not fully functional or effective, which leads to increased incidents 
during which polymerase is arrested or stalled in the transcribed genes (Saponaro, Kantidakis 
et al. 2014). 
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Figure 1.6 Cartoon explaining the role of the CNOT complex in transcription elongation. 
Top Panel left; Forward translocation of a stalled RNA Pol II by increasing histone H3 K4 
methylation through polyubiquitylation of Jhd2 by NOT4 and its proteasomal degradation. 
Bottom panel left; Cleavage of the displaced transcript in backtracked RNA Pol II by TFIIS. 
CNOT complex improves the recruitment of TFIIS to transcription unit. Obtained from (Collart 
2016). This article published by Wiley Interdiscip Rev RNA is under an open access license 
(published material can be re-used without obtaining permission as long as a correct citation 
to the original publication is given).  
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1.2 Cell cycle 
The cell cycle consists of four phases: gap-phase 1 (G1), synthesis of DNA (S), gap-phase 2 (G2) 
and mitosis (M). The mammalian cell cycle progression is controlled by a family of cyclin-
dependent kinases (CDKs), in conjunction with several activators (cyclins) and inhibitors 
(CKIs) that form the regulatory subunits of CDKs. CDK activators belong to three different 
classes: G1 cyclins (D-type cyclins D1, D2 and D3), G1/S cyclins (E-type cyclins E1 and E2), S 
cyclins (A-type cyclins A1 and A2), and G2/M cyclins (A-type cyclins and B-type cyclins B1 and 
B2). D-type cyclins can interact with CDKs 2, 4, 5 and 6, while cyclins E, A and B interact with 
CDK1 and CDK2 only. CDK inhibitors have been divided into three families; INK4a proteins 
(p16INK4a, p15INK4b, p18INK4c, p19INK4d) are inhibitors of CDK4 and of CDK6. The other family of 
CKIs, comprising CIP (p21cip1/waf1) and KIP (P27kip1, p57 kip2) proteins can inhibit all CDKs. The 
expression of cyclins is cell cycle-dependent and their concentration varies in a cyclical 
fashion, promoting the cell cycle progression through different phases (Figure 1.7). Unlike 
the other cyclins, the level of cyclin D gradually increases with no oscillation, through the 
stages of the cell cycle based on cell growth regulatory signals. For example, a mitogen-
stimulating signal in G0/G1 cells promotes the expression of cyclin D proteins which 
interact with CDK4 and CDK6, stimulating their kinase activities. The increase in 
concentration of E-type cyclins begins in G1 and peaks dramatically at the G1/S boundary, 
promoting G1/S transition; the level of expression then drops in early S phase. Cyclin E 
complexed to CDK2 begins to induce the initial processes of DNA replication. The active 
cyclin D-CDK4/6 complexes mono-phosphorylate the tumour suppressor RB and its 
homologues p107 and p130. Hypo-phosphorylation of RB promotes the G0/G1 transition 
and activation of cyclin E which in return hyper-phosphorylates RB and removes the 
negative inhibitory effect of RB, leading dissociation from E2F. Free E2F is then able to 
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promote expression of genes, including cyclin E, which drive G1/S transition and DNA 
synthesis. The cyclin E-CDK2 complex also triggers hyper-phosphorylation of pRB leading to 
further dissociation of pRB from E2F family members. Increased level of cyclin E parallels an 
increase in cyclin A. Expression of cyclin A1 is limited to germ cells while cyclin A2 is 
expressed in dividing somatic cells. The cyclin A2-CDK2 complex is implicated in DNA 
replication in S phase; however, the cyclin A2-CDK1 complex is involved in the G2/M 
transition, followed by cyclin B1-CDK1 activation. Wee1 and Myt1 kinases phosphorylate 
CDK1 on Tyr15 and Tyr14 respectively, causing inactivation of cyclin B1-CDK1 complexes 
during G2. The G2/M transition is promoted by dephosphorylation of CDK1 by CDC25C. 
Mitotic entry is triggered by a positive feedback loop at the end of G2 when active cyclin 
B1-CDK1 complexes phosphorylate CDC25A/B/C, which, in turn, activate further cyclin B1-
CDK1 complexes. As G2 cells begin to enter mitosis cyclin B1 concentration increases with 
the maximum concentrations at metaphase. The cyclin B1-CDK1 complex promotes the 
assembly of mitotic spindles and alignment of sister-chromatids at the metaphase plate of 
the mitotic spindle and is degraded when cells begin to enter anaphase.  
Deregulated activity of certain cyclin-CDK complexes, such as cyclin E-CDK2, has been 
reported to play a role in carcinogenesis. The overexpression of cyclin E decreases the 
duration of G1 and accelerates premature entry into S-phase. Unscheduled S-phase entry 
does not allow cells enough time to gather all the necessary materials required for DNA 
replication, resulting in aberrant DNA replication but continued proliferation (Bester, Roniger 
et al. 2011). 
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Figure 1.7 The diagram shows the different cyclin concentrations across the cell cycle. 
Cyclin D is present for most stages of the cell cycle and gradually increases with no oscillation 
during G1 and S phases. The increased concentration of cyclin E begins in G1 and peaks at 
the G1/S boundary, promoting G1/S transition; it then and drops in early S phase. The 
concentration of cyclin A begins to increase in late G1 and remains high during S and G2. 
Cyclin B peaks at the transition from G2 to M followed by a rapid reduction in the middle of M 
phase. Adapted from Wikimedia Commons, the free media repository.  
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1.2.1 The Cell Cycle Checkpoints 
G0/G1, G1/S, S and G2/M checkpoints are the mechanisms that monitor correct replication, 
segregation or repair of damaged DNA throughout the cell cycle.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.8 The cell cycle and its checkpoints. 
Transition through each cell cycle phase (G1, S, G2 and M) is regulated by Cyclin-CDK 
complexes. Cyclin D-CDK4/6 and Cyclin E-CDK2 complexes are responsible for progression 
through G1. Progression through S phase is mediated by cyclin A-CDK2. The G2/M transition 
is promoted following formation of cyclin A-CDK1 complex and completed by formation of 
the cyclin B-CDK1 complex. This activation of CDKs occurs once their N-terminal inhibitory 
phosphates are removed by CDC25 phosphatases. The cell cycle checkpoint arrest is 
performed by different mechanisms; 1) CDK inhibitors such as p21 and p27. 2) CDC25 
phosphorylation, inhibition and sequestering by the Chk1/Chk2/Plk/MAPK kinases.  
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1.2.1.1 The G0/G1 Checkpoint 
Somatic cells can enter a reversible (quiescent) or irreversible (senescent and differentiated) 
G0 state. Quiescent cells are able to re-enter the cycle, whereas senescent cells are 
permanently arrested in G0 (Figure 1.8). The G0/G1 checkpoint regulates the entry of 
quiescent cells, where the cells are neither dividing nor preparing to divide, back into the 
cycle. However, the difference between the G0 and G1 phase has remained obscure. In G0 
cells, RB promotes the recruitment of the nucleosome remodelling complex SWI/SNF and the 
histone deacetylases (HDACs) to E2F binding sites, leading to repression of E2F target genes 
such as cyclin E (Swanton and Jones 2001).  Exiting from G0 to G1 is initiated by exogenous 
mitogens that induce expression of cyclin D that, in a complex with CDK4 or CDK 6, removes 
the  inhibition of cyclin E expression through the phosphorylation of Rb and release of HDACs 
(Swanton and Jones 2001). It is noteworthy that most p27 is in a complex with cyclin D-
CDK4 and less with cyclin E-CDK2 (Quintanilla-Martinez, Davies-Hill et al. 2003). The levels 
of p27 have been reported to be higher in quiescent cells in G0, while p21 levels are lower; 
however, they readily increase in response to mitogenic stimulation and entry into G1 
(Ladha, Lee et al. 1998). 
 
1.2.1.2 The G1/S Checkpoint 
The G1 checkpoint is in place to prevent initiation of replication in cells with DNA damage, 
before S phase entry. G1 checkpoint arrest is achieved through two mechanisms; firstly, Chk1-
mediated phosphorylation of CDC25A at multiple sites. Chk1, downstream of ATR, mediates 
phosphorylation and degradation of CDC25A preventing aberrant or excessive replication 
firing during unperturbed S phase. This is achieved through the downregulation of CDK2, in 
association with cyclin E (Sørensen, Syljuåsen et al. 2004). In the absence of CDC25A, de-
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phosphorylation of cyclin E–CDK2 complexes is inhibited, which in turn, blocks the loading of 
Cdc45 onto the pre-RC complex. Secondly, p53-dependent phosphorylation of p21 and p27 
can occur. Stabilization and activation of p53 is achieved through phosphorylation of p53 
directly by ATM on Ser15 (Banin, Moyal et al. 1998) and by Chk1 on Ser20/Thr18 (Canman, 
Lim et al. 1998) (Shieh, Ahn et al. 2000). Phosphorylation of these amino acids  disrupts the 
binding between p53 and MDM2, which prevents MDM2-mediated nuclear export and 
degradation of p53 (Dumaz and Meek 1999). Increased stabilisation of p53 leads to induction 
of the transcriptional activation of its targets such as p21 and p27 and subsequently impairing 
of the progression of the cell cycle from the G1 to S phase (Figure 1.8). The E3 ubiquitin ligase 
SCFSkp is thought to be responsible for ubiquitin-mediated proteasomal degradation of both 
p27 and cyclin E in response to G1/S arrest or G1/S transition, respectively.  Several groups 
have reported dual regulatory behaviour between Cyclin E and p27. For example; p27 
accumulation leads to the inactivation of cyclin E–CDK2 kinase activity followed by 
phosphorylation of cyclin E on Thr380, securing it from cyclin E-specific F-box degradation 
(Mazumder, DuPree et al. 2004). In contrast, the data from  Bornstein, Bloom et al showed 
that cyclin E–CDK2 can facilitate its own activation by phosphorylating p27 on Thr187 to 
trigger its degradation by the SCF SCFSkp ubiquitin ligase (Bornstein, Bloom et al. 2003). p27 
can inhibit origin firing independent of CDK inhibition by interacting with, and blocking, 
MCM7 (Nallamshetty, Crook et al. 2005). 
 
1.2.1.3 The S phase checkpoint 
The S-phase checkpoint is a surveillance mechanism to ensure that faulty DNA is not 
replicated, in order to preserve genome integrity. Three canonical S-phase checkpoint 
pathways exist: the intra-S phase checkpoint, the replication checkpoint and the S/M 
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checkpoint (Bartek, Lukas et al. 2004). The replication checkpoint contributes to salvaging of 
stalled forks by increasing dNTP replenishment and this is achieved via integrating signals 
from RPA, ATRIP, and RAD17 as we will discuss in more detail in section 1.4.2. The S/M 
checkpoint blocks the transition into M phase to ensure that replication has been accurately 
completed before cells divide. The S/M checkpoint is a Chk1-dependent pathway, since 
treatment of mammalian cells, lacking ATR expression, with replication inhibitors still 
prevents M phase entry (Brown and Baltimore 2000, Brown 2003). S/M checkpoint arrest is 
achieved by inhibiting the cyclin B-CDK1 complex, which progressively increases throughout 
the cell cycle to promote entry into mitosis. Unlike the latter two checkpoints, the intra-S 
phase checkpoint does not require replicating DNA and is triggered by DSB structures. Both 
ATM and ATR kinases stall cell cycle progression through S phase by phosphorylation of 
CDC25A, leading to the consequent inhibition of cyclin A-CDK2 activity and CDC7-Dbf4 
(Sørensen, Syljuåsen et al. 2004) (Figure 1.8). 
 
 
1.2.1.4 The G2/M Checkpoint 
The G2/M DNA checkpoint prevents cells from entering mitosis until unrepaired/damaged 
DNA or incompletely replicated DNA is sufficiently repaired. CDC25 phosphatases (CDC25A, 
CDC25B, CDC25C) are predominantly phosphorylated and inhibited by Chk1 and Chk2, leading 
to the inactivation of the Cyclin B1-CDK1 complex which is necessary for the progression into 
M phase. Phosphorylation of CDC25B/C facilitates the binding of 14-3-3 proteins to this 
phosphatase  which sequesters it in  the cytoplasm (Abraham 2001). Further phosphorylation 
and sequestering of CDC25B/C protein to the cytoplasm is mediated by polo-like kinase 3 
(Plk3) and the p38 mitogen-activated protein kinase (MAPK) pathway; these activities are ATR 
and ATM  dependent (Bahassi, Hennigan et al. 2004) and  (Bulavin, Higashimoto et al. 2001). 
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In parallel, p53-dependent inhibition of CDK1 also regulates the G2/M checkpoint arrest 
through the transcriptional activation of cell cycle inhibitors such as p21, 14-3-3σ and 
GADD45α. p21 inhibits CDK1 directly, 14-3-3σ relocates CDK1 to the cytoplasm, and GADD45α 
prevents the association between CDK1 and Cyclin B1 (Hermeking, Lengauer et al. 1997, 
Wang, Zhan et al. 1999) (Figure 1.8).  
 
 
1.2.1.5 The M phase checkpoint 
The M phase checkpoint, that is also known as the spindle assembly checkpoint (SAC), 
functions at the point in metaphase where all the chromosomes align at the mitotic equator 
under bipolar tension and attach from their centromeres to kinetochore microtubules 
extended from the poles at  either end of the cell (Lara-Gonzalez, Westhorpe et al. 2012). The 
inaccurate attachment leads to generation of daughter cells with aneuploidy. Daughter cells 
with fewer or a greater number of chromosomes may result in cell death, or the generation 
of severe genetic disorders (Kops, Weaver et al. 2005). When chromosomes are incorrectly 
attached to the spindle apparatus, the SAC is activated and maintained in an active state until 
they properly attach. The SAC prevents cells from entry into anaphase  by inhibiting the 
anaphase promoting complex/cyclosome  (APC/C), RING finger E3 ubiquitin ligase that targets 
several anaphase inhibitors for proteolysis, including securin and cyclin B1 (Joazeiro and 
Weissman 2000, Thornton and Toczyski 2003). The mechanism by which APC/C is inhibited is 
poorly understood; however, it is thought that the mitotic checkpoint complex (MCC) 
indirectly inhibits the activity of the APC/C complex by binding to the APC/C activator CDC20 
and this precludes passage into anaphase (Manchado, Eguren et al. 2010). In addition, the 
centromere protein CENP-E actives BubR1 which hinders metaphase-anaphase transition 
(Chan, Jablonski et al. 1999). When chromosomes are correctly attached to the spindles, the 
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MCC complex is disassembled in order to liberate CDC20 so that it can activate the APC/C. 
The APC/C is now free to degrade proteins containing D-box degrons, such as cyclin B1 and 
securin. Securin binds to, and inhibits, a Separase which catalyses the degradation of the 
cohesin rings that keep the two sister chromatids together; thus by ubiquitylation-mediated 
degradation of securin the sister chromatids can be separated and anaphase onset promoted 
(Yu 2002) (Figure 1.8).  
 
1.2.1.6 Senescence  
One of the most significant findings in modern cell biology was the observation that primary 
mammalian cells have a limited, very reproducible lifespan in culture under defined 
conditions (Hayflick and Moorhead 1961, Hayflick 1965). It was shown that after a certain 
number of population doublings (slightly more than 50 in the case of human foetal fibroblasts) 
the cells became quiescent and went into what was termed ‘replicative senescence’. The 
number of population doublings could vary depending on the culture conditions and the age 
of the donor. In senescence, as it is generally known, the cells are still viable and metabolically 
active but fail to go through the cell cycle or divide. Since the original observations, it has been 
demonstrated that the limitations on cell growth are due to telomere erosion (Allsopp, Vaziri 
et al. 1992). The telomeres shorten because DNA polymerase fails to duplicate the lagging 
strands totally. The telomere erosion acts as a ‘molecular clock’ determined by the number 
of cell divisions until the cells reach their ‘Hayflick limit’. When the telomeres reach a minimal 
length, the DDR is activated and DDR foci can be seen, staining positive for γH2AX, 53BP1 and 
MDC1 (di Fagagna, Reaper et al. 2003). In addition, the p53, CDC25 and the p16INK4A-Rb 
pathways are also activated, leading to cell cycle arrest. Telomeres are maintained by the 
telomerase enzyme, which is present in stem cells but is absent for human somatic cells; 
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however, primary cells can be immortalised in vitro by the expression of the telomerase 
holoenzyme, hTert (Bodnar, Ouellette et al. 1998, Vaziri and Benchimol 1998). 
Importantly, senescence can also occur before telomere shortening occurs and this has been 
termed ‘premature senescence’. A number of different events can trigger premature 
senescence, such as cellular stress induced in vitro by changes in cell culture conditions (Sherr 
and DePinho 2000) or oncogene activation (Serrano, Lin et al. 1997). It was originally shown 
that activated RAS, when expressed in primary human cells, induces cell cycle arrest and 
produces a state very similar to replicative senescence. This is in contrast to what happens 
when it is introduced into already immortalised cells or with a second co-operating oncogene 
(such as adenovirus E1A) when it gives rise to a permanently transformed cell line (Land, 
Parada et al. 1983), (Franza Jr, Maruyama et al. 1986, Serrano, Lin et al. 1997). Although the 
triggers for replicative and premature senescence are not the same, similar pathways appear 
to be affected; for example, p53 and p16INK4A –Rb are involved in both cases, at least in human 
cells. 
Senescence is always accompanied by cell cycle arrest although inactivation of the p53 
pathway is able to put cells back into cycle (Beauséjour, Krtolica et al. 2003, Dirac and 
Bernards 2003). In addition, changes in cellular morphology are very common although these 
can vary depending on the cause of senescence and the original cell type. In some cases, cells 
become larger, flatter, and multi-nucleate whereas others may become spindle- shaped 
(Kuilman, Michaloglou et al. 2010). For example, it has been reported that expression of 
mutant HRAS in melanocytes leads to premature senescence, which is accompanied by 
extensive vacuole formation (Denoyelle, Abou-Rjaily et al. 2006). This may be explained by an 
increase in the endoplasmic reticulum-mediated unfolded protein response (UPR) leading to 
increased size of the ER. This is a specific response, determined by the cell type and the 
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oncogene as it was not observed with NRAS (Denoyelle, Abou-Rjaily et al. 2006). In this case, 
premature senescence did not involve the p53 or p16INK4A pathways. Senescence is also 
accompanied by an increase in lysosomal β-galactosidase activity in the lysosomes leading to 
an increase in SA-β-GAL; this is often used as a diagnostic marker for senescent cells in vitro. 
Others features of oncogene-induced senescence include DNA damage foci, increased level 
of reactive oxygens, DNA damage, ER stress as mentioned above and activation of the 
senescence associated secretory phenotype.  
However, as mentioned above, the p53 and p16INK4A-Rb pathways are considered the main 
mediators of senescence, although other pathways may sometimes be involved. In many 
cases hypophosphorylated Rb accumulates, as does an increased level of transcriptionally 
active p53. Activation of Rb is probably due to accumulation of p16INK4A and/or p15INK4B. Links 
have been established between senescence and autophagy (see section 1.2.1.7) although the 
relationship is not clear-cut (Aguilera, Delgui et al. 2018). Some studies have suggested that 
autophagy decreases in senescent cells (Cuervo and Dice 1998, Patschan, Chen et al. 2008). 
However, more recent reports have shown that autophagy is activated during senescence 
and, similarly, inhibition of autophagy delays the onset of markers of senescence (Narita, 
Young et al. 2011). As well as undergoing cell cycle arrest, there are extensive changes in gene 
expression in senescent cells. This includes changes in the secretion of cytokines, chemokines 
and growth factors, giving rise to the senescence-associated secretory phenotype (SASP) 
(Kuilman and Peeper 2009, Coppé, Desprez et al. 2010). It has been shown that SASP factors 
can favour growth arrest or transmit the senescent phenotype to adjacent cells. SASP is not 
dependent on p53 or the p16INK4A- Rb pathway (Campisi 2013). Significantly, autophagy is 
involved in SASP through the TOR autophagy spatial coupling compartment (TASCC) (Narita, 
Young et al. 2011). It has been shown that the transcription factor GATA4 is stabilised during 
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senescence, regulating it and SASP (Kang, Xu et al. 2015). Normally GATA4 is degraded during 
autophagy but this degradation is inhibited during senescence leading to increased levels of 
GATA4, which can go on to activate NFκ-B, initiating SASP and senescence (Kang, Xu et al. 
2015). GATA4 activity is not dependent on p53 or p16-Rb but is regulated by the DDR (Kang, 
Xu et al. 2015). The senescence-associated secretory phenotype can also contribute to 
tumourigenesis as well as being anti-tumourigenic. A large number of studies have shown 
that ligands and proteins secreted by senescent cells can encourage tumour development in 
vivo and proliferation in vitro (Coppé, Desprez et al. 2010). The specific factors involved vary 
from tissue to tissue and cell type to cell type. Furthermore, senescent cells will secrete 
factors which lead to cell migration and invasion angiogenesis and metastasis in vivo (Coppe 
et al. 2010; Sun et al. 2018). The majority of studies of senescence have used primary cells; 
therefore, how much of this description applies to tumour cell lines, which are commonly 
used for laboratory-based cell biology studies, is not clear. However, it seems likely that many 
of relationships still apply although this has not been confirmed in some cases. 
 
1.2.1.7 Autophagy 
The phenomenon of autophagy has been recognised for well over half a century. Its most 
obvious phenotype in mammalian cells is the presence of large vacuoles present in the 
cytoplasm of autophagic cells (De Duve and Wattiaux 1966, Ericsson 1969). The mechanism 
by which this occurs was unclear until a detailed analysis of autophagy in yeast was published 
throughout the 1990s (Klionsky and Ohsumi 1999). It was shown that autophagy was 
dependent on a complex pathway comprising a set of Apg proteins (later termed ATG 
proteins), of which approximately 35 have been confirmed in yeast (Nakatogawa, Suzuki et 
al. 2009). Orthologues were later shown to be present in mammalian cells (Hammond, Brunet 
INTRODUCTION 
50 
 
et al. 1998, Mizushima, Yoshimori et al. 2011). It is now clear that autophagy is a process 
ubiquitous in eukaryotes.  
During macroautophagy (usually just termed autophagy) small areas of the cytoplasm are 
isolated with a membrane, resulting in the formation of the autophagosome. The 
autophagosome matures and fuses with the endosomes and then with lysosomes.  Lysosomal 
enzymes hydrolyse the enclosed macromolecules to produce smaller building blocks, such as 
amino acids. Autophagy may also be involved in the breakdown of organelles such as 
mitochondria. In general, autophagy can be seen as a response to cellular stress and adverse 
conditions. Following starvation, it is used to generate amino acids from degraded proteins; 
it is also used to control the levels of various substrates, to degrade pathogens and in the 
monitoring of organelles and proteins. 
Autophagosomes form transiently, often with a half-life of a few minutes before they fuse 
with lysosomes. The autophagosome membrane appears to originate in the pre-
autophagosomal structure/phagophore assembly site (PAS) which is located in a particular 
site in the ER. The formation of the membrane structures involves a number of pathways, 
some of which are still unclear. However, it is known that several autophagic protein 
complexes are required for formation of the PAS. These include the ULK protein kinase 
complex (FIP200/ULK1/ATG13/ATG101), the Class III PI3K complex (ATG14/Beclin-
1/P150/VPS34), the ATG12 ubiquitin ligase-like complex (ATG12, ATG7, ATG10, ATG16, ATG5) 
and the ATG8/LC3 conjugation system (ATG8/LC3/ATG3ATG4/ATG7) (Mizushima, Yoshimori 
et al. 2011, Rubinsztein, Shpilka et al. 2012). After maturation, the autophagosome fuses with 
the endolysosome. Proteins required for this include syntaxin-17, SNAP29 and VAMPS, which 
are SNARE proteins and the HOPS complex (Itakura, Kishi-Itakura et al. 2012). 
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During selective autophagy, the ATG8 family complex interacts with a variety of proteins such 
as ATG19, ATG32 and p62/SQSTM1 (the neighbour of the BRCA1 gene) and incorporate them 
into autophagosomes (Lamark, Svenning et al. 2017). It has been suggested that that this is 
part of the targeting mechanism for the PAS or autophagosome formation site (Mizushima, 
Yoshimori et al. 2011). Thus, p62/SQSTM1 is an autophagy receptor that connects selected 
cargo to ATG8 adaptors on the inside of the growing phagophore. Several other autophagy 
receptors, such as NBR1, BNIP3 and TAX1BP1, have been characterised (Lamark, Svenning et 
al. 2017). Under normal circumstances, levels of autophagy receptors remain low due to rapid 
degradation. In response to stress, particularly that due to oxidation, p62 is up regulated by 
NRF2 via an ARE in its promoter. p62 also contributes to the stabilisation of NRF2, forming  a 
positive feedback loop (Komatsu, Kurokawa et al. 2010). 
 
1.3 DNA Replication 
Preparation, initiation, progression and completion of DNA replication is controlled by the cell 
cycle. Correct DNA replication is essential in order to preserve genome integrity. 
 
1.3.1 DNA origin licencing and activation 
The generation of DNA replication components, such as the synthesis of histones, dNTPs and 
the pre-replication complex (pre- RC) occurs exclusively in G1. DNA replication is licenced 
during the late phase of mitosis and continues through to the G1 phase (Fragkos, Ganier et 
al. 2015). The pre-RC consists of the hexameric origin recognition complex proteins 1-6 (ORC1-
6), cell division cycle 6 (Cdc6), cell division cycle 10-dependent transcript 1 (Cdt1) and the 
inactive mini chromosome maintenance (MCM) helicase complex (a hexamer consisting of 
the six subunits MCM2-7) (Fragkos, Ganier et al. 2015). To ensure DNA re-replication is 
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suppressed during S phase, cells employ two non-overlapping mechanisms. Prior to S phase, 
origins are licensed by recruitment of the pre-RC to chromatin. During S phase, these are 
activated by the subsequent association of Cdc45 and MCM10 with the pre-RC complex, 
which then binds to GINS to form the active CMG (Cdc45-MCM-GINS) replicative helicase 
(Moyer, Lewis et al. 2006). In addition, downregulation or inhibition of licensing proteins prior 
to early S phase would mean that no more origin sites can be licensed (Li and Blow 2005). For 
example, the recruitment of the MCM complex to chromatin by Cdt1 during S and G2 phases 
is disrupted once the replication inhibitor geminin (GMNN) binds to Cdt1 (Wohlschlegel, 
Dwyer et al. 2000). Moreover, in response to replication stress during S phase two kinases, 
ATR and Chk1, also inhibit DNA origin re-licencing. ATR phosphorylates MLL at Ser-516, which 
disrupts its association with, and thereby its degradation by, the SCF (Skp2) E3 ligase, leading 
to its accumulation and stabilization on chromatin. Stabilised MLL methylates histone H3K4 
and hinders CDC45 binding to origins during checkpoint activation, blocking origin firing (Liu, 
Takeda et al. 2010). In addition, the ATR-Chk1 pathway limits origin firing by restricting CDK2 
activity in cyclin E/CDK2 and cyclin A/CDK2 complexes; this normally marks the G1/S phase 
transition where origin firing is initiated (Buisson, Boisvert et al. 2015). Formation of the pre-
RC and CMG replicative helicase promotes separation of the inactive MCM2–7 
double hexamer into two active single MCM hexamers and the phosphorylation-dependent 
binding of multiple replication proteins, such as TOPBP1, RECQL4 and MTBP onto origins 
(Fragkos, Ganier et al. 2015). 
The active MCM helicase unwinds the helix at DNA origins to form a replication fork. The 
recruitment of the rest of the replication machinery, such as RFC, PCNA, RPA, TIPIN-TIMELESS-
CLAPSIN, and the DNA polymerases α, ε and δ behind the active helicase leads to the 
formation of the replisome that moves bi-directionally from the activated origin (Masai, 
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Matsumoto et al. 2010). DNA replication initiates with synthesis of a short RNA segment by 
the primase subunit of Pol α and this is elongated by Pol ε and δ. Due to the 5’ to 3’ polarity 
of DNA synthesis, DNA replication occurs only in one direction as the CMG helicase moves in 
a 3’->5’ direction. This continuously synthesised strand is the leading strand. The other strand, 
named the lagging strand, is made as short discontinuous fragments of nascent strands of 
DNA, and these are termed Okazaki fragments. The lagging strand DNA polymerase begins 
the replication of Okazaki fragments in the opposite direction to the helicase. The synthesis 
of the lagging strand is slower as it needs to wait for the leading strand to expose 
the template strand that is used for the Okazaki fragment synthesis (Alberts, Johnson et al. 
2002). During maturation of Okazaki fragment, Pol δ displaces the RNA primer associated with 
the preceding Okazaki fragment into a 5′ flap. Structure-specific nucleases, DNA2 (the long 
flaps) or FEN1 (the short flaps), identify the displaced flap, bind to the flap and resolve it. 
Association of Pol δ with the 5′–3′ helicase Pif1 increases flap formation in the downstream 
Okazaki fragment, generating a longer 5′ flap. The long flaps (>22 nt in length) are coated by 
RPA and become resistant to FEN1 endonuclease activity. Therefore, the action of DNA2 
nuclease is required for proper cleavage of RPA-bound flaps. DNA2 removes RPA and cuts the 
flap at different sites leaving a shorter product of ∼ 5–6 nt in length, which is removed by 
FEN1 to create a nick, before being ligated by DNA ligase I (LIG1)  (Balakrishnan and Bambara 
2013)  (Figure 1.9). Once DNA replication is complete, the replisomes disassemble from the 
DNA to allow the genome to be replicated once per cell cycle, thus avoiding interference with 
other chromatin-based processes such as transcription, DNA repair or the next round of 
replication. 
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Figure 1.9 A schematic diagram showing maturation of Okazaki fragment in two pathways. 
Right panel shows the mechanism of long flap removal; Pif1 contributes to generation of a 
longer 5’ flap in the downstream Okazaki fragment. DNA2 cleaves the RPA-bound flaps and 
leaves a shorter flap of ∼ 5–6 nt length, which is removed by FEN1. Left panel shows the 
mechanism of short flap removal by FEN1. A terminal nick generated by FEN1 is ligated by 
DNA ligase I (LIG1). Obtained from (Balakrishnan and Bambara 2013). This article is published 
under an open access license (published material can be re-used without obtaining permission 
as long as a correct citation to the original publication is given). 
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1.3.2 DNA replication stress response 
Replication stress (RS) can refer to any deviation in the process, coordination and timing of 
DNA synthesis. To avoid genome instability, several surveillance pathways have evolved to 
deal with RS. Central to these genome surveillance pathways is the ATR/Chk1 axis. In 
response to a wide range of DNA damage, such as SSBs and bulky lesions, ATR is activated 
and, together with its primary substrate kinase Chk1, it controls different signalling cascades, 
including cell cycle checkpoint activation, DNA damage repair induction, and regulation of 
origin firing and stabilization of replication forks. Although ATR and Chk1 have long 
been considered to function in the same kinase cascade Buisson, Boisvert et al showed that 
DNA-PK can also phosphorylate Chk1 to provide a backup pathway inhibiting origin firing in 
ATRi-treated cells.  
 
1.3.3 Activation of the ATR/Chk1 pathway and fork stabilization 
The uncoupling of DNA replication from the replicative CMG helicase during fork stalling can 
lead to increased RPA-coated ssDNA formation, which, in turn, activates the ATR recruitment 
via its binding partner ATRIP (Cortez, Guntuku et al. 2001). RAD17-RFC clamp loader interacts 
with RPA and recruits a RAD9-RAD1-HUS1 (9-1-1) clamp complex onto 5’ ends adjacent to the 
region of RPA-coated ssDNA. The 9-1-1 complex is required for loading of TOPBP1 which 
induces a large increase in ATR-ATRIP kinase activity, enabling it to phosphorylate numerous 
downstream targets including its effector kinase Chk1 (Saldivar, Cortez et al. 2017). ETAA1 
has  recently  been recognised as a novel RPA-binding protein that activates ATR in line with 
TOBP1/RAD17/9-1-1 and functions at stalled replication forks (Bass, Luzwick et al. 2016). The 
other protein complexes at replication forks that regulate the activation of Chk1 by ATR are 
Clapsin and TIPIN-TIMELESS (Yang and Zou 2009). Recently, a replication factor, DONSON, has 
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been shown to contribute to the efficient functioning of the ATR / Chk1 pathway (Reynolds, 
Bicknell et al. 2017) (Figure 1.10). 
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Figure 1.10 A schematic diagram showing ATR-mediated fork stabilization. 
Replication stress induces RPA-coated ssDNA, which is identified and captured by the ATR-
ATRIP complex. This is followed by recruitment of the 9-1-1 complex in an RCF–dependent 
manner. ETAA1 is recruited directly to RPA-coated ssDNA. Activation of ATR kinase activity 
depends on the recruitment of the other mediators, such as ETAA1 and TOBP1. ATR 
phosphorylates Clapsin, which together with another replication factor Tipin-Timeless 
mediates the phosphorylation of Chk1 by ATR. Chk1, downstream of ATR, phosphorylates key 
targets preventing aberrant or excessive replication firing and cell cycle arrest. Modified from 
(Thomas 2013). This article is published under an open access license (published material can 
be re-used without obtaining permission as long as a correct citation to the original 
publication is given). 
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Chk1, downstream of ATR, mediates phosphorylation of the CDC25A preventing aberrant or 
excessive replication firing during unperturbed S phase. This is achieved through the 
downregulation of CDK2, in association with cyclin E or A, and Cdc7 in a complex with Dbf4 
(Sørensen, Syljuåsen et al. 2004). Chk1 prevents firing of dormant origins by blocking the 
interaction between Treslin and TOBP1 which inhibits the assembly of the CMG (Cdc45-MCM-
GINS) replicative helicase (Boos, Sanchez-Pulido et al. 2011). Future 
research will be needed to identify the exact mechanisms by which the ATR/Chk1 pathway 
can supress new origin firing during replication. Chk1 also phosphorylates CDC25B and 
CDC25C, preventing entry into mitosis (Schmitt, Boutros et al. 2006). In addition to Chk1, 
phosphorylation of many more checkpoints proteins such as H2AX, BRCA1, RAD17, RPA2, 
SMC1, Clapsin, FAND2 and p53 are ATR-dependent  (Petermann and Caldecott 2006). In 
response to replication blocks, ATR also mediates Rad51 recruitment (Zellweger, Dalcher et 
al. 2015) and FANCD2 monoubiquitination (Andreassen, D'Andrea et al. 2004).  
 
1.3.4 Replication forks reversal 
Two steps can be envisaged for the replication fork reversal (RFR) model: firstly, remodelling 
of the fork to form a four-stranded DNA structure, reminiscent of Holliday junction-like (HJL) 
structures. This can occur through the separation of two newly synthesised leading and 
lagging strands from their parental strands and their annealing to each other, simultaneously 
with the two template strands also re-annealing; secondly, restart of the reversed fork 
structure, also referred to as regressed forks or  ‘chicken foot’ structures (Postow, Ullsperger 
et al. 2001). The template switching involved in regression may facilitate excision repair of 
unrepaired DNA lesions that exist on the template strand by relocation of the DNA damage 
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into the double-stranded region of the DNA; this allows the conventional excision repair 
mechanism enough time to repair the damage correctly. This process may also provide an 
error-free alternative to translesion synthesis,  using newly synthesised strands as a template 
for DNA replication through template switching in order to bypass a DNA lesion on the 
parental strand (Higgins, Kato et al. 1976). Finally, unwinding and pairing of newly synthesised 
strands limits the extent of exposed ssDNA, ensuring fork stabilisation. The first fork reversal 
model in higher eukaryotes in vivo was suggested by (Chaudhuri, Hashimoto et al. 2012). They 
have shown that TOP1 poisoning by CPT causes an immediate induction of replication-fork 
slowing and PARP1-mediated fork reversal, which can be independent from DSB formation, 
at sub-lethal inhibitor doses. Further work from this group showed that PARP1 stabilises 
regressed forks following CPT-mediated TOP1 inhibition by limiting restart activity of the 
RECQ1 helicase (Berti, Chaudhuri et al. 2013). Another piece of supporting evidence showed 
that DNA2 in collaboration with WRN promotes replication fork restart by degradation of the 
‘fourth arm’ of the reversed fork (Thangavel, Berti et al. 2015). In addition, Rad51 has been 
shown to be pivotal in the conversion of single stranded DNA into reversed forks in response 
to TOP inhibitors, nucleotide depletion  or inter-strand crosslinks (Zellweger, Dalcher et al. 
2015). Fork reversal mechanisms assist DNA replication, not only when faced  with topological 
stress, induced by TOP1 inhibitors but they also limit the damage associated with DNA 
synthesis inhibitors, inter-strand cross-linking inducers and alkylating agents (Zellweger, 
Dalcher et al. 2015). A wide range of proteins with fork remodelling activities has been implicated 
in fork restart. DNA helicases BLM and WRN, which are both substrates of ATM, contribute to 
resolution of replication intermediates (Ralf, Hickson et al. 2006) (Bétous, Glick et al. 2013). The 
Fanconi Anaemia DNA helicase FANCM and its working partners FANCJ and FANCD2 (in 
corporation with CtIP) generate an effective fork recovery mechanism in response to replication 
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stress (Gari, Décaillet et al. 2008). This occurs  in conjunction with three members of the SWI/SNF-
related family helicases (SMARCAL1, ZRANB3 and RAD54)  (Bétous, Mason et al. 2012), (Bugreev, 
Rossi et al. 2010, Vujanovic, Krietsch et al. 2017), and FBH1 (Fugger, Mistrik et al. 2015). In 
particular, SMARCAL1, which is regulated by the activity of PARP1, through its replication protein 
A (RPA)-binding motif, binds to RPA-coated ssDNA and catalyses the processing and remodelling 
of perturbed replication forks (Bansbach, Bétous et al. 2009). DNA translocase ZRANB3 
participates in the fork reversal process, this requires an interaction with polyubiquitinated PCNA 
(Vujanovic, Krietsch et al. 2017). The human RecQ homologue, RECQ1, has also been shown in 
vivo to be involved in restoration of TOP1 inhibitors-associated reversed forks to their original 
three-armed configuration (Gari, Décaillet et al. 2008). 
 Various restart pathways, such as re-priming, homologous recombination (HR), template 
switching, TLS and DSB-mediated restart mechanisms may function at stalled forks to allow restart 
of DNA replication (Figure 1.11).  
 
1.3.4.1 Fork restart via re-priming 
The DNA replication machinery may bypass DNA damage, leaving an un-replicated gap to be 
repaired by post replication repair (PRR).  PrimPol, a recently characterised human primase, 
and TLS polymerase mediate post-replicative gap repair. PrimPol synthesises short 
RNA/DNA primers on leading and lagging strands downstream of the lesion, which are 
extended later by replicative DNA polymerases ϵ and δ. In fact, repriming activity of PrimPol 
is critical for DNA replication restart (Kobayashi, Guilliam et al. 2016). Unlike the other TLS 
polymerases, such as Rev 1 and Pol η the recruitment of PrimPol to DNA is not suppressed in 
the presence of ATR and Chk1 inhibitors (Mourón, Rodriguez-Acebes et al. 2013)(Figure 1.11). 
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1.3.4.2 Fork restart via homologous recombination 
HR-mediated fork restart functionally differs from HR-mediated DSB repair. HR-mediated fork 
restart promotes the repair of post-replicative ssDNA gaps through DNA-end resection 
machinery. An initial short-range resection (in the region of∼100–150 bp) is catalysed by the 
Mre11/Rad50/Nbs1 (MRN) complex and CtIP followed by a long-range resection of DSBs 
mediated by the DNA nucleases EXO1 or DNA2, generating larger ssDNA regions of up to 1KB 
which facilitates loading of the HR factor Rad51. Rad51 promotes the 3’ overhang invasion 
into the homologous sister chromatids, priming DNA synthesis followed by restoration of 
replication forks through endonucleolytic resolution of the recombination D-loop 
intermediates. HR proteins, such as RAD51, BRCA2/PALB2, BRAC1, and the RAD51 paralogue 
XRCC3, have been reported to be crucial for maintaining replication fork stability and restart 
(Petermann, Orta et al. 2010, Zellweger, Dalcher et al. 2015). BRCA2 protects nascent DNA from 
Mre11-dependent DNA resection at stalled forks and also promotes Rad51 loading and 
filament formation during replication restart (Hashimoto, Chaudhuri et al. 2010) (Figure 1.11). 
 
1.3.4.3 Fork restart via double-strand break formation 
Prolonged fork stalling can lead to the collapse of forks into DSBs, predominately formed by 
structure-specific nucleases MUS81-EME1, XPF-ERCC1, SLX4 or EXO1 in particular regions of 
the genome called common fragile sites (CFSs) which are difficult-to-replicate loci. The stalled 
fork is cleaved by MUS81–EME1 during the G2-phase of the cycle (Forment, Blasius et al. 
2011). The entry of cells with un-replicated CFSs into mitotic prophase promotes the 
recruitment of Rad52 and POLD3-dependent DNA synthesis at the sites and, with the help of 
SLX4-MUS81, facilitates mitotic DNA synthesis (MiDAS) (Minocherhomji, Ying et al. 2015, 
Sotiriou, Kamileri et al. 2016). In addition, recruitment of the RECQ5 helicase by MUS81 
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promotes Rad51 filament removal from stalled forks to allow DSB formation by MUS81-EME1 
and MiDAS formation (Di Marco, Hasanova et al. 2017). MiDAS protects CFSs from an 
extended mis-segregation and non-disjunction during anaphase. In fact, these studies have 
shown that the lack of MiDAS promotes the appearance of 53BP1 bodies, anaphase bridges 
and chromosomal rearrangements, acceleration of tumour growth and increased 
vulnerability to aphidicolin (Figure 1.11).  
The details of Translesion synthesis (TLS) and template switching (fork reversal) mechanisms 
are described elsewhere in this chapter in sections 1.4.1 and 1.3.4, respectively. 
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Figure 1.11 The repair of a stalled fork. 
When DNA polymerase collides with an obstacle in its path, the replisome is backtracked and 
the CMG complex unwinds DNA ahead of the stalled fork leaving ssDNA behind. 
Stalled replication forks can restart DNA replication by different mechanisms such as 
translesion synthesis, template switching, repriming, break-induced replication, or 
homologous recombination. If this fails, MUS81- EME1 dependent cleavage of stalled forks is 
required during G2-phase before entry into metaphase. In metaphase, Rad52, POLD3, and 
MUS81–SLX4 collaborate to perform mitotic DNA synthesis (MiDAS). In anaphase, lack of 
MiDAS during chromosomal separation can lead to formation of ultra-fine anaphase bridges 
(UFBs) at the CFSs, which will be manifested as micronuclei or 53BP1 bodies in the daughter 
cells. Obtained from (Kotsantis, Petermann et al. 2018). This article is published under an open 
INTRODUCTION 
64 
 
access license (published material can be re-used without obtaining permission as long as a 
correct citation to the original publication is given). 
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1.3.5 Oncogene-induced replication stress  
As aforementioned, DNA replication stress can refer to any deviation in the process, 
coordination and timing of DNA synthesis. Oncogene-induced replication stress (OIS) is 
generally attributed  to aberrant origin firing, replication–transcription conflicts (TRC), 
reactive oxygen species (ROS), or defective nucleotide metabolism (Kotsantis, Petermann et 
al. 2018). 
Oncogenes impede replication fork progression through dysregulation of origin firing by 
promoting either increase or decrease or re-firing of the same origin. Therefore, cells will 
enter mitosis with incompletely replicated or over-replicated regions that may cause genome 
instability (GIN). Interestingly, the level of origin firing  is  inversely correlated to the number 
of active forks which, in turn, alters the availability of essential replication factors such as the 
replication machinery itself, nucleotide supply, histones and histone deposition machinery 
(Zhong, Nellimoottil et al. 2013). Oncogenes may hinder the timing of origin firing by causing 
unscheduled S-phase entry with limited replication factors or by allowing insufficient time for 
loading of the replication origins (Bester, Roniger et al. 2011). For example, a hyper-
proliferative phase has been shown to occur immediately after induction of activated RAS and 
this is accompanied by increased origin firing, leading to replication stress (Di Micco, Fumagalli 
et al. 2006). It seems that the overexpression of cyclin E has a dual influence on pre-replication 
complex (pre-RC) formation. In one report it has been shown that cyclin E induction inhibits 
MCM2, 4 and 7 recruitment onto chromatin during telophase and early G1, which contributes 
to a reduced number of active origins in early S-phase (Ekholm-Reed, Méndez et al. 2004). On 
the other hand, other groups have shown that overexpression of cyclin E elevates origin firing 
in S-phase (Bester, Roniger et al. 2011, Jones, Mortusewicz et al. 2013). This inconsistency 
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could be as a result of different properties of the cell lines used in the studies although it is 
possible that both explanations are valid.  
A growing body of evidence suggests that OIS is also linked to deregulated transcriptional 
activity, although the molecular mechanism by which oncogenes contribute to replication 
stress and genome instability has not been completely elucidated. It has been frequently 
reported that replication stress is induced in vitro following overexpression of oncogenes such 
as MOS, c-MYC, RAS, HPV-16 E6/E7, CDC25A and Cyclin E (Bartkova, Rezaei et al. 2006, Di 
Micco, Fumagalli et al. 2006, Dominguez-Sola, Ying et al. 2007, Bester, Roniger et al. 2011, 
Jones, Mortusewicz et al. 2013, Kotsantis, Silva et al. 2016). 
The general transcription factor, TATA-box binding protein (TBP), is upregulated following 
increased global RNA synthesis in response to overexpression of HRAS V12-induced 
replication stress (Kotsantis, Silva et al. 2016). (Jones, Mortusewicz et al. 2013) showed that 
cyclin E-induced replication stress is due to increased levels of transcription, which, together 
with R-loop accumulation, gives rise to replication fork slowing and genome instability. These 
authors have shown that treatment with the CDC7/CDK9 dual inhibitor PHA-767491, which 
inhibits both origin firing and transcription elongation through effects on CDC7 and CDK9 
respectively, could rescue cyclin E-induced replication stress. Similarly, an increase in co-
transcriptional R-loop formation in estrogen (E2) receptor-positive breast epithelial cells has 
been identified as a source of E2-induced DSBs (Stork, Bocek et al. 2016). Induction of RAS-
associated transcription activity also occurs following activation of mitogen-activated protein 
kinase extracellular single-regulated kinase (ERK), which activates several transcription 
factors, such as TIFIA (RRN3), UBTF, TIFIIIB (BRF1) and TBP (Johnson, Mandavia et al. 2000, 
Zhao, Yuan et al. 2003). Similarly, overexpression of c-MYC stimulates the universal 
INTRODUCTION 
67 
 
amplification of gene expression by all three RNA polymerases  (Lin, Lovén et al. 2012, Nie, 
Hu et al. 2012). 
These data indicate that deregulated transcription could be a source of tumorigenesis in pre-
cancerous lesions, as mentioned above, by compromising the stability of the genome. This 
hypothesis is supported by a report from (Hatchi, Skourti-Stathaki et al. 2015) showing that 
SETX is recruited at termination regions (TRs)  of actively transcribed genes, in a BRCA1-
dependent manner,   to inhibit formation of R-loop-driven DNA damage. RNA export factor 
TREX2 regulates recruitment of BRCA2 to the ssDNA generated at the RNA Pol II pausing sites 
to avoid formation of R-loops (Bhatia, Barroso et al. 2014). The Fanconi Anaemia pathway has 
also been reported to be involved in the repair of R-loops generated by transcription 
replication collisions and this action requires the branch migration activity of FANCM 
(Schwab, Nieminuszczy et al. 2015).  
Replication fork progression can be disrupted as a result of transcription–replication conflicts 
(TRC). Conflicts include head-on or co-directional collisions between two machines or 
between replisomes and R-loops (Lin and Pasero 2012) (Figure 1.12). In head-on conflicts, R-
loop formation is elevated leading to activation of the ATR/Chk1 pathway. In contrast, co-
directional collisions promote R-loop resolution and activation of the ATM/Chk2 pathway 
following DSB formation (Hamperl, Bocek et al. 2017). In fact, co-directional collisions have 
little effect on replication fork progression compared to the head-on collisions with respect 
to fork slowing (Prado and Aguilera 2005). Head-on movement of both replication and 
transcription machineries can increase the development of positive torsional stress in front 
of them, which needs to be relaxed by topoisomerases.  While the two events progress 
towards each other the newly produced transcripts may be trapped in the nuclear pore 
complex (NPC) producing obstacles to fork progression (Kotsantis, Petermann et al. 2018). 
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Interestingly, the CCR4-NOT complex participates in mRNA export and nuclear quality control 
by interactions with Mlp1, present in the inner basket of the NPC (Libri, Dower et al. 2002). 
R-loops can either increase chromatin compaction, marked by H3 phosphorylation at Ser-10, 
or can modulate formation of G-quadruplexes (G4) which, in turn, can facilitate R-loop 
stabilization (Abraham, Chan et al. 2016). Formation of G4 structures within promoters of 
highly transcribed genes such as c-MYC (Siddiqui-Jain, Grand et al. 2002) or KRAS (Cogoi and 
Xodo 2006) plays an important role in regulation of gene expression. Taken together, these 
data indicate that oncogene-dependent transcription-replication encounters contribute to 
replication stress.    
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Figure 1.12 Transcription-dependent replication stress. 
A) Upon head-on encounters between transcription and replication machineries, R-loop 
formation is elevated leading to activation of the ATR / Chk1 pathway. B) Co-directional TRC 
decreases R-loop structures, which leads to activation of the ATM / Chk2 pathway following 
DSB formation. C) RNA Poll can be stalled or backtracked once it encounters an obstacle during 
elongation. D) RNA Poll can also pause or backtrack when confronted with an R-loop. In both 
cases, this will cause a queue of stalled or backtracked RNA Poll that impedes fork progression. 
E) Head-on collision of both replication and transcription machineries can also increase the 
development of positive torsional stress in front of them, which hinders progression of both 
events. F) While two events progress towards one another, the long nascent RNA may be 
trapped in the nuclear pore complex (NPC) producing obstacles to fork progression. G) and H) 
R-loops can either increase chromatin compaction, marked by H3 phosphorylation at Ser-10, 
or modulate formation of G-quadruplexes (G4); both of these inhibit fork progression Obtained 
from (Kotsantis, Petermann et al. 2018). This article is published under an open access license 
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(published material can be re-used without obtaining permission as long as a correct citation 
to the original publication is given). 
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The building blocks of DNA are nucleotides and a ready supply is critical for the maintenance 
of genome stability; therefore, any changes in their structure or level has an immediate effect 
on fork progression (Figure 1.13). The metabolism of nucleotides can be altered during  
oncogenesis; for example, the binding of Bcl2 to RRM2 disrupts the activity of the RNR 
complex leading to depletion of the dNTP pool and retardation of DNA replication (Xie, Yen 
et al. 2014). In addition, induction of RAS downregulates RRM2 through binding of the 
transcription repressor E2F7 to the start site of RRM2, causing exhaustion of the dNTP pool 
and eventually RAS-induced senescence (Aird, Zhang et al. 2013). Inhibition of ATR or Chk1 
induces replication stress and synthetic lethality in conjunction with the action of the 
oncogenes cyclin E (Toledo, Murga et al. 2011), c-MYC (Schoppy, Ragland et al. 2012) and 
H/KRAS (Gilad, Nabet et al. 2010). Suppression of Chk1 increases CDK-dependent origin firing, 
reducing dNTP supply. This causes fork slowing and induction of excess ssDNA that is coated 
by RPA in an ATR-dependent manner. Therefore, following inhibition of ATR this protective 
signal is disrupted, leading to senescence as a response to oncogenic stress (Gilad, Nabet et 
al. 2010). In contrast, c-MYC upregulates genes involved in nucleotide biosynthesis, increasing 
dNTP pools and enabling/enhancing cell proliferation (Mannava, Grachtchouk et al. 2008). 
Reduction in dNTP supply increases the level of rNTP mis-incorporation by DNA polymerases. 
Since rNTP are more susceptible to hydrolysis than dNTPs, their incorporation into DNA will 
affect fork progression and may cause GIN. It is likely that oncogene-associated rNTP mis-
incorporation occurs during hyperproliferation, following induction of oncogene expression 
(Kotsantis, Petermann et al. 2018). Oncogene-induced reactive oxygen species (ROS) appear 
to oxidise nucleotides that, when used by DNA polymerases, can initiate fork slowing, breaks 
and mutations in the DNA and senescence (Rai, Onder et al. 2009). 8-oxoG, which is a major 
oxidative DNA lesion, is found at elevated levels in senescent cells as a result of RAS induction 
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(Homma, Tsunoda et al. 1994, Rai, Onder et al. 2009). In addition, (Rai, Onder et al. 2009)  
showed that overexpression of MTH1, which hydrolyses oxidised dNTPs, can prevent the 
onset of markers of senescence, such as elevated levels of p21(Cip1), p53, and p16(INK4A), thus 
preserving genomic integrity. It seems that 8-oxo-dGTP-associated delayed DNA synthesis is 
due to a decreased rate of chain elongation. This delay is offset following treatment with 
Staurosporine, a protein kinase C inhibitor (Kai, Matsunaga et al. 2002).  
Different oncogenes utilise different mechanisms for induction of replication stress. For 
instance: the oncogenes RAS and cyclin E create a unique ‘fragility landscape’ that varies from 
the fragile sites induced by the replication inhibitor aphidicolin (Miron, Golan-Lev et al. 
2015).Furthermore, dysregulation of cyclin E causes chromosomal instability (CIN) in human 
cells, which is not seen after induction of cyclins A or D1 (Spruck, Won et al. 1999). 
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Figure 1.13 The molecular mechanisms of oncogene action in nucleotide metabolism and 
aberrant DNA replication. 
Formation of dNTPs is performed either through the de novo pathway from glutamine, 
glycine, folic acid, aspartate, 5-phosphoribosyl-1-pyrophosphate or through the salvage route 
by turnover of nucleotides (recycling pathway). The RNR reductase complex catalyses the 
conversion of NTPs to dNTPs. Oncogenes may affect fork progression by inhibiting the activity 
of the RNR complex or by causing aberrant cell proliferation that will reduce the dNTP supply. 
Moreover, oncogene overexpression contributes to ROS induction, including the production of 
O2ˉ, H2O2 and OH radicals. O2ˉ is generated either by oxidation of NADPH by NOX enzymes or 
through mitochondrial respiration. Superoxide dismutase (SOD) catalyses the conversion of 
O2ˉ to H2O2. In the presence of Fe2+, OH radicals can be formed from H2O2. Obtained from 
(Kotsantis, Petermann et al. 2018). This article is published under an open access license 
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(published material can be re-used without obtaining permission as long as a correct citation 
to the original publication is given). 
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1.4 Transcription-induced stress response 
1.4.1 Repair of Intra-strand crosslinks (ICLs) and DNA bulky adducts  
RNA Pol II senses DNA lesions or epigenetic modifications: in particular, intra-strand 
crosslinks (ICLs) such as UV-induced pyrimidine dimers (CPDs) and DNA bulky adducts, such 
as those produced by cisplatin and MMC (Shin, Xu et al. 2017). The ways in which RNA Pol 
II stalls at these different DNA lesions varies. For example, cisplatin-induced DNA bulky 
adducts prevent the lesion from entering the RNA Pol II active site whereas UV-induced 
CPDs can enter the active site; subsequent stalling is then dependent on which 
ribonucleotide is incorporated into the nascent RNA complementary to the damaged DNA 
template.  RNA Pol II preferentially incorporates adenine across from these sites, which is 
error-free and will not arrest RNA Pol II. However, the CPD 5'-thymine leads to uridine mis-
incorporation into mRNA, which blocks RNA Pol II progression (Brueckner, Hennecke et al. 
2007). These DNA lesions not only shut down transcript production but can also arrest DNA 
replication fork progression; both of these carry the threat to genome stability (Muniandy, 
Thapa et al. 2009). 
 Nucleotide excision repair (NER) is predominantly invoked in response to UV-induced DNA 
damage (Rastogi, Kumar et al. 2010). The NER pathway may be divided into two subtypes; 
global genomic NER (GG-NER), and transcription coupled NER (TC-NER). The GG-NER 
pathway is involved in repair of lesions in the entire genome, including un-transcribed 
regions and silent DNA strands; while transcription coupled NER (TC-NER) triggers a 
transcription-dependent genome repair pathway (Sugitani, Sivley et al. 2016). Various 
forms of DNA damage are recognised by two different sets of proteins, appropriate for each 
pathway. However, after damage recognition, the two subtypes have the same steps of dual 
incision, repair, and ligation. The lesion site on the non-transcribed strand is detected by 
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the global GG-NER structure-specific recognition complex of XPC, RAD23B and CENTN2 
(Marteijn, Lans et al. 2014). In addition, the DDB1-DDB2 (XPE) complex binds to DNA lesions 
to stabilise XPC association to the lesion site. After initial lesion- recognition, the remaining 
NER cascade triggers DNA double helix unwinding by the two helicase subunits of the 
transcription factor TFIIH, XPB and XPD, around the damaged site. TFIIH recruits XPA and 
RPA, which subsequently activate XPF-ERCC1 and XPG (a 5’ endonuclease and 3’ 
endonuclease, respectively) to incise a 22-30 nucleotide long DNA strand containing the 
damage site (Figure 1.14).  
In contrast, on the transcribed strand during elongation, the lesion site is recognised by RNA 
polymerase II itself, which becomes arrested at the site.  Stalled RNA Pol II directly recruits 
CSB at the site of damage and forms a complex with UVSSA and USP7 followed by 
recruitment of CSA (Nakazawa, Sasaki et al. 2012). Indeed, TC-NER has been involved in two 
activities: firstly, backtrack of the arrested RNA Pol II in order to provide accessibility for the 
downstream NER repair components to the DNA lesion and, secondly, removal of a strong 
signal for apoptosis (Ljungman and Zhang 1996), (Fousteri and Mullenders 2008, Stubbert, 
Smith et al. 2010). 
Following unhooking of the DNA lesion, the gap is filled by DNA polymerases and ligases 
(Deans and West 2011). A bypass platform is supported by binding of ubiquitinated PCNA 
to translesion DNA synthesis (TLS) polymerases such as Rev 1, Pol ζ, Pol κ and Pol ε (Godon, 
Mourgues et al. 2012) (Figure 1.13). (Zafar, Ketkar et al. 2014) have also reported PrimPol-
mediated re-priming and elongation of nascent DNA accurately downstream of the DNA 
lesion. Repair of ICLs or DNA adducts in the G1 and S phases of the cell cycle may use 
different mechanisms. In G1, bypass repair is carried out by TC-NER repair and translesion 
DNA synthesis. However, in S phase the Fanconi Anemia (FA) pathway, homologous 
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recombination (HR) and TLS are responsible for ICL removal during DNA replication (Deans 
and West 2011). Repair of ICLs in the G1 phase of the cell cycle has received appreciably 
less attention as ICL tolerance in G1 is much greater than in S-phase, where induction of 
stalled replication forks can be highly toxic (Guainazzi and Schärer 2010, Muniandy, Liu et 
al. 2010). The ligase III-XRCC1 complex facilitates the ligation step (Moser, Kool et al. 2007). 
It has been reported in yeast that deficiency in  TC-NER is associated with mutations in the 
CNOT complex, possibly suggesting functions for the CNOT complex in DNA repair during 
transcription elongation (Gaillard, Tous et al. 2009) 
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Figure 1.14 The molecular mechanisms of GG-NER and TC-NER in mammals. 
The NER repair pathway consists of five different steps; DNA damage detection (it differs in 
GG-NER and TC-NER), unwinding, DNA incision, gap filling and ligation (these are the same 
in both sub-pathways of NER). Obtained from (Ryan 2016). 
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Apart from CPDs and DNA bulky adducts, 8-Oxoguanine (8-oxoG) can also be repaired via 
the TC-NER pathway in a transcription dependent manner. Formation of 8-oxoG is one of 
the most common consequences of oxidative stress resulting from reactive oxygen species 
; this is produced in DNA by normal cellular metabolism (mitochondrial respiration) or after 
exposure to exogenous damaging agents such as ionizing radiation. Persistence of this 
lesion in DNA is associated with G > T transversions with deleterious effects on genome 
stability. 8-OxoG can block transcription mediated by RNA polymerase II by interfering with 
gene expression, DNA replication and repair of the damage (Tornaletti, Maeda et al. 2004). 
The base excision repair (BER) of 8-oxoG from an 8-oxoG:C pair is initiated by OGG-1 DNA 
glycosylase / AP lyase leaving an apurinic-apyrimidinic (AP) site (Lindahl 1974). In mammals, 
special DNA glycosylases / AP lyases, nuclear α-hOGGl and mitochondrial β-hOggl, identify 
8-OxoG and incise DNA resulting in AP site formation. OGGl protein is required for the repair 
of 8-OxoG in both the transcribing strand (TS) and non-transcribing strand (NTS); however, 
it has been reported that 8-OxoG removal from TS is faster compared to NTS, suggesting 
that TC-NER also contributes to 8-OxoG repair (Le Page, Klungland et al. 2000). These 
authors showed that in OGGl -/- MEFs transcription can progress through oxidative 
damaged bases on TS. It is also possible that MutY, a DNA glycosylase, excises adenine 
inserted opposite 8-OxoG, and mismatch repair removes the mutation induced by lesion on 
NTS  (Le Page, Klungland et al. 2000).  
Tornaletti, Maeda et al  showed that any changes in the dNTP pool influenced the extent of 
RNA Pol II stalling at the 8-oxoG lesion (Tornaletti, Maeda et al. 2004). These authors have 
also observed that reduction in the ATP concentration increased RNA Pol II blockage at the 
8-oxoG site.  
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TLS DNA polymerase PrimPol accurately bypasses 8-oxo-dG and catalyses dCMP insertion 
opposite 8-oxo-dG with 2 to 6-fold greater efficiency than dAMP mis-insertion (Zafar, Ketkar 
et al. 2014). PrimPol, a recently characterised human primase and TLS polymerase, is 
capable of using both dNTPs and rNTPs to make primers and reinitiate DNA synthesis after 
dNTP depletion, which would be rate limiting for DNA replication. Unlike, Pol-α and Pol- ε, 
which generate a continuous leading strand, PrimPol promotes discontinuous synthesis of 
the leading strand (Rudd, Bianchi et al. 2014). Expression of PrimPol mRNA is cell cycle-
dependent and peaks in G1/S phase; however, protein levels remain unchanged throughout 
the cell cycle. Unlike the other TLS polymerases, such as Rev 1 and Pol η the recruitment of 
PrimPol to DNA is not suppressed in the presence of ATR and Chk1 inhibitors  (Göhler, 
Sabbioneda et al. 2011), (Mourón, Rodriguez-Acebes et al. 2013, DeStephanis, McLeod et 
al. 2015).  
 
1.4.2 Imbalanced rNTP / dNTP pool ratio and DNA polymerase-mediated incorporation 
errors  
Deoxynucleoside triphosphates (dNTPs) are the building blocks of the DNA and are critical in 
the maintenance of genome stability; therefore, any changes in their structure or levels has 
an immediate effect on DNA replication, repair and rates of mutagenesis. Ribonucleotide 
reductase (RNR) catalyses the conversion of ribonucleotides into deoxyribonucleotides by 
removing the 2'-hydroxyl group of the ribose ring of the nucleoside diphosphates. RNR is a 
tetrameric protein complex and consists of two catalytic (RRM1) and two regulatory (RRM2, 
RRM2B) subunits (Niida, Shimada et al. 2010). RRM2 expression is cell-cycle dependent and 
is approximately threefold more abundant during DNA replication in S phase than in G1; this 
is to maintain the balance of dNTP pools (Kotsantis, Petermann et al. 2018). In response to 
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DNA damage ATR is responsible for an increase in the level of RRM2 and consequently the 
dNTP pools (D'Angiolella, Donato et al. 2012). In addition, in response to replication stress, 
active ATR phosphorylates Chk1 which, in turn, supresses cyclin F. Cyclin F, an F-box protein,  
is the substrate binding subunit of SCF (Skp1-Cul1-F-box protein) ubiquitin ligase complexes 
and indirectly regulates the level of RRM2 by degradation of transcription factor E2F1, which 
activates the RRM2 gene promoter, in late G2 phase of the cell cycle (D'Angiolella, Donato et 
al. 2012). Upregulation of cyclin F mRNA, which reversibly decreases the level of RRM2 has 
been reported in patients with skin cancer (cutaneous melanoma) with poorer prognosis due 
to increased DNA damage repair and drug resistance. In addition, poorer patient outcome 
was observed when the high expression of cyclin F mRNA coincided with increased levels of 
proliferative factors, such as cyclin E, PCNA, pro-survival factors such as p27 or FOXM1 and 
proteins connected with AKT pathway activation (INPP4B) (Gagat, Krajewski et al. 2018). Thus, 
Chk1-mediated inhibition of cyclin F supresses the degradation of both E2F1 and RRM2 
(Zhang, Jones et al. 2009). Interestingly, Buisson, Boisvert et al. reported that treatment with 
ATR inhibitor or cyclin F siRNA + ATRi were not able to rescue the level of RRM2. However, 
overexpression of E2F1 could successfully inhibit degradation of RRM2 in ATRi-treated cell, 
suggesting reduction of RRM2 by ATRi is a direct consequence of E2F1 degradation (Buisson, 
Boisvert et al. 2015). Downregulation of RRM2 in response to induction of the activated RAS 
oncogene is due to an increased binding of the atypical transcriptional repressor E2F7 with 
the RRM2 gene promoter region and a simultaneous reduction in association of 
transcriptional activator E2F1 to the RRM2 gene promoter. This gives rise to dNTP pool 
depletion prior to oncogene-induced senescence (Aird, Zhang et al. 2013). Very recently, 
using a CRISPR screen the synthetic lethality between ATR or Chk1 inhibition and cyclin F loss 
has been reported. However, cyclin F knockout cells showed more vulnerability to inhibition 
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of Chk1 than ATR and this is consistent with the fact that inhibition of Chk1 has 
more deleterious effect on cycling cells than ATR inhibition (D'Angiolella, Yang et al. 2019). 
Exhaustion of dNTP pools, following downregulation of RRM2, reduces replication fork 
progression. Interestingly, the yeast Ccr4-Not complex is required for transcription activation 
of the RNR subunits by facilitating the recruitment of TBP, RNA pol II and the 
methyltransferase Set1p to the promoter site of RNR3 following replication stress and DNA 
damage in yeast (Mulder, Winkler et al. 2005). DNA replication under normal dNTP levels will 
increase the presence of embedded ribonucleoside monophosphates (rNMPs) in genomic 
DNA (gDNA). The mis-insertion rate of rNMPs by Family B replicases (Pol α, δ, and ε) has been 
reported to be surprisingly high (1 in 625, 5000, and 1250 for each polymerase, respectively) 
despite effective nucleotide discrimination by their active site; this is likely to be aggravated 
by decreased level of dNTP (McElhinny, Watts et al. 2010). Incorporation of rNMPs in the 
genome constitutes the most abundant DNA lesion occurring during DNA replication and it is 
predicted that 1 million rNMPs or more may be incorporated for each replication cycle in the 
mouse genome (Reijns, Rabe et al. 2012). The pyrimidine rCTP is the most frequently inserted 
nucleotide and rUTP the least (Potenski and Klein 2014). In mammalian cells, an excess of 
cellular rCTP reduces basal Poly [ADP-ribose] polymerase 1 (PARP-1) activity and 
consequently disruption of Chk1 activity at the replication fork, leading to under-replicated 
DNA and ultrafine anaphase bridge (UFBs) formation (Gemble, Buhagiar-Labarchède et al. 
2016). An imbalanced rNTP / dNTP pool ratio threatens genome stability due to an increased 
mutation rate leading to growth retardation (Bester, Roniger et al. 2011). Chen, Zhang et al 
showed that regulation of the dNTP pool and senescent autophagy are reciprocally linked, so 
that suppression of RNR induces autophagy and autophagy reduces the dNTP source (Chen, 
Zhang et al. 2014). 
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1.4.3 Repair of mis-inserted rNMPs in genomic DNA by ribonucleotide excision repair 
(RER)  
The proofreading of mis-inserted rNMPs is less efficient than the monitoring of incorrect 
bases by DNA polymerases; rNMP removal post-replication is performed by ribonucleotide 
excision repair (RER) (Sparks, Chon et al. 2012, Williams, Clausen et al. 2012). The presence 
of rNMPs in gDNA increases the number of alkali-sensitive sites; indeed, the 2'-hydroxyl 
group in the ribonucleotide makes RNA chemically more unstable and susceptible to 
hydrolysis compared to DNA (Reijns, Rabe et al. 2012). RNase H2-dependent RER repair can 
incise the 5′ phosphodiester bond of the ribonucleotide incorporated within DNA. The 
eukaryotic RNase H2 complex consists of one catalytic subunit, RNase H2A, and two non-
catalytic subunits, RNase H2B and RNase H2C, which are likely involved in interaction with the 
other proteins such as PCNA localised at the replication sites. Cells lacking RNase H2 show 
accumulated mono- and polyubiquitylated PCNA, whereas no significant effect is observed in 
PCNA sumoylation (Lazzaro, Novarina et al. 2012). In addition, these authors have shown that 
loss of RNase H2 had a synthetic effect when a second deletion occurs in RAD18 E3 ligase, 
responsible for conjugating ubiquitin to PCNA. In the absence of RNase H2-mediated repair 
of rNTPs, the TLS polymerases can bypass them (Lazzaro, Novarina et al. 2012). 
In yeast strains with a defective RNase H2-initiated ribonucleotide excision repair (RER) 
pathway, an alternative repair system incises rNMPs incorporated into DNA. In this TOP1-
dependent pathway, a nick produces 5’-OH and cyclic 2’-3’ phosphate terminated chains. 
Since such nicks cannot be extended by DNA polymerases or sealed by ligases, this results in 
single strand break formation. If a TOP1-dependent cyclic 2’-3’ phosphate nick is opposite a 
second TOP1 cleavage complex (TOP1cc) on the other strand a DSB could result. As a 
consequence of erroneous and abortive activity of TOP1 this alternative pathway is 
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significantly mutagenic although the targets are not all  yet characterised (Kim, Shar-yin et al. 
2011, Sparks, Chon et al. 2012).  
TOP1-associated SSBs are predicted to involve PARP1.  The rapid binding of PARP1 to the site 
of a break is crucial for the re-ligation of SSBs (Murai, Shar-yin et al. 2012). In a recent CRISPR 
screen of genes whose mutation causes increased PARP inhibitor sensitivity the RNase H2 
enzyme complex (RNase H2A, RNase H2B and RNase H2C) and several CNOT genes were 
identified (Zimmermann, Murina et al. 2018). TOP1-associated PARP1-trapping DNA lesions 
increase the sensitivity of RNaseH2A-depleted Chronic Lymphocytic Leukaemia (CLL) cells to 
PARPi. Depletion of TOP1 could decrease the number of γ-H2AX foci in RNase H2-deficient 
CLL primary cancer cells (Zimmermann, Murina et al. 2018). In another CRISPR screen it was 
shown that RNase H2 and CNOT complex deficiency are synthetically lethal with ATR 
inhibition both in vitro and in vivo (Wang, Wang et al. 2018). These authors have shown that 
RNase H2-depleted HeLa cells exhibit increased levels of DNA damage; in combination with 
ATR inhibitor (AZD6738) treatment (short time), the cells underwent apoptosis; however, 
prolonged treatment (6 days) with ATRi induced a senescence pathway. 
 
1.4.4 Repair of TOP1-dependent single-stranded DNA (ssDNA) nicks 
Approximately one hundred and fifty thousand oxidative adducts per cell are generated from 
endogenous ROS each day and this represents a huge source of modified DNA bases. Insertion 
of rNMPs into the gDNA by replicative and repair DNA polymerases vastly outnumbers 
oxidative lesions, with up to one ribonucleotide embedded per thousand bases during normal 
replication in yeast. It is now well- established that many DNA alterations have been 
processed by topoisomerase reactions, which in return increases the levels of TOPcc and DNA 
damage. 
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TOP1 relieves DNA hyper-negative supercoiling during transcription and DNA replication that 
would otherwise accumulate and disrupt  transcription elongation and DNA replication fork 
progression (Baranello, Wojtowicz et al. 2016). The function of TOP1 is to reduce super helical 
torsion. In doing this it creates a ‘nick’ transiently in the DNA but itself remains covalently 
attached at the 3’-side of the nick. Generally, TOP1 functions to generate an immediate 
resealing of the ‘nick’ in the DNA backbone. If the cleavage–re-ligation cycle is inhibited, this 
results in the formation of abortive TOP1–DNA complexes that are known as TOP1cc 
(Pommier, Sun et al. 2016). TOP1 inhibitors, such as camptothecin, inhibit TOP1 re-ligation 
activity, leading to the enzyme being trapped on a nicked DNA intermediate in the replicating 
cell. Indeed, replication fork collapse at a pre-existing nicked DNA may result in a 
replication run-off in close vicinity to the TOP1-trapped site which is frequently linked to DSB 
generation during  DNA replication (Chaudhuri, Hashimoto et al. 2012). Two pathways are 
involved in TOP1cc removal; firstly, one involving a ubiquitous enzyme, tyrosyl-DNA 
phosphodiesterase 1 (TDP1), and secondly, one based on the activities of the endonucleases, 
XPF–ERCC1 and Mre11. At TOP1cc sites, TDP1 also associates with, and is stabilised by, PARP1, 
which also implicates the role of TDP1 in the repair of TOP1-associated PARP1 trapping DNA 
lesions.  The removal of TOP1cc by TDP1 leaves a 3ʹphosphate end, which is dephosphorylated 
by polynucleotide kinase phosphatase (PNKP) (Pommier, Sun et al. 2016, Kawale and Povirk 
2017). The Auto-PARylation of PARP1 and its target proteins allows the recruitment of a 
number of proteins that have roles in BER to the SSB. One such protein is X-ray repair cross 
complementing protein (XRCC1), which is a partner of DNA ligase III (El‐Khamisy, Masutani et 
al. 2003). In the other pathway, TOP1cc can be released by the 3ʹflap endonuclease complex 
(XPF–ERCC1) and the 3ʹ–5ʹ exonuclease Mre11 (Postel-Vinay, Bajrami et al. 2013). The choice 
between repair by TDPs or by endonucleases needs further investigation (Figure 1.15). 
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Figure 1.15 Repair of TOP1-PARP trapping lesions. 
TOP1-PARP trapping lesions are repaired by two different pathways. 1) The TDP1-dependent 
pathway of hydrolysis of the tryosyl-DNA covalent linkage and completion of repair via the 
BER pathway. 2) The endonuclease complex (XPF–ERCC1)-dependent pathway of excision of 
the lesion and completion of repair via the NER pathway. Modified from (Zimmermann, 
Murina et al. 2018), (Postel-Vinay, Bajrami et al. 2013, Kawale and Povirk 2017).  
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1.4.5 Repair of R-Loop-dependent genome instability  
RNA-DNA hybrids (R-loops) may be formed in a variety of circumstances; for example, they  
can be directly associated with the transcription-blocking DNA lesions seen in trapped TOP1cc 
sites (Das, Huang et al. 2014) and / or as a consequence of collision between replication forks 
and the transcription machinery (Lin and Pasero 2012). In these circumstances if replication 
restarts downstream of the prolonged arrested RNA Pol II at trapping sites this gives rise to 
the accumulation of gaps in the DNA. In these gaps the template DNA could then be 
hybridised with a nascent RNA, while the homologous ssDNA is displaced and R-loops could 
result (Dutta, Shatalin et al. 2011). Transcription may affect genome integrity if co-
transcriptional products such as R-loops are not efficiently removed behind RNA polymerase 
II. R-loops  threaten genome integrity by colliding with replication and transcription 
complexes and by increasing the rate of mutagenesis over transcribed regions, such 
as  ribosomal genes (Kantidakis, Saponaro et al. 2016). It has been shown that induction of 
DSBs through processing of R-loops by components of the TC-NER pathway is due to the 
action of the endonucleases XPF and XPG (Sollier, Stork et al. 2014). Finally, R-loops are  
associated with trinucleotide expansion (GAA)n- promoting gene silencing in Friedriech’s 
Ataxia and Fragile X Syndrome through enrichment of the histone modification H3K9me2 
which is strongly associated with transcriptional repression (Groh, Lufino et al. 2014, Neil, 
Liang et al. 2018). 
Genome stability is protected against R-loop formation via two groups of surveillance factors; 
the first group prevents R-loops forming and the second group actively resolves the R-loop 
structures. DNA topoisomerase enzymes suppress R-loop formation by the relaxation of 
transcription-induced negative supercoiling behind moving RNA Pol II. The THO/TREX 
complex prevents R-loop formation by binding to transcripts or by packaging nascent RNA 
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into heterogeneous nuclear ribonucleoprotein (hnRNP) complexes (Reese 2013). Splicing and 
3’ end processing factors that interact with nascent RNA are also believed to suppress R loop 
formation (Skourti-Stathaki and Proudfoot 2014). It seems that the length of the nascent RNA 
is an important determinant in forward translocation of stalled RNA Pol II by the CNOT 
complex (Collart 2016). RNA/DNA helicases such as Senataxin (SETX) and/or Aquarius (AQR) 
and RNase H enzymes remove R loops once they are formed (Mischo, Gómez-González et al. 
2011)and (Wahba, Amon et al. 2011) (Figure 1.16). The potential for R-loops to act as 
replication primers was originally reported by (Itoh and Tomizawa 1980). In certain regions of 
the genome, as seen in rDNA, replication forks can reinitiate replication from stalled DNA-
RNA polymerase; the replisome then uses the nascent RNA as a primer to restart synthesis of 
the leading-strand after removing a co-directional RNA polymerase from the DNA (Pomerantz 
and O’donnell 2008). This action results in a discontinuous leading strand while the replisome 
remains associated with DNA during the entire process (Pomerantz and O’donnell 2008). The 
genome–wide mapping of R-loop formation during transcription in 2013 by the Chedin group 
introduced R-loops for the first time as potential regulators of gene expression; this was 
based on the observation that  they were enriched at the 5′ and 3′ ends of human genes, 
where they form and disappear following transcriptional activity (Ginno, Lim et al. 2013). Soon 
after, (Skourti-Stathaki, Kamieniarz-Gdula et al. 2014) showed that R-loop formation at the 3′ 
end of genes promotes the Ago2-dependent H3K9me2 chromatin architecture which 
facilitates RNA Pol II pausing before efficient termination of transcription. More recently, it 
was shown that R-loop formation at the 5’ end of genes regulates the recruitment of two key 
chromatin-regulatory complexes, histone acetyltransfrase TIP60-p400 and polycomb 
repressive complex 2 (PRC2) which  keep the chromatin in an open conformational state  
facilitating transcription (Chen, Chen et al. 2015). 
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Figure 1.16 R-loop resolution  
Two groups of surveillance factors are involved in R-loop removal; the first group prevents R-
loops forming; these include proteins such as DNA topoisomerase enzymes, the THO/TREX 
complex and Splicing and 3’ end processing factors. The second group actively removes the R-
loop structures; for example, the RNA/DNA helicases such as Senataxin (SETX) 
and/or Aquarius (AQR) and RNase H enzymes. Adapted from (Skourti-Stathaki and Proudfoot 
2014). This article is published under an open access license (published material can be re-
used without obtaining permission as long as a correct citation to the original publication is 
given). 
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1.5 Double-strand break repair 
The cellular genome is subjected to thousands of DNA lesions per day, arising from both 
endogenous and environmental sources. In order to maintain the integrity of the genome 
cells have evolved mechanisms known collectively as the DNA damage response (DDR). The 
DDR employs different repair mechanisms to deal with various types of damage,  such as 
photoreactivation, base excision repair (BER), nucleotide excision repair (NER), and 
mismatch repair (MMR) (Rastogi, Kumar et al. 2010). DNA double-strand breaks (DSBs) are 
considered to be  the most lethal form of DNA damage, mainly caused by UV or IR, and they 
can be repaired by two main pathways; either by homologous recombination (HR) or by non-
homologous end-joining (NHEJ) (Rapp and Greulich 2004). As the complementary DNA strand 
is required for HR it can only occur in S, G2 and early M phases of the cell cycle. NHEJ can 
operate throughout the cell cycle predominately in G1 phase where there is no homologous 
chain available (Figure 1.17). A better understanding of how these two major DSB repair 
mechanisms (HR and NHEJ) function can help with the therapeutic purposes of radiation used 
in tumour radiotherapy by differentially targeting HR and NHEJ function in tumour and normal 
tissues (Khanna and Jackson 2001). 
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Figure 1.17  The choice between HR and NHEJ at DSBs. 
NHEJ can be performed throughout the cell cycle and is the predominant pathway of DNA 
repair in G1 and early S phase. This is due to the presence of haploid DNA and there is no 
possibility of repair using a homologous chain. By progression through S phase, the cellular 
DNA becomes diploid and provides a template strand to allow HR to become more dominant. 
Obtained from (Krajewska, Fehrmann et al. 2015). This article is published under an open 
access license (published material can be re-used without obtaining permission as long as a 
correct citation to the original publication is given). 
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1.5.1 Homologous recombination (HR) pathway  
Rad51 –mediated homologous recombination is the major pathway for repairing DNA double-
strand breaks in mammalian cells in S and G2 phases of the cell cycle, although, overall, non-
homologous end joining plays the predominant role in the repair of IR and HU-induced DSBs 
(Bai and Symington 1996). Homologous recombination involves the exchange of molecules of 
DNA between sequences with similar or identical homology with hundreds of base pairs 
coverage. However, NHEJ repairs the breaks with no need for a homologous template (Takata, 
Sasaki et al. 1998). In mammalian cells, the MRN (Mre11-Rad50-NBS1) complex recognises 
the break and recruits ATM at blunt or minimally processed DNA ends (Williams, Williams et 
al. 2007). DNA blunt ends undergo 5′–3′ nucleolytic degradation, resulting in 3′-single-
stranded DNA overhangs which enable repair of DSBs by HR. This process is regulated by 5′-
Mre11-Rad50 nuclease-ATPase and CtIP removing small oligonucleotides from the DNA ends 
to form an early intermediate (DNA end resection) (Limbo, Chahwan et al. 2007). Immediately 
after this, the Exo1 endonuclease, DNA2 and BLM helicase complete this intermediate and 
generate extensive tracts of single-stranded DNA (Zhu, Chung et al. 2008). The 3′-ended 
ssDNA is coated by the replication protein A (RPA) complex, removing the hairpin-
containing DNA structures and serving 3’-ssDNA as a substrate for the recombinase RAD51. 
Paradoxically, the RPA supresses the binding of RAD51, while  recombination mediators 
resolve this inhibitory effect of RPA (Sugiyama and Kowalczykowski 2002). RAD51 displaces 
RPA from the ssDNA-RPA in a BRCA2-dependent manner and forms a presynaptic filament 
with ATP and ssDNA. The ssDNA-RAD51-ATP complex is now active and able to undertake 
homology searches and DNA strand exchange, although the precise role of RAD51 
ATPase activity in filament assembly is still somewhat unclear (Baumann, Benson et al. 1996). 
Once the RAD51 nucleoprotein filaments are assembled the second DNA strand is able to bind 
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and exchange DNA with the paired homologous region and form a “Holliday junction” 
structure. How the exchange mechanism really works between paired chromosomes is still 
under debate. It is thought that a rare random collision juxtaposes complementary nucleotide 
sequences on two matching ssDNA strands (Alberts, Johnson et al. 2002) (Figure 1.18). NBS1 
facilitates the translocation of ATM to the site of the DNA break (Waterworth, Altun et al. 
2007). ATM is an essential protein required for phosphorylation of H2AX at serine 139 residue, 
however, it is not well-understood whether the binding of ATM to NBS1 promotes this 
phosphorylation or ATM is recruited in its active form (Kinner, Wu et al. 2008).  The 
phosphorylated form of H2AX (γ-H2AX) binds to MDC1 (mediator of DNA damage checkpoint) 
which is thought to bridge the binding of the MRN complex to γ-H2AX. Moreover, (Saito, 
Fujimoto et al. 2013) have reported the interaction between H2AX and NBS1 is necessary for 
NBS1 focus formation, as NBS1 focus formation was not observed in response to DSB damage, 
neither in H2AX-/- mouse cells nor siRNA-depleted H2AX human cells.  
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Figure 1.18 The mechanism of HR repair pathway. 
Initial endo-cleavage step is mediated by MRN in conjunction with CtIP and BRCA1. Further 
resection is performed by either EXO1 or DNA2 in concert with BLM, generating the 3’ 
overhang ssDNA. RPA rapidly binds the 3’ overhang ssDNA, which is displaced by the 
recombinase Rad51 in a BRCA2-dependent manner, generating a presynaptic filament with 
the ssDNA. The nucleoprotein filament begins homology searches and DNA strand exchange. 
HR intermediate “Holliday junction” structures can be resolved by the endonucleases MUS81, 
EME1, SLX1/SLX4 and GEN1 (Ryan 2016).  
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1.5.2 Non-Homologous End Joining  
The process of NHEJ initiates with an immediate recognition of the DSB by the Ku70/80 
heterodimer, which forms a ring-like structure around each end of the DSB with high affinity. 
The formation of the ring-like structure is imperative as it protects DNA ends from 
degradation. Recruitment of 53BP1 antagonises resection of the DNA, thus promoting NHEJ. 
Ku70/80 heterodimer promotes the recruitment and activation of the DNA-PK catalytic 
subunit (DNA-PKcs). Formation of DNA-PK holoenzyme activates its kinase activity, resulting 
in auto-phosphorylation; DNA-PK also phosphorylates a number of downstream NHEJ 
proteins, such as Ku70/80, XRCC4 and Artemis. Similar to HR, H2AX is phosphorylated to 
H2AX by DNA-PKcs. The auto-phosphorylation of DNA-PK provides an accessible platform for 
the other NHEJ mediators to the site of the DSB, such as Artemis and the DNA ligase IV 
complex (ligase IV, XRCC4 and XLF) once the holoenzyme is removed. The end-processing 
enzyme Artemis, using its endonuclease activity of 5′- and 3′-DNA overhangs and DNA 
hairpins, returns the DNA ends of the DSB to their conventional 3’OH and 5’P DNA termini 
before they are re-ligated by DNA ligase IV complex. Once the blunt ends are in place, the 
ligase IV complex performs the final crucial ligation step to join the DNA ends together (Figure 
1.19).  
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Figure 1.19 The mechanism of NHEJ repair pathway. 
DSB structures are recognised by Ku70/Ku80 heterodimer that orchestrates the recruitment 
and activity of DNA-PKcs. DNA-PKcs phosphorylates and activates additional repair mediators, 
including itself and the endonuclease Artemis. Artemis processes the DNA ends prior to 
ligation. The blunt ends are joined by the activity of DNA ligase IV, XRCC4 and XLF (Ryan 2016). 
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1.5.3 Fanconi anaemia pathway and interstrand cross-links 
The Fanconi anaemia (FA) pathway comprises in excess of 20 proteins and is activated in 
response to interstrand crosslinks (ICLs) (Niraj et al., 2019; Walden and Deans, 2014; Kim and 
D’Andrea, 2012). ICLs arise following exposure to chemicals such as cisplatin and mitomycin 
C and result in the covalent cross linking of two DNA strands, inhibiting transcription and 
imposing a block on replication. They can also occur due to the effect of endogenous 
metabolic intermediates, such as formaldehyde and acetaldehyde, which result from lipid 
peroxidation and alcohol metabolism. The FA core complex, comprising nine components, 
constitutes an E3 ubiquitin ligase which ubiquitylates FANCI and FANCD2 (the ID complex) in 
response to ICLs. FANCL is the E3 enzyme and FANCT, the E2 ubiquitin conjugating enzyme. 
The FA anchor complex containing a number of proteins such as FANCM (Walden and Deans, 
2014) recognises the ICL. The monoubiquitylated ID2 complex binds to chromatin and recruits 
various DNA repair proteins such as structure specific nucleases (FANCP and FANCQ) that 
cleave the DNA and ‘unhook’ the cross-link. HR proteins are engaged in the later stages of ICL 
repair, resolving the DSBs, which arise (Walden and Deans, 2014). FANCD1 (BRCA2) and FANCJ 
(BACH1) are involved in the process at this stage. 
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1.6 Hypothesis and aims 
We hypothesise that the mammalian CNOT complex is required for regulation of steady-state 
level of mRNAs including those are involved in the cell cycle progression. Furthermore, we 
suggest that depletion of CNOT1, a scaffold protein for the complex, will may increase the 
level of mRNA synthesis and decrease the mRNA decay, resulting in disruption of the cell cycle 
and transcription-induced replication stress and genome instability with low DNA repair 
response.  
The aims of the investigation are: 
1. To determine the effects of CNOT1 depletion on the cell cycle progression throughout 
the difference phases.  
2.  To investigate whether depletion of CNOT1 can result in cell death via apoptosis or 
senescence.  
3. To study the role of CNOT1 in regulation of global transcription activity.  
4. To examine the effects of CNOT1 depletion on global gene expression using RNA-Seq 
analysis. 
5. To examine the effects of CNOT1 depletion on DNA replication using DNA fibre assays  
6. To investigate possible different forms of genome instability caused by depletion of 
CNOT1.  
7. To determine the effect of CNOT1 depletion on the ATM and ATR pathways. 
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2 MATERIALS AND METHODS 
 
 
2.1 CELL CULTURE TECHNIQUES 
2.1.1 Human Cell Lines 
 
Cell line Supplier and Cat No Information 
HeLa S3 cells ATCC-CCL-2.2 ™ Adherent epithelial cell line derived from a human 
cervical cancer expressing human papilloma virus 
(HPV-18) proteins 
U2OS ATCC® HTB-96™ Adherent epithelial cell line derived from a human 
osteosarcoma  
H1299 ATCC® CRL-5803™ Adherent epithelial cell line derived from a human 
lung  metastatic site: lymph node 
 
Table 2.1 List of cell lines used in this study 
HeLa cells were used in all experiments throughout this project apart from the homologous 
recombination (HR) assay, in which U2OS was used.  
 
2.1.2  Tissue Culture Media 
Cells were grown in Dulbecco’s Modified Eagle’s Medium-high glucose (Sigma) with 10% FCS 
(Sigma) in 5% 𝐶𝑂2 at 37 °C. When necessary, media was supplemented with Gentamicin 100 
µg/ml. For 70-80% confluency, 5 × 106 cells were plated in 10-cm cell culture dishes 
(Corning) 24 h before use.  
 
2.1.3 Maintenance of Human Cell Lines 
Cells were split when they reached 70-80% confluency by removing existing media rinsing 
once with Dulbecco's Phosphate Buffered Saline (PBS) and incubating with 0.05% trypsin 
(Invitrogen) at 37 °C until cells had detached. Detached cells were collected in fresh warm 
culture medium and centrifuged at 470 x g for 3 minutes. Medium was discarded without 
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disrupting the cell pellet and fresh warm medium was added to the cells which were re-
plated at the desired confluency.  
2.1.4 Cryopreservation of human cell Lines 
Cells were detached and pelleted as mentioned in section 2.1.3. Cell pellets were re-
suspended in freezing medium containing 10% dimethylsulphoxide (DMSO) (Sigma-Aldrich) 
and 10% FCS. Cells were transferred into cryovials and placed inside a freezing container 
filled with isopropanol for overnight incubation at 80 °C. The following day, frozen vials were 
transferred to the vapour phase of a liquid nitrogen for long-term storage at -180 °C. When 
needed, cells were retrieved by thawing at 37 °C followed by centrifugation at 470 x g for 3 
minutes and resuspension in fresh DMEM media.   
 
2.2 CELL BIOLOGY TECHNIQUES 
 
2.2.1 siRNA transfection of cell lines 
On-target plus siRNA-SMART pools were obtained from GE Dharmacon; all were designed 
to reduce gene expression of human CNOT1, CNOT2, CNOT4, CNOT6, CNOT6L, CNOT7, 
CNOT8, Tab182 and BRCA2. A list of all the siRNAs used in this project is summarised in 
Table 2.2.  Oligofectamine™ (Invitrogen) was used as the cationic lipid cell transfection 
reagent. A transfection complex of 10 µL of siRNA (0.2nmoles) and 8 µL of Oligofectamine 
was added to 1 mL Opti-MEM® (Invitrogen-31985-047) and mixed thoroughly by pipetting.  
Following 30 minutes incubation at room temperature the mixture was added to cells in a 
6 cm dish supplemented with 1 mL Opti-MEM. After 5-6 hours, incubation at 37 °C the Opti-
MEM transfection mixture was removed and replaced with fresh DMEM medium containing 
10% FCS. Cells were incubated until harvested or split. 
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Target siRNA  Sense sequence Antisense sequence Supplier 
lacZ 198- 
non  
silencing 
control 
Custom CGUACGCGGAAUACUUCGAdT
dT 
AhAhUCGAAG 
UAUUCCGCGUACG  
Dharmacon 
CNOT1 SMARTpool CUAUAAAGAGGGAACGAGA 
CCAGAAACUUUGGCGACAA 
GGCCAAAUUGUCUCGAAUA 
CAAGUUAGCACUAUGGUAA 
UCUCGUUCCCUCUUUAUAG 
UUGUCGCCAA AGUUUCUGG 
UAUUCGAGAC AAUUUGGCC 
UUACCAUAGU GCUAACUUG 
Dharmacon 
CNOT2 SMARTpool CAUGAAUGGAGGAGACGUA 
GGCAAUUGGCUUACGCAAA 
GGCAAGUUUAUACGGGCAA 
GCACUCAGUUACCGAGCCA 
UACGUCUCCUCCAUUCAUG 
UUUGCGUAAGCCAAUUGCC 
UUGCCCGUAUAAACUUGCC 
UGGCUCGGUAACUGAGUGC 
Dharmacon 
CNOT4 SMARTpool CCAAUUCUCUCAAUAGUAC 
CGUCUUUGUUGUAGGUUUA 
UAACAGAGUCACAGUCGUU 
GGUAGUAGAUGGCAGAACA 
GUACUAUUGA GAGAAUUGG 
UAAACCUACA ACAAAGACG 
AACGACUGUG ACUCUGUUA 
UGUUCUGCCA UCUACUACC 
Dharmacon 
CNOT6 SMARTpool GAAAGAACGUGGCUAUAAU 
GGGCAGAGCUUGAAAUAAG 
GAGCACAGGUGGAGUAGAA 
GCUAUAAUGUUCUUUGUGA 
AUUAUAGCCA CGUUCUUUC 
CUUAUUUCAA GCUCUGCCC 
UUCUACUCCA CCUGUGCUC 
UCACAAAGAA CAUUAUAGC 
Dharmacon 
CNOT6L SMARTpool UGACAGCGCUGCACCUAAA 
GAGCAGGUAUGAAGCCUAU 
CCAAUUACACCUUUGAUUU 
GGUAUUAGAGGUCCACAAA 
UUUAGGUGCA GCGCUGUCA 
AUAGGCUUCA UACCUGCUC 
AAAUCAAAGG UGUAAUUGG 
UUUGUGGACC UCUAAUACCA 
Dharmacon 
CNOT7 SMARTpool CAGCUAGGACUGACAUUUA 
GGAGAAUUCAGGAGCAAUG 
UCAUAGCGGUUACGACUUU 
GUUAGAGCUGGAACGGAUA 
UAAAUGUCAGUCCUAGCUG 
CAUUGCUCCUGAAUUCUCC 
AAAGUCGUAACCGCUAUGA 
UAUCCGUUCCAGCUCUAAC 
Dharmacon 
CNOT8 SMARTpool UUUCGUAGUUCCAUAGAUU 
AAUAUCAGCUUCUGCGGUG 
GAGAUAGCCAGGUUAUCU 
CCAUAGAUCUCCUUGCUAA 
AAUCUAUGGA ACUACGAAA 
CACCGCAGAA GCUGAUAUU 
AGAUAACCUG GCUAUCUC 
UUAGCAAGGA GAUCUAUGG 
Dharmacon 
TAB182 SMARTpool GAGUUUGGGAAGAGCGCUU 
CAGAAGCUUUGGAACGAGA 
AGGACCAGGAAUUCGGAAA 
CACCAAGGCCUGCGGUUGA 
AAGCGCUCUU CCCAAACUC 
UCUCGUUCCA AAGCUUCUG 
UUUCCGAAUU CCUGGUCCU 
UCAACCGCAG GCCUUGGUG 
Dharmacon 
BRCA2 
 
 
SMARTpool GAAACGGACUUGCUAUUUA 
GGUAUCAGAUGCUUCAUUA 
GAAGAAUGCAGGUUUAAUA 
UAAGGAACGUCAAGAGAUA 
UAAAUAGCAAGUCCGUUUC 
UAAUGAAGCAUCUGAUACC 
UAUUAAACCUGCAUUCUUC 
UAUCUCUUGACGUUCCUUA 
Dharmacon 
 
Table 2.2 List of siRNAs used in the study 
The siRNAs used to study the gene function of various candidate proteins belonging to CNOT 
complex components and BRCA2 are shown.  
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2.2.2 Transient transfection of DNA 
Cells were treated with siRNA 48 hours prior to DNA plasmid transfection. On day three, the 
transfection complex was prepared by diluting DNA as indicated below and 9 μl of 
Lipofectamine 2000 (Invitrogen) into 250 µl of Opti-MEM in two separate tubes. Both tubes 
were mixed by pipetting and then left at room temperature for 5 minutes. The two solutions 
were then mixed together and incubated for another 25 minutes at room temperature. 500 
µl transfection mixture was added to cells in DMEM, without changing the medium, for 
overnight incubation at 37 °C. Opti-MEM transfection complex was removed and replaced 
with warm DMEM medium supplemented with 10% FCS and incubated until needed. 
 
 
Table 2.3 A List of DNA plasmids used during this study 
Their doses and sources are indicated.  
  
Cloning vectors Doses used for 6cm 
dishes/ 6 well 
plates 
Manufacturer 
pCMV6-AC-RNase H1-GFP 2.5 µg/µl Origene-PS100010  
 
I-SceI-GFP (Moynahan, 
Pierce et al. 2001) 
 
3 µg/µl A gift from G. Stewart lab  
pcDNA 3.1 2 µg/µl Invitrogen-V79020 
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2.2.3 Cytotoxic Agents 
All drugs used in this study are outlined in Table 2.4.  
 
Table 2.4 A List of all cytotoxic components used during this study 
Their stock and working concentration, exposure time, source and brief information about 
their function are shown.  
Reagents Stock 
concentration 
Working 
concentration 
Time of 
treatment 
Manufacturer Information 
5, 6-
Dichlorobenzimid
azole 1-β-D-
ribofuranoside 
(DRB) 
50 mg/mL 100 µm 100 min Sigma-D1916 Transcription 
inhibitor that 
prevents activating 
phosphorylation of 
the RNA Pol II C-
terminal domain. 
1,5,6,7-
Tetrahydro-2-(4-
pyridinyl)-4H-
pyrrolo[3,2-
c]pyridin-4-one 
hydrochloride, 2-
Pyridin-4-yl-
1,5,6,7-
tetrahydro-
pyrrolo[3,2-
c]pyridin-4-one 
hydrochloride, (P
HA-767491) 
 
50 mg/mL 10 µm 60 min Tocris Bioscience- 
767491 
Dual DNA 
replication and 
transcription 
elongation 
inhibitor. 
Cdc7/cdk9 
inhibitor. 
RNase H1 5,000 units/ml 2 U per µg of 
DNA 
120 min NEB - M0297S Endoribonuclease 
that catalyses the 
cleavage of RNA in 
an RNA-DNA 
hybrid. 
Mitomycin C 
(MMC) 
25 0ug/mL 1 µm 24 hours Sigma Inhibits DNA 
synthesis by 
formation of 
DNA crosslinks 
Hydroxyurea  10 g 1, 2.5, 5, 10 & 
20 mM 
2 hours Sigma Inhibits DNA 
synthesis by dNTP 
pool depletion.  
Nocodazole  1 mg/mL 200 ng/mL 18 hours Sigma Inhibits mitosis by 
disruption of 
mitotic spindle 
function. 
AZD6738  
 
1 mM 2 µm 2 hours Astrazeneca ATR kinase inhibitor 
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2.2.4 Buffers Recipes 
All buffers and their recipes used for cell biology in this study are summarised in Table 2.5. 
Buffer Name Recipe 
Comet Lysis Buffer 2.5 M NaCl, 0.1 M EDTA pH8, 10 mM Tris pH10, adjusted to pH 10 
with 10 M NaOH  
Comet Electrophoresis Buffer 1 mM EDTA pH8 and 50 mM NaOH  
Fibre Spreading Buffer 0.2 M Tris-HCI pH 7.4, 50 mM EDTA and 0.5% SDS  
Fibre Blocking solution  1% BSA, 0.01% Tween 20 in PBS 
PBST Buffer (Phosphate Buffered Saline 
Tween-20) 
Phosphate buffered saline containing 1%Tween 20. 
NETN Buffer 1% NP-40, 0.15 M NaCl, 50 mM Tris-HCl pH 7.4, 5 mM EDTA  
CBF Buffer A 10 mM Hepes pH 7.2, 10 mM KCL, 1.5 mM MgCl2, 0.34 M Sucrose, 
10% Glycerol  and 1 mM DTT  
CBF Buffer B 3 mM EDTA, 5 mM EGTA and1 mM DTT  
SDS sample Buffer 5% SDS, 5 M urea, 20 mM Tris HCL pH 7.4 and 0.1 M β-
mercaptoethanol 
Western blot Running Buffer 100 mM Tris/Bicine and 1% SDS 
Western blot Transferring Running Buffer 200 mM Tris, 190 mM Glycine and 20% v/v methanol 
TBST Buffer 50 mM Tris-HCl pH 7.4, 0.15 M NaCI, 1% Tween 80 
SSC Buffer (Saline and Sodium Citrate) 0.30 M NaCl, 30 mM trisodium citrate, pH7 
10 X TBE Buffer 1 M Tris, 1M Boric acid, 20mM EDTA 
Alkaline Running Buffer 50 mM NaOH, 1 mM EDTA 
Alkaline Neutralizing Buffer 1M Tris HCl pH 8.0, 1.5 M NaCl  
Deadenylation Buffer 50 Mm Hepes-NaOH pH 8.0, 0.15 M NaCl, 2 mM MgCl2, 10% 
glycerol 
RNA Loading Buffer 95% formamide, 0.025% SDS, 5 mM EDTA, Blue-orange loading 
dye (Promega) 
 
Table 2.5 A List of all buffers used during this study  
Their concentration and recipes are indicated. The source of all chemicals are from Sigma-
Aldrich 
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2.2.5 Colony Survival Assays 
CNOT1 siRNA-transfected and control siRNA-transfected HeLa cells were plated at 
appropriate concentration into 6 cm dishes. On the following day, cells were mock-treated or 
treated with HU or MMC with different dosages. After treatments, cells were washed twice 
with PBS and incubated with fresh DMEM medium. Cells were incubated in a humidified 
atmosphere with 5% CO2 for 2 weeks until large colonies formed > 1 mm (Colonies of more 
than 50 cells were counted). Colonies were rinsed with PBS, stained with 0.5% crystal violet 
in 20% ethanol and counted.   
 
2.2.6 Natural Comet Assay 
On day one, comet slides (X-tra® Slides from Leica Biosystem) were prepared. The slides 
were scratched with an engraving pen.  0.6% normal agarose (Sigma) was prepared by 
dissolving 120 mg agarose in 20 mL PBS and microwaving for 1-3 minutes. The melted 
agarose was placed in a 42°C water bath during slide preparation. 600 µl of melted agarose 
was added to each slide and spread over the scored area to make an agarose layer of 2-3 
mm thickness. After the agarose was set on the slides, they were placed in a slide box and 
left in at 4 °C overnight.  On day two, 1.2% LMP agarose (Sigma) was made up by dissolving 
240 mg agarose in 20 mL PBS and incubated in a 42 °C water bath. 5×105 cells/mL final 
concentration was calculated for each control and CNOT1 siRNA-transfected sample (each 
sample was in triplicate). The cells were placed in universal tubes on ice and kept in the cold 
until electrophoresis was completed. Samples were washed twice with sterile cold PBS at 4 
°C, and dispensed so that 600 µL (at 5×105cells/mL) of each sample was placed into a 1.5 
mL tube on ice. Agarose covered slides from day one were placed on a slide tray on ice. 600 
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µL LMP agarose was pipetted into each sample and mixed well by pipetting up and down 2 
or 3 times.  600 µL of mixture of LMP Agarose and sample was spotted onto slides quickly 
and stored at 4 °C for ≥ 30 minutes. Comet lysis buffer was prepared (Table 2.5). DMSO and 
Triton X-100 (Sigma) were added to the lysis buffer to a final concentration of 1% for each 
≤ 20 minutes before use. Slides were transferred to a blacked-out Coplin jar with lysis buffer 
and left for 60 minutes in the dark. The comet tank was refrigerated, and electrophoresis 
buffer was completed by adding 10 mL DMSO < 20 minutes before use. Slides were washed 
3 times with ice cold water and submerged in the comet tank with electrophoresis buffer 
for 45 minutes in the darkness.  Electrophoresis was performed for 25 minutes at 21 V. 
Slides were removed from the electrophoresis tank, rinsed quickly with ice-cold water and 
transferred to the Coplin jar with 1 M Tris pH 7 for ≥ 30 minutes. Slides were rinsed in ice-
cold water and heated at 42 °C overnight and then placed at 4 °C. Slides were stained with 
1 mL of SYBR Green in PBS (1: 10,000) and cover slips were applied. Excess SYBR Green was 
removed and 200 Comets viewed at 20X magnification. Mean Tail moment were calculated 
using Open Comet plugin ImageJ bundle.  
 
2.2.7 DNA Fibre Assay 
24 hours prior to labelling, control and siRNA-transfected HeLa cells were plated in 6 cm 
dishes. Exponentially growing cells at 40-50% confluency were pulse labelled with 20 µl 2.5 
mM 5-Chloro-2’-deoxyuridine (CldU) (Sigma) (final concentration 25 μM) for 20 minutes at 37 
°C. Cells were treated with RNase H1, DRB, and PHA for 24 hours, 100 minutes and 60 minutes, 
respectively, if required (Table 2.4). In order to remove excess CIdU, cells were rinsed 2 times 
with warm DMEM. Cells were pulse-labelled with 222 µl CO2-equilibrated 2.5 mM 5-Iodo-2’-
deoxyuridine (IdU) (Sigma) (final concentration 250 µM) for 20 minutes at 37 °C. DMEM / IdU 
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solution was removed and cells were washed twice with ice-cold sterile PBS. Cells were 
trypsinised, re-suspended in 1 mL ice cold PBS to a concentration of 5×104 cells/mL cells/mL 
and transferred to ice cold 1.5 mL Eppendorf tubes. 2 μl of each re-suspended sample in PBS 
was placed on a slide, near to the frosting, and left for 4 minutes until the edges of the drops 
became crinkly, lysis occurred after 7 μl of spreading buffer was added (Table 2.5). The two 
together were stirred 5 times and left for 2 minutes at room temperature until lysis was 
accomplished. Slides were briefly tilted to start the DNA moving down the slide; excess liquid 
was allowed to run off the end, and the slide left to air-dry for 10 minutes. DNA fibre spreads 
were fixed in methanol / acetone (3:1) for 15 minutes and air-dried for 10 minutes. Slides 
were stored at 4 °C and were stable for up to 1 year. 
 
2.2.8 Homologous Recombination Assay 
The U2OS DNA homologous recombination reporter cell line was transfected with control 
siRNA or CNOT1-siRNA. 24 hours prior to transfection of the plasmid DNA, cells (1×106/mL) 
were plated in 6 well plates supplemented with DMEM plus 10% FCS. 3 µl of I-SceI DNA and 
9 µl Lipofectamine™ 2000 (Invitrogen) were added to 250 µl of Opti-MEM in a 1.5 mL 
eppendorf tube (per reaction). The contents of the tube were mixed thoroughly by pipetting 
and left at room temperature for 30 minutes. The transfection complex was added to cells 
plated in 6 well plates supplemented with 250 µl of DMEM plus 10% FCS and incubated at 37 
°C overnight. The following day, medium was removed and replaced with fresh DMEM and 
incubated at 37 °C for another 5-6 hours. Cells were trypsinised, pelleted by centrifugation at 
410 x g for 5 minutes and washed with sterile PBS (all media and washes were kept at every 
step and transferred to a 50 mL Falcon tube to avoid losing any mitotic cells). Cells were re-
suspended in 3 mL ice-cold PBS and 7 mL of ice-cold absolute ethanol was added drop-wise 
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while vortexing at medium speed. Cells were stored at -20 °C for up to 2 weeks (a minimum 
of 24 hours fixation is required). Cells were removed from the freezer and pelleted by 
centrifugation at 535 x g for 5 minutes. Ethanol was removed from the loosely attached cell 
pellet and 10 mL of PBS was added to the dehydrated cells and left for 30 minutes on ice. Cells 
were pelleted by centrifugation at 535 x g for 5 minutes. The PBS wash was repeated. The 
supernatant from the final wash was discarded and cells were re-suspended in PBS. Cells were 
permeabilised in 10 mL of ice-cold 0.25% Triton- X100 in PBS for 15 minutes. Cells were 
incubated in 1 µg/mL propidium iodide together with 0.1 µg/mL RNase A in PBS and for at 
least 30 minutes at room temperature. Cells were analysed on a BD Accuri C6 flow cytometer 
using FL-2 channel on slow flow setting.  
 
 
2.2.9 Cell Growth Assay  
HeLa Cells were transfected with control or siRNAs of the CCR4-NOT subunits (CNOT1, 2, 6, 
6L, 7, 8 and TAB182). 200 µl of 2×104 cells/mL suspension in DMEM were seeded (final 
concentration of 2×103 cells/well) per well in 96-well solid white polystyrene microplates in 
triplicate and incubated for the indicated times. Control wells containing DMEM without cells 
were also set up in triplicate to obtain a value for background luminescence. CellTiter-Glo® 
Luminescent reagent (Promega) and the 96-well microplate were both equilibrated at room 
temperature for 30 minutes. 50 µl CellTitre Glo reagent was added to each well followed by 
gentle agitation on a shaker for 2 minutes to complete cell lysis. In order to stabilise the 
luminescent signal, cells were incubated at room temperature for 30 minutes. Relative 
luminescence unit (RLU) was measured with a Pherastar Plate Reader (BMG LABTECH). The 
RLU mean was calculated for the medium-only wells and subtracted from the RLU mean of 
wells with CellTitre Glo reagent. In order to calculate the relative survival fraction for each 
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CNOT siRNA, the RLU mean corresponding to the CNOT siRNA was divided by the RLU mean 
of the control siRNA-treated wells. 
 
2.2.10 Cell Cycle Analysis  
2.2.10.1 Synchronizing cells with mitotic shake-off method 
CNOT1 siRNA-transfected and control siRNA-transfected HeLa cells were grown in T75 flasks 
24 hours prior to nocodazole treatment. Cells were synchronised in mitosis using nocodazole 
(200 ng/mL) for 18h.  Mitotic cells were visualised using an EVOS fluorescence inverted digital 
microscope from Advanced Microscopy Group (AMG). Loose round mitotic cells were 
mechanically detached by tapping the flask on a hard surface and collected. Cells were rinsed 
once in PBS (all media and washes were kept to avoid losing any mitotic cells). The flattened 
cells remaining attached after shaking off, were trypsinzed and transferred to a separate tube 
for further investigation. Nocodazole shake-off cells were centrifuged at 470 x g for 5 minutes. 
Medium was removed and pellet was washed once with PBS. Mitotic cells were released from 
the G2/M block into fresh media and sub-cultured into 6 cm dishes and were harvested at 0, 
1, 2, 4, 8, and 24 hours later. The pellet obtained from the trypsinised cells was retained for 
further investigation. Cell pellets obtained from different time points were washed once with 
PBS and lysed in UTB lysis buffer (whole cell lysate) or subjected to sub cellular fractionation 
as explained below in section 2.3.1. 
 
2.2.10.2  FACS analysis 
Cell culture medium was removed from 72 hours CNOT1 siRNA-transfected and control 
siRNA-transfected HeLa cells. Following the ethanol-fixation step as explained above in 
section 2.2.8 cells were rehydrated with 10 mL ice-cold PBS on ice for 30 minutes. Cells were 
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centrifuged at 535 x g for 4 minutes and PBS /ethanol was discarded. 10 mL ice-cold PBS was 
added to cell pellets and transferred to 25 mL universal tubes. Cells were centrifuged at 535 
x g for 4 minutes and PBS was discarded. Cell pellets were re-suspended in remaining PBS and 
incubated with 10 mL ice-cold 0.25% Triton-X100 in PBS on a rocker at 4 °C for 15 minutes. 
Cells were centrifuged at 535 x g for 4 minutes and rinsed once with 1% BSA in PBS. In order 
to discriminate between G2 and M phase cells, simultaneous staining of DNA with PI and the 
mitotic marker, anti-phospho-histone H3 serine 10 (pH3) antibody was performed. Cells were 
incubated in 200 µl of 1% BSA/PBS containing 1:500 dilution of pH3 antibody at room 
temperature and transferred to 1.5 mL Eppendorf tubes. Tubes were gently flicked 
occasionally to re-suspend cells with the antibody. After 1 hour incubation with antibody cells 
were washed with 1% BSA/PBS twice and centrifuged at 677 x g for 5 minutes. Cells were 
incubated in 200 µl of 1% BSA/PBS containing 1:50 dilution of secondary antibody Alexa fluor® 
488 at room temperature in the dark for 1 hour. Tubes were gently flicked occasionally. Cells 
were washed once with 1% BSA/PBS followed by one PBS wash. Cells were incubated in 1mL 
PI (final concentration 10 µg / mL) in PBS containing 0.1 mg / mL RNase A at room temperature 
in the dark for 30 minutes. Cells were transferred to BD FACS™ tubes and analysed on a BD 
LSRFortessa™ X-20 flow cytometer on slow flow setting.  
 
2.3 PROTEIN BIOCHEMISTRY TECHNIQUES 
2.3.1 Protein Extraction 
Cell lysates were prepared for Western blotting as follow. 80% confluent CNOT1 siRNA-
transfected and control-transfected cells were washed twice with ice-cold PBS and lysed in 
250-500 µl of UTB lysis buffer (8 M Urea, 50 mM Tris HCl pH7.4 and 0.15 M β-
mercaptoethanol) depending on the cell number. Cells were scrapped off the culture dish and 
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collected in 1.5 mL tubes. Cells were sonicated (5 watts for 15 seconds) and pelleted at 535 x 
g for 4 minutes at 4 °C. The supernatants containing the proteins were collected and 
transferred to new tubes.  
Cell lysate preparation for Co-Immunoprecipitation (CIP) and Subcellular Chromatin 
Fractionation (SCF) assays was carried out as follow. Medium was removed from cell culture 
dishes; cells were washed with pre-warmed PBS once and trypsinzed as before. Cells were 
pelleted by centrifugation at 470 x g for 4 minutes. Culture medium containing trypsin was 
removed and pellets were washed with ice-cold PBS twice. Once PBS was removed from the 
final wash, for CIP assay cells were lysed in 1 mL NETN buffer (Table 2.5). The lysis was 
completed by adding 50 µL of 5 M NaCl per 1 mL NETN buffer, vortexing and homogenising 
using a Wheaton-Dounce homogeniser. Homogenised cell lysates were centrifuged at 
100,000 x g for 5 minutes at 4 °C. The supernatant was retained at every step of the 
preparation and the pellet discarded. The supernatant from each sample was carefully 
removed and dispensed into 1.5 mL Eppendorf tubes (500 µL per tube). Eppendorf tubes were 
centrifuged at 364 x g for 8 minutes at 4 °C.  The supernatant was transferred into new tubes 
and centrifuged at 100,000 x g for 30 minutes at 4 °C using an Optima MAX-TL Beckman 
Coulter ultracentrifuge. The final supernatant was transferred into the new tubes for antibody 
incubation overnight.  
For SCF assays, cell pellets were washed twice with ice-cold PBS as described above and lysed 
in 1 mL Buffer A (Table 2.5) supplemented with 100 µL 10% Triton on ice for 8 minutes. 200 
µL of this suspension was retained as a Whole Cell lysate Fraction (WCF). The remaining 
suspension was centrifuged at 10,000 x g for 5 minutes at 4 °C. Both supernatant and pellet 
were collected as crude cytoplasmic fraction (S1) and nuclear fraction (P1), respectively. S1 
was subjected to additional centrifugation at 364 x g for 15 minutes; the supernatant was the 
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cytoplasm (S2) and the pellet contained the organelles (P2). P1 fraction was washed with 
buffer A without Triton and centrifuged at 535 x g for 5 minutes at 4 °C. The supernatant was 
discarded, and the pellet was lysed in buffer B (Table 2.5) on ice for 30 minutes. The lysed P1 
fraction was centrifuged at 10,000 x g at 4 °C and two fractions were designated nucleoplasm 
(S3) and chromatin (P3). P3 fraction was solubilised in UBT buffer and centrifuged at 535 x g 
for 5 minutes at 4 °C. The supernatant containing Chromatin-bound proteins was collected 
into the new tubes. 
 
2.3.2 Protein Determination (Bradford Assay) 
Cell lysates were prepared as explained above (section 2.3.1). A range of bovine serum 
albumin (BSA) concentrations was used to produce a standard protein curve and were made 
up of 0, 2, 4, 6, 8 and 10 µg BSA in 1 mL diluted Bradford reagent (Bio-Rad) (1:5 in water). 1 
µL of each experimental cell lysate was added to 1 mL diluted Bradford reagent. Absorbance 
readings were measured using Eppendorf Biospectrometer at a wavelength of 595 nm. 
Protein concentation was calculated using a BSA standard curve. 
 
2.3.3  SDS‐Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
Proteins were fractionated on polyacrylamide gels based on their molecular weight. For low 
molecular weight proteins (15 kDa-120 kDa), a 10% acrylamide gel was used and for high 
molecular weight proteins (> 120 kDa) an 8% acrylamide gel was used (Table 2.6). The gel 
was set in a Hoefer Studier apparatus. Generally, 30 µg of each protein sample per well was 
denatured in SDS sample buffer (Table 2.5) and heated at 90 °C for 5 minutes. Samples were 
loaded onto the gel along with molecular weight markers (BlueEasy Pre-Stained Protein 
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Ladder, (6.5 – 270 kDa) from GenFlow. Gels were run at 20 mA for 4-5 hours or overnight at 
10 mA in running buffer (Table 2.5).  
 
Ingredients Supplier 8% Gel 10% Gel 
H20 --- 42 mL 39 mL 
1 M Tris 1MBicine Sigma 6 mL 6 mL 
40% Acrylamide (N,N, -
methylene-bis-
acrylamide) 
Severn Biotech 
12 mL 15 mL 
10% SDS (sodium 
dodecyl sulphate) 
Severn Biotech 
I mL 1 mL 
TEMED (N, N, N,. N,-
tetra-methyl-
ethylenediamine) 
 
Melford 
200 μl 200 μL 
10 % APS (ammonium 
persulphate) 
 
Sigma 150 μl 150 μl 
 
Table 2.6 Polyacrylamide Gel Recipe 
Polyacrylamide gel recipe used for western blot in this study are listed.  
 
2.3.4 Electrophoretic Transfer of Protein 
Once fractionation was completed on SDS-PAGE, proteins were electrophoretically 
transferred onto a nitrocellulose membrane (Biotrace). The gel and membrane were held 
together between two sponges and pre-soaked Whatman filter paper and placed into a 5 L 
Hoefer transfer gel electrophoresis tank within a gel holder cassette. Transfer was overnight 
at 200 mA or 6 hours at 300 mA in the buffer described (Table 2.5).  
 
2.3.5 Visualisation of Protein Bands on Nitrocellulose Membranes 
In order to confirm success of the protein transfer, Ponceau S stain (0.1% Ponceau S in 3% 
trichloroacetic acid (TCA)) was applied to the nitrocellulose membrane and agitated for 2 
minutes. The Ponceau S stain was removed and membrane washed with distilled H2O a few 
times to remove excess dye. The quality of protein loading and transferring procedure were 
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checked and the result noted. Nitrocellulose membrane was cut according to the protein 
ladder and the size of proteins being investigated. The cut membranes were completely 
destained in TBST buffer (Table 2.5). The membranes were incubated in blocking buffer (3-5% 
skimmed milk powder in TBST or 3-5% BSA in TBST depending on the protein being 
investigate) on a shaker for 30 minutes.  
 
 
2.4 IMMUNOCHEMISTRY TECHNIQUES 
 
2.4.1 Antibodies  
All the antibodies used in this study are listed in Table 2.7 and 2.8. 
 
 
2.4.2 Immunodetection of proteins 
After blocking the membranes (2.3.5 section), solutions of primary antibodies were 
prepared in 5% milk or 5% BSA to the appropriate concentration (Table 2.7). The 
nitrocellulose membranes were then incubated in primary antibodies in a sealed bag at 4 
°C overnight with gentle agitation. On the following day, membranes were washed in TBST 
buffer six times for 5 minutes each. Membranes were then incubated in the secondary 
antibodies diluted in 5% milk to the appropriate concentration (Table 2.8) for two hours at 
room temperature while rocking. Following incubation, membranes were washed in TBST 
buffer six times for 5 minutes each. Membranes were incubated in Enhanced Chemical 
Luminescence (ECL) (GE Healthcare) solution for 1 minute.  Blots were exposed to X-ray film 
(Kodak) for different lengths of time. Protein bands were developed and visualised using 
the X-ray film processor ECOMAXTM.  
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Primary Antibody Species Application Dilution Supplier 
CNOT1 Rabbit WB/IP 1:1000 Proteintech 
CNOT2 Rabbit WB 1:500 SantaCruz 
CNOT4 Rabbit WB 1:500 SantaCruz 
CNOT6 Rabbit WB 1:500 SantaCruz 
CNOT7 Rabbit WB 1:500 SantaCruz 
CNOT10 Rabbit WB 1:500 SantaCruz 
Tab182 Rabbit WB/IP 1:3000 In house 
Pan3 Rabbit WB 1:500 SantaCruz 
ATR Goat WB/IP 1:1000 SantaCruz 
ATM Mouse WB 1:1000 Gift from P. Byrd 
pATM (S1981) Rabbit WB 1:500 R & D Systems 
KAP1 Rabbit WB 1:1000 Bethyl Laboratories 
pKAP1 (S824) Rabbit WB 1:1000 Bethyl Laboratories 
53BP1 Rabbit IF/WB 1:1000 Novus 
p53 (DO1) Mouse WB 1:2000 Gift from D. Lane 
H2AX Rabbit WB 1:1000 Millipore 
γH2AX (S139) Mouse WB/IF 1:1000 Millipore 
H2B Rabbit WB 1:2000 Abcam 
Rad51 Rabbit WB 1:1000 Millipore 
Cdc25A Mouse WB 1:1000 SantaCruz 
TOPBP1 Rabbit WB 1:1000 Bethyl 
MCM2 Rabbit WB/IP 1:500 SantaCruz 
MCM3 Rabbit WB/IP 1:500 SantaCruz 
MCM7 Rabbit WB/IP 1:500 SantaCruz 
ORC3 Rat  WB/IP 1:500 SantaCruz 
PCNA Mouse WB 1:1000 SantaCruz 
TOP1 Mouse WB 1:1000 SantaCruz 
TOP2α Mouse WB 1:1000 SantaCruz 
TOP2β Mouse WB 1:1000 SantaCruz 
RNase H1 Rabbit WB/IF 1:500 Proteintech 
RNase H2A Rabbit WB 1:500 Gift from A. 
Agathanggelou 
SETX Rabbit WB 1:500 SantaCruz 
CSB Rabbit WB 1:500 Bethyl 
XPG Rabbit WB 1:500 Bethyl 
XPF Mouse WB 1:500 NeoMarkers 
XPC Rabbit WB 1:500 SantaCruz 
Chk1 Mouse WB 1:1000 Santa Cruz 
pChk1(S345)&(S317
) 
Rabbit WB 1:1000 Cell Signalling 
Chk2 Rabbit WB 1:1000 Steve Elledge 
pChk2 (T68) Rabbit WB 1:1000 Cell Signalling 
RPA32 Mouse WB/IF 1:1000 Calbiochem 
pRPA32 (S4/S8) Rabbit WB 1:1000 Bethyl 
PARP1 Mouse WB 1:1000 SantaCruz 
DNAPK Mouse WB 1:1000 Santa Cruz 
FANCD2  Mouse WB 1:500 SantaCruz 
IdU Mouse DNA fibres 1:500 Becton Dickinson 
CldU Rat DNA fibres 1:750 AbD SeroTec 
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Cyclin A Rabbit WB/IF 1:500 SantaCruz 
Cyclin B Rabbit WB 1:500 SantaCruz 
Cyclin E Rabbit WB 1:500 Abcam 
Cyclin D1 Mouse WB 1:500 SantaCruz 
p27Kip1 Rabbit WB 1:500 SantaCruz 
p21Cip1 Rabbit WB 1:500 Abcam 
TBP Rabbit WB 1:1000 SantaCruz 
RNA Poll  C-
terminal domain 
(CTD) 
Rabbit WB 1:1000 SantaCruz 
Histone H3 Rabbit WB 1:3000 Abcam 
pHistone H3 (Ser-
10) 
Rabbit WB 1:100 Cell signalling 
H3K4me3 Rabbit WB 1:1000 Abcam 
Mre11 Mouse WB 1:1000 Genetex 
NBS1 Rabbit WB 1:10000 Genetex 
pNBS1 (Ser-343) Rabbit WB 1:1000 Abcam 
β-Actin Mouse WB 1:1000 Sigma-Aldrich 
GAPDH Mouse WB 1:500 SantaCruz 
R-loop (S9.6) Mouse WB 1:1000 Gift from E.Peterman 
CENPF Rabbit WB/IF 1:1000 Abcam 
SSDNA Mouse WB 1:5000 Millipore 
Cdc7 Mouse WB 1:500 SantaCruz 
LC3β Mouse WB/IF 1:4,000 Novus Biologicals 
 
 
Table 2.7 Table demonstrates the primary antibodies used in this study including species, 
application, dilution and supplier 
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Table 2.8 Table demonstrates the secondary antibodies in used this study including species, 
application, dilution and supplier 
 
 
2.4.3 Co-Immunoprecipitation 
The final supernatants obtained from 2.3.1 section were incubated with 10μl of primary 
CNOT1 and Tab182 antibodies at 4 °C overnight. On the following day, the antibody-
containing lysates were centrifuged at 10,000 x g at 4 °C for 15 minutes and the supernatant 
collected to the new tubes. The immunocomplexes were captured by incubating on a 
rotator with 40 μl of protein G-Sepharose beads for 1 hour at 4 °C. Immunocomplexes on 
the Sepharose beads were centrifuged at 10,000 x g for 1 minute at 4°C and the supernatant 
removed. Following this, beads-bound immunocomplexes were washed four times in NETN 
buffer, centrifuging at 10,000 x g for 1 minute at 4 °C each time.  The supernatant was 
removed between each wash. Washed beads were boiled in 40 μl SDS sample buffer. The 
samples were centrifuged at 360 x g for 2 minutes and the supernatants loaded onto SDS-
PAGE gels.  Proteins were detected by immunoblotting as described above in sections 
2.3.4/5 and 2.4.2, respectively. 
 
 
 
 
 
Secondary Antibody Species Application Dilution Supplier 
Mouse IgG (Green) Goat WB 1:2000 DAKO Laboratories 
Rabbit IgG (Red) Swine WB 1:3000 DAKOLaboratories 
Rabbit IgG Alexa fluor® 488 (Red) Goat IF 1:1000 Invitrogen 
Mouse IgG Alexa fluor® 546 (Green) Goat IF 1:1000 Invitrogen 
Rat IgG Alexa fluor® 555 (Red) Goat DNA fibres 1:500 Invitrogen 
Mouse IgG Alexa fluor® 488 (Green) Goat DNA fibres 1:500 Invitrogen 
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2.4.4 Subcellular Chromatin Fractionation (SCF) assay 
 
The supernatant containing chromatin-bound proteins obtained from 2.3.1 section were 
separated by SDS-PAGE and developed by immunoblotting as described above in sections 
2.3.4/5 and 2.4.2, respectively. 
 
2.4.5 Immunofluorescence 
Poly-L-lysine coated circular cover slips (Dixon Glass Ltd Marketplace) were dipped in 
absolute ethanol for 20 seconds and placed in 24-well plates and washed once with 2 mL 
warm DMEM. Control and CNOT1-KD cells were aliquoted (4×104 cells/well) on the 
coverslips in 24 well plates and incubated at 37 °C overnight. If required, cells were 
transfected with DNA plasmid (pCMV6-AC-RNase H1-GFP / pcDNA 3.1) (refer to section 
2.2.2) and incubated at 37 °C overnight. Growth medium was removed from cells and 
coverslips were washed once with ice-cold PBS. Cells were fixed in 500 μl of ice-cold 
paraformaldehyde (4% PFA in PBS, pH 7.2) for 10 minutes followed by a PBS wash and 10 
minutes permeabilization in 0.5% Triton X-100 in PBS. For R-loop (S.96 antibody) 
immunofluorescence labelling, cells were fixed and permeabilised in 500 μl of ice-cold 
absolute methanol at -20 °C for 15 minutes.  
In all cases cells were washed with ice-cold PBS once and blocked in 5% FCS in PBS at room 
temperature for 30 minutes - 1 hour.  Blocking solution was removed from each well and 
replaced with the primary antibodies from Table 2.7 diluted in 5% FCS/PBS for overnight 
incubation at 4 °C. Primary antibodies were removed and coverslips were washed three 
times with 5% FCS/PBS. Cells were incubated in the dark with secondary antibodies (Alexa 
fluor® 546 & 488 from Invitrogen) diluted to the required concentration in 5% FCS/PBS 
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(Table 2.8) at room temperature for 1 hour. Excess secondary antibodies were discarded 
followed by three PBS washes. Cells were stained with 4′, 6-diamidino-2-phenylindole 
(DAPI) for 15 minutes in the dark at room temperature. Excess DAPI stain was removed with 
two PBS washes. A drop of immune-mount mounting medium (Vectashield Mounting 
Medium from Vector Laboratories) was added onto rectangular slides (Surgipath). The 
coverslips were removed using tweezers and located on the slides. In order to seal the edges 
of the coverslips, a gentle pressure was applied and the edges of the coverslips were sealed 
using colourless nail polish. Glass slides were stored at 4 °C in a slide box. Cells were 
visualised using a Nikon Eclipse E600 microscope and analysed using Velocity software 
version 4. 
 
2.4.6 Immunostaining of DNA Fibres 
Methanol / acetone fixed DNA fibres on slides (from section 2.2.7) were placed horizontally 
in a humidified blackout chamber. Slides were washed twice with deionised water, rinsed 
once in 2.5 M hydrochloric acid (HCl) and immersed in 2.5M HCl for 1 hour 15 minutes. 
Upon completion of denaturation, slides were washed once in PBS, followed by two washes 
in blocking solution (Table 2.5). Additional blocking solution was applied on each slide for 
30 minutes-1 hour. Blocking solution were tipped off and slides were incubated with 200 μl 
primary antibodies (rat anti-BrdU to detect CIdU and 200 μl mouse anti-BrdU to detect IdU) 
diluted in blocking solution at the required ratio (Table 2.8) for 1 hour. Slides were gently 
covered with a coverslip to spread the primary antibodies solution evenly. Primary 
antibodies were tipped off and coverslips were discarded, followed by three washes with 
PBST (Table 2.5).  Slides were fixed with 500 μl of ice-cold 4% PFA for 10 minutes. Slides 
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were then washed three times with PBST followed by three washes with blocking solution. 
Slides were incubated with 200 μl secondary antibodies (anti- rat Alexa fluor® 555 [Red] and 
200 μl anti-mouse Alexa fluor® 488 [green]) diluted in blocking solution at the required ratio 
(Table 2.8) for 1.5 hour. Slides were gently covered with a coverslip to spread the secondary 
antibodies solution evenly. Slides were washed twice in PBST, followed by three washes in 
blocking solution and then twice in PBS. 2 drops of mounting medium were spread over the 
surface and a long rectangular coverslip was applied. Slides were left to dry for 10-15 
minutes and sealed using nail varnish.  DNA fibres were viewed using a Nikon Eclipse E600 
microscope and analysed using Image J software. 
 
2.4.7 Transcription Assay 
Coverslips and 24 well plates were prepared as explained in section 2.4.5.  Cells were 
incubated with 500 μl of 1 mM 5-ethynyl uridine (EU) (Click-iT® RNA Imaging Kit) diluted in 
pre-warmed complete medium for 1 hour at 37 °C. Inhibition of transcription was achieved 
by treating cells with DRB (Table 2.4). DRB and EU were added to the cells at the same time 
and cells were maintained at 37 °C for 100 minutes.   Culture medium including EU or EU / 
DRB was removed and cells were washed twice with ice-cold PBS. Cells were fixed in 500 μl 
of ice-cold 4% PFA in PBS for 10 minutes, followed by 10 minutes permeabilization in 0.5% 
Triton X-100 in PBS with a PBS wash in between. Click-iT reaction cocktail was freshly 
prepared according to the manufacturer’s instructions. Permeabilization solution was 
removed and cells were washed once with PBS. Cells were incubated with 500 μl Click-iT 
reaction cocktail while protected from light for 30 minutes. Click-iT reaction cocktail was 
removed and cells were washed with 1 mL Click-iT reaction rinse buffer.  Click-iT reaction 
rinse buffer was discarded and cells were incubated with 500 μl diluted Hoechst (DAPI) 
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(1:1000 in PBS) protected from light for 10 minutes, followed by two washes with PBS. 
Images were viewed using a Nikon Eclipse E600 microscope and analysed using Image J 
software. Based on DAPI staining a nuclear mask was generated in Image J and the mean 
Alexa fluor® 594 fluorescence intensities per pixel were quantified per nucleus.  
 
2.4.8 Deadenylase Assay 
The method was adapted from (Mittal, Aslam et al. 2011). The whole cell lysates from control, 
CNOT1, CNOT7 and TAB182-depleted HeLa cells were washed twice with deadenylation 
buffer. 2 µl of 5’-fluorescein-labeled RNA substrate (Flc-5’-CCUUUCCAAAAAAA‐3’ final 
concentration 0.2 µM, Sigma-Aldrich) was incubated with equal amounts of whole cell lysates 
of control, CNOT1, TAB182 and CNOT7-depleted cells for 10, 30, 60 and 120 minutes at 37 °C. 
The reaction was stopped by addition of 10µl RNA loading buffer (for buffer recipe refer to 
section 2.2.4) and heating for 3 minutes at 85 °C. Aliquots of the assay mixtures were 
fractionated on 20% polyacrylamide gel containing 8 M urea and TBE. Flc-labeled RNAs were 
visualised using a FUSION-FX imaging system. 
 
2.5 MOLECULAR BIOLOGY TECHNIQUES 
2.5.1 Total Nucleic Acid Isolation 
72 hours post siRNA transfection total nucleic acid was extracted using a FlexiGene Kit 
(Qiagen). 1 × 107 Cells per 6 cm dish were pelleted and washed once with PBS.  The cell 
pellet was re-suspended in 300 µl Buffer FG1 and mixed by pipetting up and down. 300 µl 
Buffer FG2 and 3 µl QIAGEN Protease K were added to cell lysates. The tube was inverted 3 
times and placed in a heating block at 65 C for 5-6 hours. 600 µl absolute isopropanol was 
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added to each cell lysate and mixed thoroughly by inverting until the white thread-like strands 
of DNA formed a visible clump. Tubes were centrifuged at 360 x g for 5 minutes. Supernatants 
were carefully removed and the tubes inverted onto a clean piece of absorbent paper for 5-
10 minutes. 600 µl 70% ethanol was added to the DNA pellet and the tube vortexed for few 
seconds. Centrifugation was repeated and supernatants discarded, this was followed by 
inversion of the tube onto a clean piece of absorbent paper for 10-15 minutes. DNA pellets 
were air-dried until all the liquid had evaporated. The DNA pellet was dissolved in 100 µl 
Buffer FG3 for 5-6 hours at 65 °C in a heating block. DNA samples containing RNA were stored 
at -20 C. 
 
2.5.2 DNA Concentration Quantification 
Purity of DNA was determined using a Nanodrop 1000 spectrophotometer (Thermo-Fisher 
Scientific) and ratio OD260 /OD280 was calculated. DNA concentrations were measured in 
ng/μL. 
 
2.5.3 Densitometric quantification of DNA 
Equal amount of nucleic acid measured by Nanodrop from each sample and a 1 KB DNA ladder 
(New England Biolabs) were fractionated on 0.85% agarose gel (0.85 g agarose, 100 mL TBE 
buffer (Table 2.5) microwaved for 1 minutes). Staining of gels using ethidium bromide at a 
concentration of 0.5 µg per mL was performed for 1 hour. DNA bands were visualised using 
UV illumination FUSION-FX (Vilber) and images collected. Densitometric readings were 
obtained using Image J software for DNA samples and the DNA ladder separately. Intensity of 
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each DNA sample was normalised against its equivalent DNA ladder band intensity and the 
results compared between two samples. 
 
2.5.4 Alkaline Hydrolysis of Genomic DNA  
Total nucleic acids extracted as described in section 2.5.1 were heated in 40 μl 0.3 M NaOH 
for 2 hours at 55 °C and fractionated on 1% alkaline agarose gel (1 g agarose, 100mL 50 mM 
NaOH, 1 mM EDTA) with alkaline running buffer (Table 2.5). Electrophoresis was performed 
at 10 V/cm overnight. Following electrophoresis, the gel was neutralised by soaking in 
neutralizing buffer (Table 2.5) for 1 hour, and then post-staining was carried out using 0.5 
μg/ml ethidium bromide in neutralizing buffer for an additional hour.  The density of the 1kb 
DNA ladder (Invitrogen) and each samples were measured and plotted using Image J software 
as described above in section 2.5.3. 
 
2.5.5 Slot Blots 
In order to give an equal loading of DNA determined by densitometry sufficient volume of 
nucleic acid for each control siRNA and CNOT1 siRNA treated sample (46 ng/μl and 161 ng/μl 
respectively) was incubated  with +/- 2 U of RNase H (New England Biolabs) per μg of gDNA 
for 2 hours at 37 °C. One piece of Whatman filter paper and nitrocellulose membrane were 
cut according to the dimensions of the slot blot apparatus. Filter paper and membrane were 
first rinsed with deionised H20 and then with 2 X SSC buffer (Table 2.5).  The slot blot 
apparatus was assembled and air bubbles removed. Each well was washed twice with 200 μL 
2 X SSC buffer. All samples were loaded twice and sucked through the apparatus under 
vacuum.  Each well was washed twice with 200 μL 2 X SSC buffer. The apparatus was 
dissembled and the membrane was cross-linked using a Stratalinker (UV irradiation of 0.12 
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J/M2). The membrane was blocked with 1% BSA/TBST for 30 minutes - 1 hour. The membrane 
was then cut in half and one half was blotted with S9.6 antibody (for R-loops) and the other 
half for ssDNAs (Table 2.7) overnight at 4 °C. For a loading control the membrane was first 
denatured in (0.5 N NaOH, 1.5 M NaCl) for 10 minutes and neutralised in (1 M NaCl, 0.5 M 
Tris-HCl pH 7.0) for 10 minutes and then blotted with ssDNA antibody. The next day, primary 
antibodies were removed and the blots were washed 6 times with TBST buffer. Following 
TBST washes, blots were incubated with the secondary antibodies (Table 2.5) for 1 hour with 
gentle agitation at room temperature. Blots were washed 6 times with TBST buffer and 
proteins were visualised with ECL reagent and detected on X-ray film. 
 
 
2.5.6 Isolation of Total RNA 
72 hours post siRNA transfection total RNA was extracted using RNeasy Plus Mini (Qiagen). 
1 × 107 Cells per 6 cm dish were pelleted and washed once with PBS. Cell pellets were 
disrupted by adding 600 μl lysis buffer RLT Plus. Cell lysis was completed by vortexing or 
vigorous pipetting of the cell lysate. Cells were homogenised by passing the cell lysate a few 
times through a 20G needle fitted to a syringe. The homogenised lysate was transferred to a 
gDNA Eliminator spin column placed in a 2 ml collection tube and centrifuged for 1 minute at 
360 x g. The flow-through in the collection tube was saved and the spin column was discarded. 
600 μl of 70% ethanol was added to the flow-through and mixed thoroughly by pipetting. 600 
μl of flow-through was transferred to an RNeasy spin column placed in a new 2 ml collection 
tube and centrifuged for 1 minute at 360 x g. This time the flow-through was discarded and 
spin column was saved. The spin column was washed once with 600 μl buffer RW1, followed 
by additional two washes with 500 µl Buffer RPE. In order to eliminate residual flow-through 
the spin column was placed in a new 2 mL collection tube and centrifuged at 535 x g for one 
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minute. The spin column was placed in a new 1.5 mL collection tube and 30-50 μl RNAse-free 
water was directly added to the spin column membrane and left for 2 minutes at room 
temperature. The spin column was centrifuged for 1 minute at 360 x g and eluted RNA was 
stored at -80 °C. 
 
2.5.7 RNA Quality Control 
The quality and quantity of extracted RNA were measured using a Qubit 2.0 Fluorometer (Life 
Technologies) and an Agilent 2200 TapeStation system, respectively. RNA concentrations and 
purity were measured in pg/μL and RIN (RNA Integrity Number), respectively and results were 
recorded (Table 2.9). The RIN 7 was set as the cut off value for sequencing (the highest score 
for RIN is 10). The 28S:18S rRNA ratio was also calculated as a marker for RNA quality (Table 
2.9). A 28S:18S rRNA ratio of 2:1 was considered as a representative of good-quality RNA.  
 
Well Conc. (pg/μl) RINe  Sample ID 28S/18S (Area) 
A0 3850 --- Electronic Ladder --- 
A1 4430 9.5 Con siRNA 3.7 
B1 4770 9.7 CNOT1 siRNA 3.9 
 
Table 2.9 RNA concentration and purity measured by Qubit 2.0 and TapeStation system 
 
2.5.8 Total RNA-Sequencing  
Dual-indexed, strand-specific RNA-Seq library was prepared from submitted total RNA, using 
RiboZero (Illumina) rRNA depletion and the NEBNext Ultra Directional RNA library preparation 
kit (NEB). RNA-Seq was performed on 2 lanes of HiSeq4000 (paired-end, 2x150bp) platform 
to generate ~80M reads per sample.  
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2.5.9 Bioinformatics data analysis 
2.5.9.1 RNA-Sequencing data 
The raw data files were generated in binary base call (BCL) format and converted to FASTQ 
format using bcl2fastq Conversion Software (Illumina). FASTQ format readings were 
transferred to BaseSpace® Sequence Hub (Illumina). The assay was run in 4 lanes in paired-
end and 76-cycle mode. The FASTQ files were aligned using HISAT2 (Kim, Langmead et al. 
2015), and the resulting mRNA transcripts were assembled using StringTie (Pertea, Pertea et 
al. 2015) as described in (Pertea, Kim et al. 2016). All RNA-seq data was uploaded to the GEO 
database (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE141496) with the 
accession number GSE141496. 
 
2.5.9.2 Differential Gene Expression Analysis 
Taking the Control siRNA sample as reference, log2-transformed fold changes (log2FC) of 
CNOT1 siRNA samples were calculated. Genes with positive log2FC were considered 
“upregulated” while those with negative log2FC were considered “downregulated”. To 
determine if the change in the expression of a particular gene was significant, we used 
empirical p-values. After correcting p-values for false positive rate in multiple testing problem 
using false discovery rate as proposed in (Benjamini and Hochberg 1995), we analysed the 
enrichment of the up/down-regulated gene sets for each sample using Enrichr (Kuleshov, 
Jones et al. 2016). Finally, significant biological processes reported by Enrichr were extracted 
for further consideration. 
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3 CNOT1 AND CELL CYCLE PROGRESSION 
 
 
3.1 INTRODUCTION 
Previous studies by Dronamraju et al. (2018)  had proposed a novel role for Ccr4-Not in the 
regulation of mRNAs involved in cell cycle progression in yeast (Dronamraju, Hepperla et al. 
2018). They showed that the interaction between Spt6, a histone chaperone, and RNA PoII 
promotes the recruitment of the Ccr4-Not complex at the site of transcription in order to 
facilitate the degradation of mRNAs required for cell-cycle progression. This recruitment 
possibly occurs during G1 phase as suggested by Morel et al. (2003), who showed that the 
CNOT complex is concentrated in the nucleus in early G1 cells, but by the time the cells enter 
S phase much of it becomes cytoplasmic. In addition, Westmoreland et al. (2004) showed that 
yeast CCR4 (hCNOT6/hCNOT6L) regulates cell cycle progression through G1 and S phases 
following radiation or replication stress (Westmoreland, Marks et al. 2004). In an earlier study 
by (Liu, Toyn et al. 1997) it has been shown that, during M/G1 phase transition, Dbf2p 
(metaphase cell cycle-regulated protein kinase), is dephosphorylated  to initiate degradation 
of mRNAs required for cell cycle progression, possibly through regulation of the Ccr4-Not 
complex. In agreement with these studies, our results have revealed that depletion of CNOT1 
leads to much reduced cell cycle progression through S and G2/M phases and subsequent 
arrest of the cell cycle in G1. At later times, the cells appear to senesce and /or undergo 
autophagy. 
 Based on our results we propose the repertoire of CCR4-NOT complex mRNA homeostasis to 
include a function in cell cycle progression in mammalian cells. Indeed, it has already been 
shown  that the CNOT complex is involved in the stability of cell cycle-associated mRNAs such 
as CLB2 (cyclin B human orthologue) (Kadyrova, Habara et al. 2007), cyclins CLN2 (cyclin E 
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human orthologue) and CLB5 (cyclin A2 human orthologue), histone H2A.1 (H1A human 
orthologue)  (Dronamraju, Hepperla et al. 2018), DBF2 and SW15 (Johnston, Eberly et al. 
1990) in Saccharomyces cerevisiae. 
 
3.2 RESULTS 
 
3.2.1 Depletion of CNOT1 leads to reduction in level of the other CNOT subunits  
HeLa cells were treated with CNOT1 siRNA and control siRNA and the efficiency of knock down 
was judged by western blot at different times: 0, 24, 48, 72, 96 and 120 hours (Figure 3.1.A). 
On the basis of this result, 72 hours post CNOT1 siRNA transfection was used for most 
subsequent experiments. The expression level of the other CNOT subunits was analysed in 
control and CNOT1-depleted HeLa cells 72 hours post siRNA transfection. Depletion of CNOT1 
leads to reduction in the level of other CNOT subunits (Figure 3.1.B). 
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Figure 3.1 Depletion of CNOT1 leads to reduction in the other CNOT subunits 
A) Representative immunoblot shows the CNOT1-dependent depletion at different time 
points, 0, 24h, 48h, 72h, 96h and 120h (0.2nmol siRNA/6cm culture dish). HeLa cells were 
transfected with control or CNOT1 siRNA. B) Cells were lysed and the lysates assessed by 
immunoblotting with the indicated antibodies against different CNOT subunits and Pan 3 
72hours post siRNA transfection.  
 
A) 
B) 
CNOT1 & The CELL CYCLE PROGRESSION 
132 
 
3.2.2 Depletion of CNOT1 disrupts the cell cycle progression in HeLa cells 
Activation of the DDR can result in cell cycle arrest and, therefore, a number of DDR proteins 
can directly affect the cell cycle following their activation. To assess whether the depletion of 
CNOT1 had any effect on cell cycle progression in HeLa cells, cells were stained with the DNA 
stain PI and the cell cycle profiles were investigated using FACS analysis 0, 4, 8, 24 and 32h 
post siRNA transfection (Figures 3.2.A and B). In comparison to the control cells, CNOT1-
depleted cells gradually accumulated in G1 phase, whereas very few cells were observed in 
the S and G2 phases. The data are represented in a graphical format, where the average cell 
cycle was plotted from three independent experiments (Figures 3.2.C).  
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Figure 3.2 Ablation of CNOT1 expression leads to G1-cell cycle arrest 
HeLa cells were transfected with either control or CNOT1 siRNA and stained with PI and the 
cell cycle profiles analysed by flow cytometry at different time-points post-transfection. A & 
B) are representatives of a typical flow cytometry plots observed. C) Multiple stacked graph 
depicts the average cell cycle profile observed in three independent experiments. Relative DNA 
content were analysed using an Accuri C6 flow cytometer (BD) and FlowJo software (Tree Star 
Inc.) 
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3.2.3 Depletion of CNOT1 reduces the S-phase indices in HeLa cells 
 
EdU labelling was used to determine a full S phase of a fraction of cells in asynchronous HeLa 
cells. HeLa cells were transfected with either control or CNOT1 siRNA.  Cells were incubated 
with 10 μM EdU for 20 minutes at 24, 48 and 72 hours post siRNA transfection. Cells were 
fixed using 3.7% formadehyde diluted in PBS followed by a 0.5% Triton X-100 
permeabilisation. Cells were incubated with the fluorescent EdU detection cocktail for 30 
minutes at room temperature and protected from light. Nuclei were stained with DAPI and 
proceed for microscopic imaging (Figure 3.3 A).  The percentage of cells with positive EdU 
labelling in CNOT1-depleted cells was lower than their control counterparts, suggesting the 
progression through S phase is reduced in CNOT1-depleted cells (Figure 3.3 B).  
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Figure 3.3 Ablation of CNOT1 expression reduces the S-phase indices in HeLa cells 
HeLa cells were transfected with either control or CNOT1 siRNA and processed at the indicated 
time points. Cells were labelled with 10 μM EdU for 20 minutes. Cells were incubated with the 
fluorescent EdU detection cocktail for 30 min. Cells were visualized using a Nikon Eclipse E600 
microscope and analysed using Velocity software version 4. A) The immunofluorescence 
images illustrate both positive and negative EdU-labelled cells in control and CNOT1-depleted 
cells. B) Representative bar graphs show % cells present in S phase. 200 cells were counted in 
each experimental repeat (n = 3 independent experiments). Statistical analyses were 
performed using a two-tailed and unpaired Student t test, *P <0.05, **, P<0.01; ***, P<0.001. 
Error bars represent the StDev. Scale bars, 10 μm. 
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3.2.4 Depletion of CNOT1 remarkably reduced the G2/M cell cycle transition 
In further experiments, in order to discriminate between G2 and M phase cells, simultaneous 
staining of DNA with PI and the mitotic marker, pH3 (Serine 10), was performed at different 
time points (24, 32, 48, 56, and 7 2hours). A distinct cell cycle profile was gated to determine 
the percentage of cells present in each phase (Figures 3.4.A and B).  Very few cells were 
observed in the G2 phase and pH3-positive cells were hardly detected in CNOT1-depleted 
cells, further evidence confirming that depletion of CNOT1 disrupts the cell cycle progression 
beyond G1 phase (Figure 3.4.C) 
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Figure 3.4 Ablation of CNOT1 expression remarkably reduced the G2/M cell cycle transition 
A & B) HeLa cells were transfected with either control or CNOT1 siRNA, stained with 
simultaneous staining of DNA with PI and pH3 (with an antibody) was performed and the cell 
cycle profiles in control and CNOT1-depleted cells were analysed at different time points after 
siRNA treatment (24, 32, 48, 56 and 72 hours) on a BD LSRFortessa™ X-20 flow cytometer. C) 
Representative stacked bar graphs showing % cells present in each phase of the cell cycle (G1, 
S, G2 and M respectively). Percentages of cell cycle phase distribution represent the average 
of three independent experiments. The results are statistically significant but t-test results 
have been omitted for clarity). 
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3.2.5 Depletion of CNOT1 disrupts the cell cycle progression beyond the G1/S boundary 
The impact of depletion of CNOT1 on cell cycle progression was further assessed by 
synchronizing cells in mitosis using nocodazole (200 ng/ml), which blocks cells in pro-
metaphase by inhibiting the mitotic spindle formation, for 18h, 72 hours post CNOT1 
depletion. Mitotic cells were visualised using an EVOS fluorescence inverted digital 
microscope from Advanced Microscopy Group (AMG). Figures 3.5.A and B show HeLa cells 18 
hours after nocodazole treatment. Mitotic cells are round and weakly adherent cells, whereas 
those cells that have not entered mitosis are still flat and adhere to the tissue culture plastic. 
The dominant cell population in CNOT1-depleted cells were adherent interphase cells, 
suggesting progression into and through mitosis is inhibited in CNOT1-depleted cells. Control 
and CNOT1-depleted mitotic cells were collected by shake-off and released from the G2/M 
block by washing with fresh media. Cells were harvested at the indicated times and analysed 
by western blotting using the indicated antibodies as listed in (Figure 3.5.C). β-actin was used 
as a loading control. Separately, adherent cells were harvested by trypsinization from the 
flask and collected. Strikingly, high-level expression of cyclin E, which is responsible for cell 
cycle transition from G1 to S phase, was seen in CNOT1-depleted cells up to 24 hours after 
nocodazole release (Figure 3.5.C). Increase in expression of cyclin inhibitors p21 and p27 was 
also observed in CNOT1-depleted cells (Figure 3.5.C). Cyclin D1 was weakly expressed in 
CNOT1-depleted cells compared to controls (4 hours post G2/M release). These cells were 
considered to be in G1 phase (Figure 3.5.C). In control HeLa cells the expression level of cyclin 
B1 peaked in M phase and by entry into G1 phase was substantially reduced 2 hours post 
nocodazole washout. The level then gradually increased as the cells progressed through the 
cell cycle. However, the expression of cyclin B1 was reduced in G2/M CNOT1-depleted cells 
and into the following cycles (Figure 3.5.C). Moreover, in CNOT1- depleted cells 
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phosphorylation of the metaphase marker histone H3 (pH3) on serine 10 was lost 2 hours 
after removal of nocodazole. No further evidence of H3 phosphorylation was seen even at 
later time points (Figure 3.5.C). It is also worth noting that the CNOT1-depleted cells appear 
to progress out of mitosis more rapidly than the controls as evidenced by the absence of pH3 
after 1 hour in normal media; pH3 can be seen in control cells up to 4 hours. Cyclin A, which 
is responsible for progression through S phase, was expressed at low level during late G1 
(from 6 to 8 hours), S (at 8 hours) and G2 (at 24 hours) in CNOT1-depleted cells, suggesting 
that progression through S and G2 phases had been hindered in CNOT1-depleted cells. 
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Figure 3.5 Depletion of CNOT1 disrupts cell cycle progression beyond the G1/S boundary  
A & B) Control and CNOT1-depleted HeLa cells 18 hours after 200 ng/mL nocodazole 
treatment. Images were collected using an EVOS fluorescence inverted digital microscope. C) 
Representative immunoblot shows the comparative protein expression between control (left 
panel) and CNOT1-depleted cells (right panel). β-actin was used as a loading control. The 
expression level of cell cycle regulators at different time points up to 24 hours post nocodazole 
release is shown. The siRNA-mediated gene suppression was performed 48 h before 
nocodazole treatment. 
A) B) 
C) 
CNOT1 siRNA-72h post siRNA transfection and 18 h post 
Nocodazole treatment 
Control siRNA-72h post siRNA transfection and 18 h post 
Nocodazole treatment 
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3.2.6 p53-independent upregulation of p21 and p27 promote the G1-cell cycle 
upregulation in CNOT1-depleted HeLa and U2OS cells  
 
Since CNOT1 depletion disrupts the cell cycle progression beyond the G1/S boundary in the 
absence of DNA damage in HeLa cells, we next investigated the activation of the G1 
checkpoint in two different cell lines, HeLa and U2OS, up to 4 days post siRNA transfection. 
We have shown that the expression of cyclin inhibitors p21 (log2FoldChange in gene 
expression= + 1.073303) and p27 (no difference in gene expression was observed) gradually 
increased in CNOT1-depleted HeLa and U2OS cells (Figures 3.6.A and B). It seems that Chk2, 
independently of p53, is responsible for p21 induction in HeLa cells as no difference in p53 
gene (assessed by RNA-Seq results and it is not included) and its protein expression (assessed 
by western blot and it is included) was observed between control and CNOT1-depleted cells 
(Figures 3.6.A and B).  
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Figure 3.6 p53-independent upregulation of p21 and p27 promote the G1-cell cycle 
upregulation in CNOT1-depleted HeLa and U2OS cells. 
 A & B) Representative immunoblots shows the comparative protein expression between 
control (left panel) and CNOT1-depleted cells (right panel) in HeLa and U2OS cells 
respectively.CDK2 and β-actin were used as a loading controls. The expression level of 
indicated proteins at different time points up to 4 days post siRNA transfection is shown.  
 
B) 
A) 
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3.2.7 Depletion of CNOT1 decreased the expression of genes involved in cell cycle 
progression 
 
To assess further the cell cycle distribution of CNOT1-depleted cells, we took advantage of 
our RNA-Seq data processed by GO Enrichr tool. These results showed downregulation of 
genes involved in cell cycle progression through the S phase (GO: 0044843) (Figure 3.7 A) and 
G2/M phase transition (GO: 0044839), (GO: 0006285) and (GO: 0044772) (Figure 3.3.1 B). 
Gene ontology (GO) was applied to identify characteristic biological attributes of RNA-seq 
data. Separate gene ontology enrichment analysis using Enrichr for up-regulated and down-
regulated genes was performed. The GO data is shown in Figures 3.7 C & D. Considering the 
expression of many of these genes is cell-cycle dependent, any up- or down-regulation in their 
expression contribute to the G1-cell cycle phenotype observed in CNOT1-depleted HeLa cells.  
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Gene names 
 
log2FoldChange 
 
P-value P-adj 
 
CCNA2 -0.90561 0.000196 0.008654 
CDK1 -0.90642 0.000179 0.007997263 
ORC6 -0.95286 0.000148 0.006969 
CDKN3 -0.71543 0.006457 0.086194 
RANBP1 -0.58982 0.006463 0.086194 
PLK2 -0.76467 0.001049 0.027592 
HIST1H2AD 
 
-1.51484 
 
2.59E-07 
 
      3.92E-05 
 
HIST1H2BM 
 
-1.09616 
 
0.000175 0.00786615 
HIST1H1A 
 
-0.97789 0.000411 0.014855113 
 
HIST1H2AG 
 
-0.84148 
 
0.003343 
 
0.057579212 
HIST1H2BD 
 
-0.62675 
 
0.005821 0.080983033 
HIST1H2BH 
 
-0.81217 
 
0.001196 
 
0.029836522 
HIST1H2BO 
 
-0.8671 
 
0.000878 0.024518918 
HIST1H4A 
 
-0.96608 0.000223 
 
0.009486935 
 
A) 
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Gene 
names 
  
log2FoldChange 
 
P-value 
 
P-adj 
 
STMN1 -1.26473 7.45E-07 9.16E-05 
HMMR -1.13081 3.78E-06 0.000358865 
CEP78 -1.04606 6.03E-05 0.003474465 
CCNB2 -0.98241 7.39E-05 0.004051762 
CCNB1 -0.66348 0.003436 0.058596404 
CDK1 -0.90642 0.000179 0.007997263 
CENPF -0.6527 0.005232 0.076087796 
SKP1 -0.71037 0.001915 0.040687284 
PLK2 -0.76467 0.001049 0.027591791 
PLK4 -0.64781 0.003357 0.057729592 
CETN2 -0.68306 0.007499 0.094746499 
KIF14 -0.7639 0.001219 0.030223204 
NPM1 -0.78059 0.000968 0.026166253 
HAUS2 -0.63193 0.005177 0.075519965 
PSMD10 -0.90259 0.00042 0.015085895 
PSMA2 -0.58802 0.008214 0.099938554 
PSME1 -0.648 0.006437 0.086052333 
NEK2 -0.84308 0.000319 0.012375474 
RPS27A -0.83297 0.000366 0.013676609 
GTSE1 -0.61851 0.005085 0.074733852 
ANLN -0.78993 0.000597 0.019093037 
UBE2C -0.70916 0.001564 0.035612128 
NUF2 -0.89424 0.000141 0.006734374 
NUSAP1 -0.76365 0.000907 0.02501347 
AURKB -0.70122 0.001962 0.041184251 
SPC25 -0.84479 0.000562 0.018235204 
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Figure 3.7 Depletion of CNOT1 decreased the expression of genes involved in cell cycle 
progression through S phase and G2/M phase transition.  
 
A & B) tables show down-regulation of genes involved in cell cycle progression through S (A) 
and G2/M transition (B) 72 hours post CNOT1 siRNA treatment. The total RNA was extracted 
from 3 biological replicates and RNA-Seq was performed on 2 lanes of HiSeq4000 (paired-end, 
2x150bp) platform to generate ~80M reads per sample. The Control siRNA sample was 
D) 
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considered as the reference; log2-transformed fold changes (log2FC) of CNOT1 siRNA samples 
were calculated. Genes with positive log2FC were considered “upregulated” while those with 
negative log2FC were considered “downregulated”. The empirical p-values were used to 
determine the change in the expression of a particular gene. C & D) Gene Ontology enrichment 
analysis of molecular function for up- and down-regulated genes between control and CNOT1-
depleted HeLa cells using Enrichr platform (combined score). A threshold of 2-fold was used to 
enumerate a set of most-changed genes between conditions All RNA-seq data was uploaded 
to the GEO database (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE141496) 
with the accession number GSE141496. RNA-Seq data was generated by the Centre for 
Genomic Research, which is based at the University of Liverpool. Bioinformatics analysis was 
carried out by Dr Morteza Chalabi Hajkarim from Biotech Research and Innovation Centre 
(BRIC), which is based at the University of Copenhagen. 
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3.2.8 Autophagy, Senescence or Apoptosis? 
Irreversible accumulation of DNA damage drives mitotic cells either to adapt to stress through 
autophagy and/or senescence or to be eliminated through programmed cell death (Vicencio, 
Galluzzi et al. 2008). Therefore, we have examined whether depletion of CNOT1 can activate 
any of these pathways.  
 
3.2.8.1 Autophagy 
 
The cell culture phenotype was assessed in control and CNOT1-depleted HeLa and U2OS cells 
over a time course of 7 days using an EVOS fluorescence inverted digital microscope. CNOT1-
depleted HeLa and U2OS cells were bigger in size, with flattened morphology (between day 4 
and 5) and extensive vacuolation especially in HeLa cells at day) (Figures 3.8 A and B). This 
phenotype is commonly associated with autophagy and/or senescence. Induction of 
autophagy in CNOT1-depleted cells were confirmed by marked induction of the autophagy 
markers p16 and LC3β (Figures 3.8 C and D). Degradation of p62 (SQSTM1) during autophagy 
is another widely used marker to monitor autophagic flux. Since, p62 protein level gradually 
accumulated in CNOT1-depleted cells, with no change in its gene expression assessed by RNA-
Seq, results indicated that degradation of autophagosomes caused by lysosomal acidification 
is impaired (Figures 3.8 C and D). To confirm that induction of autophagy is p53-independent 
we monitored the cell culture phenotype and expression of p62 protein in control and CNOT1-
depleted H1299 cells, which have a homozygous partial deletion of the TP53 gene and, as a 
result, do not express the tumour suppressor p53 protein. Similarly depletion of CNOT1 
increased the formation of vacuoles in H1299 cells 7 days post siRNA transfection (Figure 3.8 
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E). Perturbation in autophagy was also monitored by upregulation of p62 protein in CNOT1-
depleted H1299 cells (Figure 3.8 F). 
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Figure 3.8 Induction of autophagy in CNOT1-depleted HeLa, U2OS and H1299 cells.  
A & B) Representative images compare the cell phenotypes in control HeLa / U2OS cells (left 
panel) and CNOT1-depleted HeLa / U2OS cells (right panel) 7 days post siRNA transfection. 
Images were collected using an EVOS fluorescence inverted digital microscope (scale bar of 
400 μm). C & D) Representative western blots show expression level of autophagy markers 
p62 (SQSTM1), LC3β, p16 between control and CNOT1-depleted HeLa / U2OS cells up to 4 days 
E) 
F) 
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post siRNA depletion. E) Representative images compare the cell phenotypes in control (left 
panel) and CNOT1-depleted H1299 (null-p53) cells (right panel) 7 days post siRNA transfection 
(scale bar of 400 μm). F) Representative western blot shows expression level of autophagy 
markers p62 (SQSTM1) between control and CNOT1-depleted H1299 cells up to 4 days post 
siRNA depletion.   
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3.2.8.2 Senescence 
It is well known that primary mammalian cells in culture eventually reach a state of ‘replicative 
senescence’ where they are metabolically active and still viable but stop dividing. Senescence 
can also be induced in most cells in response to various forms of stress. Induction of 
senescence in HeLa cells was confirmed using SA-β-gal staining at 3, 5 and 7 days post CNOT1 
siRNA transfection.  Based on the results obtained in section 3.2.1 (the knock down efficiency 
assay) and knowing that induction of senescence without drug administration is not an 
immediate response, we processed samples from 72 hours post siRNA treatment for both 
control and CNOT1-depleted HeLa cells. However, we do acknowledge the need of 0 time 
points for both control and CNOT1-depleted cells for a robust comparison with the later time 
points. We have shown that at later times, the CNOT1-depleted HeLa cells appeared to 
senesce (increased senescence-associated β -galactosidase activity) whereas the control; cells 
did not (Figures 3.9 A & B). 
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Figure 3.9 Induction of senescence in CNOT1-depleted HeLa cells.  
A) Representative images compare the development of SA-β-Gal staining (positive senescent 
cells) in control HeLa cells (top panel) and CNOT1-depleted HeLa cells (bottom panel) between 
day 3 (left panel) and day 7(right panel) post siRNA transfection. The blue colour represents 
senescent cells. Scale bar = 50 μm. B) Representative bar graphs show % SA-β-Gal positive cells 
in control and CNOT1-depleted cells 3, 5 and 7 days post siRNA depletion (n=3 independent 
experiments). Statistical analyses were performed using a two-tailed and unpaired Student t 
test, *P <0.05, **, P<0.01; ***, P<0.001. Error bars represent the StDev. 
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3.2.8.3 Apoptosis 
 
As the cells treated with CNOT1 siRNA for a long time (in excess of 6 days) appear to be in 
‘distress’ we considered the possibility that they were undergoing apoptosis.  However, no 
activation of the apoptosis pathway was observed in CNOT1-depleted HeLa cells at least via 
procaspase-3 activation or PARP1 degradation (Figure 3.10 A). Control HeLa cells treated with 
cisplatin (10 µg/mL) wereused as a positive apoptotic control. PARP1 cleavage was observed 
following cisplatin treatment for 24 h, depletion of CNOT1 did not affect PARP cleavage in 
HeLa cells.  
 In a further experiment, using CellTiter-Glo Luminescent Cell Viability Assay to measure ATP 
level as an indication of cell viability we have demonstrated that CNOT1-depleted HeLa cells 
showed decreased level of cell proliferation (negative slope) (Figure 3.10 B)., consistent with 
the other data presented here. Depletion of other CNOT components also reduced cell growth 
but not to the same extent as loss of CNOT1. In addition, we have shown that depletion of 
CNOT1 significantly reduced the ability of colony formation in CNOT1-depleted cells (0h) 14 
days after the plating of cells in the absence of DNA damaging agents (Figures 3.10 C & D).  
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Figure 3.10 Reduced cell proliferation and viability in CNOT1-depleted HeLa cells in the 
absence of activated apoptosis via procaspase-3 activation or PARP1 degradation.  
A) Representative western blot showing the activation of apoptosis (as judged by the loss of 
procaspase 3 and degradation of PARP1) between cisplatin (10µg/mL)-treated control HeLa 
cells and untreated control and CNOT1-depleted HeLa cells. B) The diagram shows the number 
of viable cells treated with different CNOT subunit siRNAs in culture based on quantitation of 
the ATP present, an indicator of metabolically active cells. All values (for each siRNA-treated 
sample) were calculated relative to cells treated with control siRNA at the appropriate time 
point. C) HeLa cells were plated at appropriate concentration 72 hours post siRNA 
transfection. At day 14, large colonies were stained with crystal violet and counted (thanks to 
Dr Katarzyna Leszczynska and Professor Ester Hammond at University of Oxford for doing this 
experiment for us). D) Representative bar graph shows the plating efficiency of the cells at 
day 14 after staining with crystal violet and counting (N=3 independent experiments). 
Statistical analyses were performed using a two-tailed and unpaired Student t test, *P <0.05, 
**, P<0.01; ***, P<0.001. Error bars represent the StDev. 
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3.3 DISCUSSION 
 
Taken together, we have shown that depletion of CNOT1 impairs cell cycle progression 
beyond the G1/S boundary judged by FACS analysis and western blotting after 
synchronization of cells in the G2/M phase. The FACS analysis showed the accumulation of a 
G1 population in CNOT1-depleted HeLa cells, whereas, very few cells were observed in the S 
and G2/M phases. In further FACS analysis, simultaneous staining of DNA with PI and the 
mitotic marker, pH3 (Serine 10) allowed us to determine the percentage of cells present in 
G2 and M phases separately. pH3-positive cells were hardly detected in CNOT1-depleted cells 
confirming G2/M transition is inhibited. In support of the FACS results, we also assessed the 
expression level of proteins involved in cell cycle progression following synchronization of 
cells into the G2/M phase using nocodazol treatment. In line with our FACS analysis, the 
expression level of cyclins A2 and B1 and pH3 were all downregulated in CNOT1-depleted 
cells. In contrast, the expression of cyclin E was appreciably higher in CNOT1-depleted cells 
during G1 and beyond. We have also shown that the expression levels of the CDK inhibitors 
p21 and p27 were both upregulated in CNOT1-depleted cells, which may explain the G1-cell 
cycle arrest phenotype. This is further evidence confirming that depletion of CNOT1 disrupts 
the cell cycle progression beyond G1 phase. Upregulation of p21 and p27 appeared to be 
independent of p53 as its gene and protein expressions were not affected in CNOT1-depleted 
cells. Moreover, it is possible that Chk2, independently of p53, was responsible for p21 
induction in HeLa cells. It has been previously reported that a novel p53-independent role for 
Chk2 in p21 induction and senescence may contribute to tumour suppression (Aliouat-Denis, 
Dendouga et al. 2005). In addition, Phalke et al. (2012) have shown that PRMT6 depletion 
induces the p21 levels by a p53-independent mechanism (Phalke, Mzoughi et al. 2012). 
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Interestingly, the gene expression of PRMT6 was downregulated in CNOT1-depleted HeLa 
cells (log2FoldChange= -2.71). It is worth mentioning that the expression of PRMT6 could be 
affected by G1-cell cycle arrest in CNOT1-depleted cells.  
Since the gene expression of p27 was not affected by CNOT1 depletion we assume this 
upregulation in its protein level was due to increased stability of its mRNA poly (A) tail which 
was already reported by Morita et al. (2007). These authors have shown that depletion of 
CNOT6L elevates the expression level of p27 protein due to increased stability of its mRNA 
poly (A) tail when deadenylase activity of CNOT complex is compromised (Morita, Suzuki et 
al. 2007). Upregulation of both p21 and p27 protein may exert the growth inhibitory effects 
through the induction of G1 arrest. It is also possible that increased half-life contributes to 
the additional protein observed. 
In addition, depletion of CNOT1 downregulated the expression of those genes involved in cell 
cycle progression through the S phase and G2/M phase transition. For example; 
downregulation of genes involved in nucleosome assembly and organization (GO: 0034728) 
such as histones was observed in CNOT1-depleted cells. Downregulation of chromatin re-
modellers which are required during replication to deal with the addition of DNA associated 
proteins to the newly synthesised DNA can also contribute to decreased S phase progression. 
Interestingly, (Alabert, Bukowski-Wills et al. 2014)  Alabert et al. (2014) using the nascent 
chromatin capture (NCC) technique, have shown that mammalian CNOT1 protein was among 
3995 proteins enriched in nascent newly synthesized chromatin (Alabert, Bukowski-Wills et 
al. 2014). The other important genes, which are responsible for progression through S phase, 
such as cyclin A, CDK1 and ORC6 were downregulated in CNOT1-depleted HeLa cells. In 
addition, using the immunofluorescence detection of EdU, we demonstrated that depletion 
of CNOT1 reduces the S phase indices in HeLa cells.   
CNOT1 & The CELL CYCLE PROGRESSION 
165 
 
G2/M cyclin B1 and B2 gene expression was downregulated in CNOT1-depleted HeLa cells.  
Cell viability assay showed the low level of cellular ATP in CNOT1-depleted cells. In addition, 
depletion of other CNOT components also reduced cell growth but not to the same extent as 
loss of CNOT1. We have also demonstrated that depletion of CNOT1 significantly reduced the 
ability of colony formation in CNOT1-depleted cells 14 days after the plating of cells in the 
absence of DNA damaging agents. Together these observations confirm the necessity of 
CNOT1 and the CNOT complex for continued cell viability and proliferation. 
Different studies have shown that depletion or mutation of different CNOT subunits 
contributes to apoptosis, senescence and autophagy (Morita, Suzuki et al. 2007, Ito, 
Takahashi et al. 2011, Mittal, Aslam et al. 2011, Yamaguchi, Suzuki et al. 2018). In agreement 
with these studies, we have shown that at later time (day 7), when we expect the effects of 
siRNA-mediated silencing of CNOT1 to be markedly decreased, CNOT1-depleted HeLa cells 
appeared to senesce and /or undergo autophagy.  Extensive vacuolation that is a common 
phenotype associated with autophagy, senescence and/or endoplasmic reticulum ER stress 
was observed in CNOT1-depleted cell. In addition, depletion of CNOT1 caused the marked 
induction of the autophagy markers p16 and LC3β. Degradation of p62 (SQSTM1) during 
autophagy is another marker, widely used to monitor autophagic flux. We observed that the 
protein expression level of p62 gradually accumulated in CNOT1-depleted cells with no 
change in its gene expression indicating that the degradation of autophagosomes caused by 
lysosomal acidification was impaired. We confirmed that induction of autophagy is p53-
independent using CNOT1-depleted H1299 cells (p53-) showing induction of p62 and vacuoles 
formation at later time points.  
We have also shown that at later times, the CNOT1-depleted HeLa cells senesce, as 
demonstrated by increasing the senescence-associated β -galactosidase activity. We do 
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acknowledge the need of 0 time points for both control and CNOT1-depleted cells for a robust 
comparison with the later time points.  
No activation of caspase-3 pathway or degradation of PARP1, which are normally taken as 
diagnostic markers of apoptosis, was not seen in CNOT1-depleted HeLa cells. However, the 
gene expression of caspase types 1 and 4 were both upregulated in CNOT1-depleted HeLa 
cells. Ito et al. (2011) had shown that the sub G1 apoptotic fraction was increased in CNOT1-
depleted HeLa cells. They further showed that CNOT1 depletion increased CHOP mRNA levels 
and activated caspase-4, which is associated with ER stress-induced apoptosis (Ito, Takahashi 
et al. 2011). ER stress induces intrinsic apoptosis independent from the DDR in the unfolded 
protein and is characterized by extensive cytoplasmic vacuolation in cancer cells. 
 Overall, these results indicate that the CNOT complex is required for progression through S 
phase and G2/M. In the absence of an active CNOT complex, or at least of CNOT1, cells 
accumulate in G1 phase, undergo, over time, senescence and probably cell death by 
autophagy or apoptosis.  
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4 CNOT1 AND DNA REPLICATION STRESS 
 
 
4.1 INTRODUCTION 
The CNOT complex regulates “Transcript Buffering” by controlling the steady-state level of 
mRNA. On the one hand, it controls the transcription initiation / elongation, and on the other, 
it regulates the mRNA degradation (Timmers and Tora 2018).  
Consistent with this, various studies have described positive and negative roles of the CNOT 
complex during transcription. The CNOT complex is the negative transcription regulator of 
TATA-less genes which in human and yeast includes 80% of genes (Anish, Hossain et al. 2009, 
Yang, Wang et al. 2014). These genes are mostly involved in energy metabolism and the 
inflammatory response. In fact, the CNOT complex is also the positive transcription regulator 
of TATA-containing genes, which in human includes 20% of genes. These genes are mostly 
involved in the cellular stress response. 
Results from in vivo protein-DNA cross-linking studies in yeast indicate that the NOT1-NOT5, 
and Ccr4 subunits associate with the 5´ region of mRNA, reflecting a role for the CNOT 
complex in transcription initiation (Lee, Wyrick et al. 1998, Badarinarayana, Chiang et al. 2000, 
Deluen, James et al. 2002, Swanson, Qiu et al. 2003, Kruk, Dutta et al. 2011). It has been shown 
that the Ccr4 (CNOT6L) protein strongly binds to promoter regions and resides in a large 
cluster of proteins  involved in transcription elongation by RNA Pol II; this may indicate the 
role of Ccr4 in transcription elongation (Kruk, Dutta et al. 2011, Sohrabi-Jahromi 2019). The 
ubiquitin E3 ligase NOT4 appears to contribute to transcription elongation by regulation of 
histone H3 K4 tri-methylation, which positively regulates transcription elongation, through 
ubiquitin-dependent protein degradation of histone demethylase Jhd2; this results in forward 
translocation of a stalled RNA Pol II (Reese 2013). This requires the association between the 
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Rpb4/7 module of the polymerase RNA Pol II and both NOT3 and NOT5 in Saccharomyces 
cerevisiae (Babbarwal, Fu et al. 2014). Stalled RNA Pol II at DNA lesions can be also removed 
by NOT4-mediated polyubiquitylation and proteasome-dependent degradation of the largest 
RNA Pol II subunit Rpb1 (Jiang, Wolgast et al. 2019).  
NOT1 negatively regulates the transcription of TATA-less promotors such as seen in the HIS3 
gene (Oberholzer and Collart 1999). CNOT1 is a ligand-dependent repressor of estragon ERα-
mediated transcription of target genes such c-Myc (Winkler, Mulder et al. 2006). Among those 
proteins involved in controlling major histocompatibility complex class II (MHC-II) 
transcription and transport, CNOT1 and CNOT2 were identified using a genome-wide RNAi 
screen (Paul, van den Hoorn et al. 2011). For the first time, Zwartjes et al. (2004) showed that 
the NOT-Box motif of the CNOT2 and CNOT3 subunits can directly repress the association of 
the promoter sequence TATA-box with RNA Pol II (Zwartjes, Jayne et al. 2004).  
Increased global transcription activity can become a potentially hazardous process promoting 
replication stress, which would ultimately cause genome instability, a hallmark of cancer cells. 
Importantly, the link between CNOT1 and cancer has been previously reported by several 
studies. Gain-of-function mutation of CNOT1 functions as an oncogene in osteosarcoma 
progression (Cheng, Li et al. 2017). Single nucleotide polymorphisms (SNPs) within 
the CNOT1 and CNOT6 genes are associated with B-cell paediatric lymphoblastic leukaemia 
(B-ALL) (Gutierrez-Camino, Lopez-Lopez et al. 2014). In addition, missense mutations, which 
are dominant mutations in the CNOT1 have been frequently reported in colorectal, 
melanoma and uterine cancers (cBoPortal & Gene online projects). 
In this chapter we first show that depletion of CNOT1 increases global transcription which is 
a well-known  mechanism of oncogene-induced replication stress in cancer (Kotsantis, Silva 
et al. 2016). We also show that depletion of CNOT1 increases formation of transcription-
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dependent R-loop intermediates, which impair the progression of replication forks. We also 
demonstrate that another source of replication stress in CNOT1-depleted cells is depletion of 
the dNTP pool as the CNOT complex is required for transcription of RNR genes (Mulder, 
Winkler et al. 2005). We also show that the level of embedded rNTP into genomic DNA 
increases in CNOT1-depleted cells following dNTP pool depletion and reduced protein 
expression of RNase H2A and B. In a recent CRISPR screen of genes whose mutation causes 
increased PARP inhibitor sensitivity the RNase H2 enzyme complex (RNase H2A, RNase H2B 
and RNase H2C) and several CNOT genes were identified (Zimmermann, Murina et al. 2018). 
In another CRISPR screen it was shown that RNase H2 and CNOT complex deficiency is  
synthetically lethal with ATR both in vitro and in vivo (Wang, Wang et al. 2018). It is 
noteworthy that we show that two subunits CNOT1 and Tab182 have physical interaction with 
ATR and different pre-RC components (MCM2, MCM7 and ORC3). Finally, we show that the 
deadenylase activity of CNOT complex is compromised when CNOT1 is depleted. 
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4.2 RESULTS 
4.2.1 CNOT1-depleted cells show increased transcription activity 
The effect of CNOT1 depletion on transcription activity was assessed by quantifying the level 
of RNA-specific labelled nucleoside 5-ethynyl uridine (EU) incorporated into nascent RNA 
(Figure 4.1.A). RNA synthesis (EU incorporation) was elevated 48 hours post CNOT1 depletion 
and was slightly decreased on day 3 and increased further on day 4; this incorporation was 
significantly greater than the level seen in control cells (Figure 4.1.B). Increased level of 
transcription activity in CNOT1-depleted cells was also indicated by western blotting results 
showing increased expression level of TATA-binding protein (TBP) and phospho-RNA Poll (C-
terminus) at serine 5 compared to the control cells (Figure 4.1.C).  
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Figure 4.1 CNOT1 depletion increases transcription 
A) HeLa cells were depleted with CNOT1 siRNA or control siRNA. Transcription elongation was 
measured after EU incorporation (1 hour) shown after 48, 72 and 92 hours. B) To quantitate 
EU incorporation, Hoechst was used to stain the nucleus of cells, generating a nuclear mask. 
Then Adobe Photoshop was used to adjust the levels of all panels equally. Quantification of 
EU signal per nucleus was performed by RStudio statistical software and shown (n=3 
independent experiments, Stats: Mann-Whitney Wilcoxon Rank Sum). C) Representative 
western blot shows the expression level of TBP and the phosphorylation of RNA Poll (S5) in 
each experimental condition. CDK2 was used as a loading control.  
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4.2.2 Depletion of CNOT1 induces replication stress through ongoing transcription 
To test the hypothesis that an increase in transcription level observed in CNOT1-depleted 
cells may underlie replication stress in CNOT1-depleted cells, RNA synthesis was inhibited 
using 100 µM DRB (100 minutes). DRB inhibits RNA polymerase II elongation by inhibition of 
CDK-activating kinase associated with the general transcription factor TFIIH (Yankulov, 
Yamashita et al. 1995).  Treatment with DRB significantly reduced the nuclear EU intensity in 
both control and CNOT1-depleted cells, consistent with decreased level of RNA synthesis 
(Figure 4.2.A & B). In a further experiment, we went on to investigate the effect of CNOT1 
depletion on DNA replication directly. Using DNA fibre analysis, as described in section 2.2.7 
and 2.4.6, we examined DNA replication fork speeds in the absence of CNOT1. Depletion of 
CNOT1 was seen to reduce fork speeds appreciably (Figure 4.2.C). However, DRB treatment 
increased replication fork speeds specifically in CNOT1-depleted cells (Figure 4.2.C). Similarly, 
treatment with PHA-767491 (CDC7/CDK9 inhibitor) which is a dual replication and 
transcription inhibitor significantly rescued replication fork progression, presumably by 
reduction in replication initiation or transcription elongation by inhibition of CDC7 or CDK9, 
respectively, in CNOT1-depleted cells (Figure 4.2.D). These data suggest that replication stress 
in CNOT1-depleted cells is associated with increased active RNA synthesis. 
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Figure 4.2 CNOT1-induced replication stress is promoted by ongoing transcription 
A) Inhibition of RNA synthesis with DRB in CNOT1 depleted HeLa cells. Cells were treated with 
CNOT1 or control siRNA. On days 2, 3 and 4 cells were exposed to DRB or the solvent DMSO 
for 100 min during EU labelling. B)  Quantification of EU signal per nucleus treated with 
transcription inhibitor DRB was performed by RStudio statistical software and shown (n=3 
independent experiments). Stats: Mann-Whitney Wilcoxon Rank Sum. C) Distribution of 
replication fork speeds 72 h after CNOT1 depletion; cells were treated with transcription 
inhibitor DRB (450 replication forks from 3 independent experiments). D) Distribution of 
replication fork speeds 72 h after CNOT1 depletion in HeLa cells treated with 10 µM pha-
767491 for 1 h (450 replication forks from 3 independent experiments). The lengths obtained 
in Image J were converted into micrometres using the scale bars on the microscope. 
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4.2.3 Depletion of CNOT1 causes replication stress through R-loop formation in HeLa 
cells 
Transcription may affect genome integrity if co-transcriptional products such as RNA-DNA 
hybrids (R-loops) are not efficiently removed behind RNA polymerase II (Skourti-Stathaki and 
Proudfoot 2014). Therefore, we investigated whether elevated transcription activity in 
CNOT1-depleted cells leads to increased R‐loop formation; to examine this slot blot analysis 
of gDNA isolated from control and CNOT1-depleted Hela cells was performed. Samples were 
generated as described in Chapter 2 (section 2.5.5) and nitrocellulose membranes from the 
slot blot were incubated with S9.6 antibody, which detects the RNA-DNA hybrid, or antibody 
against single stranded DNA (ssDNA). R-loops were significantly enriched in CNOT1 depleted 
cells compared to the control cells. The S9.6 signal was diminished by pre-treatment of gDNA 
with RNase H1 enzyme for 2 hours, demonstrating that the signal derived from RNA (Figure 
4.3.A). 
In more detailed investigations, we examined the expression levels of proteins known to be 
involved in R-loop resolution, such as RNase H1, RNase H2A or B, Senataxin (SETX) and TOP I 
(Sollier, Stork et al. 2014). If any of these enzymes fails to operate properly, R-loops may 
persist and accumulate behind the transcription machinery and cause DSBs and genome 
instability (Sollier, Stork et al. 2014).Immunoblotting of control and CNOT1-depleted cells 
showed no difference in RNase H1 expression between two experimental conditions; 
however, there was a noticeable downregulation of RNase H2A in CNOT1 knocked down cells. 
TOP I and SETX protein, which are also involved in R-loop removal, were upregulated, 
presumably to deal with the increased level of R-loops in CNOT1-depleted cells (Figure 4.3.B). 
In a further experiment, the intensity of nuclear S9.6 signal was quantified by confocal 
microscopy. Cells were co-labelled with S9.6 antibody and an antibody against the nucleolar 
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protein nucleolin (NCL). The S9.6 signal was decreased after transfection of RNase H1 cDNA 
for 24 hours. The ability of endogenous RNase H1 enzyme to remove R-loops from gDNA 
appeared to be somewhat more efficient than the transiently transfected recombinant RNase 
H1 (Figure 4.3.C and D). This could be due to the presence of RNase H-resistant hybrids or 
incomplete nuclease activity in the nucleolus, which is rich in DNA-RNA hybrids. It is also very 
likely that transfection efficiency of the construct was less than 100% (transfection efficiency 
of 20-25%). To investigate the contribution of R-loops to replication fork slowing in CNOT1-
depleted cells, recombinant RNase H1-GFP was transfected into CNOT1-depleted and control 
cells. RNase H1-GFP did not have a significant effect on replication initiation (Figure 4.3.E), 
although it rescued the replication fork progress in CNOT1-depleted cells to a limited extent, 
but not in control cells.  This observation supports the suggestion that replication stress in 
CNOT1 depleted cells is promoted by increased R-loop formation following increased RNA 
synthesis (Figure 4.3.F).  
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Figure 4.3 CNOT1-depleted HeLa cells have increased R-loop accumulation 
A) Detection of RNA-DNA hybrids using slot blot and S9.6 antibody on gDNA isolated from 
HeLa cells 72 hours post CNOT1 depletion. A ssDNA antibody was used as a loading control 
(lower panel). B) Representative immunoblot shows the expression level of RNase H1, RNase 
H2A, TOP I and SETX in each experimental condition. β-Actin was used as a loading control. 
C)  Co-immunostaining of HeLa cells with S9.6 (green) and nucleolin (red) antibodies 72 hours 
post siRNA transfection and 24 hours after recombinant RNase H1 transfection. The nuclear 
DNA was stained with DAPI. D) Quantification of S9.6 antibody signal per nucleus after 
subtraction of nucleolar staining using Image J. Statistical analysis was performed using 
RStudio statistical software. (n=3 independent experiments, Stats: Mann-Whitney 
Wilcoxon Rank Sum). E) Representative bar graph shows the percentage of new origins during 
DNA fibre labelling 72 hours post CNOT1 depletion and 24 h post transfection with pCMV6-
AC-RNase H1-GFP or pcDNA 3.1 (450 replication forks from three independent experiments). 
F) Distribution of replication fork speeds 24 h post transfection with pCMV6-AC-RNase H1-GFP 
or pcDNA 3.1 following 72 h CNOT1 depletion (450 replication forks from two independent 
experiments. The lengths obtained in Image J were converted into micrometres using the scale 
bars on the microscope. 
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4.2.4 Depletion of CNOT1 causes replication stress by an increase in embedded rNTP into 
genomic DNA following dNTP pool reduction  
Knowing that the CNOT complex is required for transcription of RNR genes (Mulder, Winkler 
et al. 2005) and depletion of the dNTP pool impairs discrimination between 
rNTP and dNTP by DNA polymerases during DNA replication (McElhinny, Watts et al. 2010), 
we first confirmed that the protein expression level of catalytic subunit RRM2 and non-
catalytic subunit p53R2 is downregulated in CNOT1-depleted cells (Figure 4.4.A). This 
downregulation was also seen at the gene expression level of RRM2 confirmed by RNA-Seq 
results (log2FoldChange= -0.79974). Treatment with the RNR inhibitor, HU slightly reduced 
the ability of CNOT1-depleted HeLa cells in colony formation, 14 days post siRNA transfection 
(Figure 4.4.B). 
Next, we speculated that the level of mis-incorporated ribonucleotides into gDNA is increased 
in CNOT1 depleted cells. To investigate this, the sensitivity of gDNA to alkaline hydrolysis was 
examined as the presence of ribonucleotides in gDNA increases its susceptibility to hydrolysis 
at high pH. For this, sufficient volume of each DNA sample was treated with 0.3 M NaOH for 
2 hours at 55°C and fractionated on a 1% alkaline agarose gel. Genomic DNA isolated from 
CNOT1-depleted cells displayed markedly increased sensitivity to alkaline hydrolysis and 
migrated faster compared to that from control cells (the DNA peak was shifted from left to 
right as seen in the densitometric intensity distribution), suggesting a high level of 
ribonucleotide embedded in gDNA in CNOT1-depleted cells (Figure 4.4.C and D). Besides, we 
observed downregulation of proteins which are involved in the enzymatic removal of mis-
incorporated ribonucleotides into gDNA (RNase H2A and B) in CNOT1-depleted cells (Figure 
4.4.E)  
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Figure 4.4 CNOT1-depleted HeLa cells show increased embedded ribonucleotide in genomic 
DNA 
A) Western blot analysis of RNR subunits RRM1/2 and p53R2 in control and CNOT1-depleted 
cells 72 hours post siRNA transfection. CDK2 was used as a loading control. B) Cells were plated 
at appropriate concentration 72 hours post siRNA transfection and then exposed to different 
concentrations of HU (mM). At day 14, large colonies were stained with crystal violet and 
counted. Clonogenic survival was expressed as a surviving fraction of non-treated controls for 
each condition and was plotted on a semi-logarithmic scale. Representative graphs were 
plotted from 3 independent experiments. Statistical analyses were performed using a two-
tailed and unpaired Student t test, *P <0.05; **, P<0.01. Error bars represent the SEM. C) 
Representative 1% alkaline agarose gel of NaOH-treated nucleic acids from control and 
CNOT1-depleted cells. D) The quantitative estimation of ribonucleotide level from the gel 
shown in “C” using the distribution of DNA densitometry intensity analysis. The intensity of 
DNA ladder bands shown is decreased by 1/3 and the intensity of the gDNA bands is increased 
three-fold to make a more obvious comparison. E) Western blot analysis of RNase H2A and B 
in control and CNOT1-depleted Hela cells 72 hours post siRNA transfection. β-Actin was used 
as a loading control   
E) 
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4.2.5 The CNOT complex may function in origin firing  
Continuing our investigation of a role for CNOT1 in DNA replication, DNA fibre analysis was 
performed, and replication structures analysed in siRNA treated cells. CNOT1 depleted HeLa 
cells showed increased stalling of forks together with an increase in first label origin and a 
decrease in second label origins (Figure 4.5.A). To gain further insight into the role of the 
CNOT1 and/or the CNOT complex in DNA replication, a series of co-immunoprecipitation (CIP) 
assays was conducted with a panel of pre-replication complex (pre-RC) antibodies (MCM2, 
MCM7 and ORC3). The CIP assays were carried out using HeLa cell lysates, prepared as 
described in chapter 2 (section 2.4.3) and revealed that MCM2, MCM7 and ORC3 associated 
with CNOT1 and TAB182 suggesting that the CNOT complex may interact with the pre-RC at 
DNA replication origins (Figure 4.5.B,C & D). The difference between the amounts of target 
protein immunoprecipitated with the TAB182 and CNOT1 antibodies is probably a reflection 
of a much higher titre in the former compared to the latter. Cellular levels of MCM proteins 
2, 3, 7 and CDC7 were similar in control and CNOT1-depleted cells 72 hours post siRNA 
depletion (Figure 4.5.E).  
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Figure 4.5 The CNOT complex regulates replication initiation in Hela cells 
DNA fibre labelling was carried out in HeLa cells 72 hours post siRNA transfection. A) 
Representative bar graph of DNA fibre structures 72 h after CNOT1 depletion. (450 replication 
forks from 3 independent experiments, mean ± SD, *p < 0.05, **p < 0.01 and ***p < 0.001). 
B, C & D) The CIP assays were conducted using HeLa cell lysates incubated with either CNOT1 
or TAB182 or irrelevant antibody (control) overnight. Antibody-bound protein complexes were 
collected on protein G-agarose beads. The immune-complexes were then fractionated by SDS-
PAGE, and western blotting was performed using MCMs 2, 7 and ORC3 antibodies. F) Levels 
of the indicated MCM proteins 2, 3, 7 and CDC7 were determined by immunoblotting of total 
HeLa cell extracts 72 h post transfection with control or CNOT1 siRNA.  
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4.2.6 CNOT1-depleted cells show reduced deadenylase activity 
To ascertain whether the deadenylase activity of the CNOT complex was reduced by depletion 
of CNOT1, a simple deadenylase assay was performed. 5’-fluorescein-labeled RNA substrate 
was incubated with equal amounts of whole cell lysates of control and CNOT1-depleted cells 
for 10, 30, 60 and 120 minutes at 37°C. The reaction was stopped by addition of RNA loading 
buffer and heating for 3 minutes at 85°C. Aliquots of the assay mixtures were fractionated on 
20% polyacrylamide gel in the presence of 8M urea. The data presented suggests that 
depletion of CNOT1 noticeably decreased the level of deadenylase activity of the CNOT 
complex compared to the control (Figure 4.6.A, B & C). The deadenylase activity of CNOT7-
depleted cells was also measured as a positive control. Surprisingly, depletion of deadenylase 
subunit CNOT7 increased the level of deadenylated ribonucleotides even greater than the 
one observed in control, suggesting that other deadenylase subunits catalyze deadenylation 
in HeLa cells (Figure 4.6.D & E). For instance, Lau et al. (2009) reported, in mammalian cells, 
that the complex contains either CNOT7 or CNOT8 (not both as in yeast), suggesting they 
compete for binding to CNOT1 (Lau, Kolkman et al. 2009). Depletion of Tab182 did not affect 
the deadenylase activity of the CNOT complex (Figure 4.6.F & G). The overall reduction in 
deadenylase activity in HeLa cells following depletion of CNOT1 was also confirmed by RNA-
Seq results and GO Enrichr tool (section3.2.7). 
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Figure 4.6 Deadenylase activity is suppressed in CNOT1-depleted HeLa cells, but not in 
CNOT7 and Tab182 -depleted HeLa cells 
 
2µl of 5’-fluorescein-labeled RNA substrate (Flc-5’-CCUUUCCAAAAAAA‐3’) was incubated with 
equal amounts of whole cell lysates (5g ) of control, CNOT1, CNOT7 and Tab182-depleted 
HeLa cells for 10, 30, 60 and 120  minutes at 37°C. The reaction was stopped by addition of 
10µl RNA loading buffer and heating for 3 minutes at 85°C. Aliquots of the assay mixtures 
were fractionated on 20% polyacrylamide gel containing 8 M urea. 5'-Fluorescein labelled 
ribonucleotides were visualised using a FUSION-FX imaging system. A) 1: 5'-Flu, 2: Control 
siRNA (10min), 3: Control siRNA (30min), 4: Control siRNA (60min), 5: Control siRNA (120min), 
6: CNOT1 siRNA (10min), 7: CNOT1 siRNA (30min), 8: CNOT1 siRNA (60min), 9: CNOT1 siRNA 
(120min). B & C) Representative bar graphs show the relative density of the RNA bands in 
Control and CNOT1-depleted Hela cells. Bands were quantified using the ImageJ software. 
Total pixel density for each lane was computed by drawing a rectangle around the bands. D) 
1: 5'-Flu, 2: CNOT7 siRNA (10min), 3: CNOT7 siRNA (30min), 4: CNOT7siRNA (60min), 5: CNOT7 
siRNA (120min), 6: Tab182 siRNA (10min), 7: Tab182 siRNA (30min), 8: Tab182 siRNA (60min), 
9: Tab182 siRNA (120min). E & F) Representative bar graphs show the relative density of the 
RNA bands in CNOT7 and Tab182-depleted Hela cells. This experiment was carried out by a 3rd 
year BSc Biomedical Science project student Amandeep Jagdev.  
 
 
 
 
 
 
CNOT1 & DNA REPLICATION STRESS 
194 
 
4.3 DISCUSSION 
 
Taken together, we have shown that depletion of CNOT1 increases the RNA synthesis in HeLa 
cells judged by EU incorporation assay. Treatment with DRB appreciably reduced the nuclear 
EU intensity in both control and CNOT1-depleted cells, consistent with decreased level of RNA 
synthesis. Importantly, treatment with transcription inhibitors DRB and PHA significantly 
increased the replication fork speed in CNOT1-depleted cells, suggesting that replication 
stress in CNOT1-depleted cells is caused by active RNA synthesis. In addition, the level of 
general transcription factors TBP and phosphorylation of RNA Poll (C-terminus) at serine 5 
were both upregulated in CNOT1-depleted cells 72 hours post siRNA transfection. The level 
of TOP I, which contributes to transcription elongation by resolving transcription-induced 
DNA hyper-negative supercoiling downstream of RNA Pol II (Shykind, Kim et al. 1997, 
Baranello, Wojtowicz et al. 2016), was also upregulated in CNOT1-depleted cells 72 hours post 
siRNA transfection. 
Increased transcription-associated R-loop formation in CNOT1-depleted cells was confirmed 
using the slot-blot assay and immunoblotting of S9.6 antibody. The S9.6 signal was diminished 
by pre-treatment of gDNA with RNase H1 enzyme for 2 hours, demonstrating that the signal 
derived from RNA. In addition, immunofluorescence detection of nuclear S9.6 confirmed the 
results obtained from the slot-blot assay. Transfection of RNase H1 cDNA for 24 hours 
decreased the S9.6 intensity in both control and CNOT1-depleted cells. The ability of 
endogenous RNase H1 enzyme to remove R-loops from gDNA in slot-blot assay was somewhat 
more efficient than the transiently transfected recombinant RNase H1 in 
immunofluorescence detection of S9.6. 
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In more detailed investigations, we examined the expression levels of proteins known to be 
involved in R-loop resolution, such as RNase H1, RNase H2A or B, Senataxin (SETX) and TOP I. 
Immunoblotting of control and CNOT1-depleted cells showed no difference in RNase H1 
expression between the two experimental conditions; however there was a noticeable 
downregulation of RNase H2A in CNOT1 depleted cells. TOP I and SETX protein levels were 
upregulated, presumably to deal with the increased level of R-loops, in CNOT1-depleted cells. 
We also showed that increased transcription-dependent R-loop formation can be a source of 
slowed replication forks in CNOT1-depleted cells. Transfection with recombinant RNase H1-
GFP did not have a significant effect on replication initiation, although it rescued replication 
fork progress in CNOT1-depleted cells to a limited extent, but not in control cells.   
 The results obtained from RNA-Seq data showed downregulation of RRM2 expression in 
CNOT1-depleted cells. In agreement with this, our western blotting data showed that the 
expression level of RRM2 protein was also downregulated in CNOT1-depleted cells. Knowing 
that the expression of RNR-encoded genes are cell cycle dependent (Chabouté, Clément et al. 
2000) we cannot confirm  whether this reduction observed in RRM2 expression levels is the 
direct effect of CNOT1 depletion or as a consequence of the cell cycle arrest phenotype in 
CNOT1-depleted cells. Treatment with different doses of RNR inhibitor HU slightly decreased 
the ability of CNOT1-depleted HeLa cells to form colonies 14 days post siRNA transfection. 
Interestingly, (Aird, Zhang et al. 2013) showed that RRM2-mediated suppression of nucleotide 
biosynthesis maintains cancer cells in stable cell growth arrest leading to senescence. In 
addition, suppression of RRM2 expression by siRNA or treatment with HU significantly induces 
autophagy (Chen, Zhang et al. 2014). As discussed in chapter 3 (section 3.2.8), both autophagy 
and senescence phenotypes were noticeably induced in CNOT1-depleted HeLa cells. 
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Ribonucleotides can be mis-incorporated into gDNA in two ways; firstly, depletion of the dNTP 
pool impairs discrimination between rNTP and dNTP by DNA polymerases during DNA 
replication, such that in order to complete DNA replication DNA polymerases erroneously 
incorporate rNTPs instead of dNTPs  (McElhinny, Watts et al. 2010). Secondly, during DNA 
replication, DNA polymerases incorporate RNA primers into the 5’ end of Okazaki-lagging 
fragments which must eventually be removed  and replaced with DNA after completion of 
DNA replication (Liu, Hu et al. 2017). The RNase H2 complex can recognise and degrade the 
embedded ribonucleotides to gDNA; failure to accomplish this is associated with genomic 
instability (Lindsey-Boltz, Kemp et al. 2015). In mammalian cells, an excess of cellular rCTP 
reduces basal Poly [ADP-ribose] polymerase 1 (PARP-1) activity and consequently disruption 
of Chk1 activity at the replication fork, leading to under-replicated DNA and ultrafine 
anaphase bridge (UFBs) formation (Gemble, Buhagiar-Labarchède et al. 2016). The 2'-
hydroxyl group makes RNA chemically unstable and susceptible to hydrolysis compared 
to DNA. Genomic DNA isolated from CNOT1-depleted cells displayed increased sensitivity to 
alkaline hydrolysis and migrated faster in gel electrophoresis compared to that from control 
cells. This suggests a high level of ribonucleotides embedded in gDNA in CNOT1-depleted 
cells. Considering that the gene expression of RNase H2, but not RNase H1, is  cell cycle 
dependent (Lockhart, Pires et al. 2019) we observed downregulation of RNase H2 A and B in 
CNOT1-depleted HeLa cells. 
To gain further insight into the role of the CNOT1 and/or the CNOT complex in DNA replication 
we analysed different fibre structures in control and CNOT1-depleted cells. CNOT1 depleted-
HeLa cells showed increased stalling of forks together with an increase in first label origins 
and a decrease in second label origins. Increase in the level of new origin firing in CNOT1-
depleted cells may lead to reduced replication fork speed (judged by the distribution of 
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replication fork speeds). Besides, CIP assay has revealed that CNOT1 and TAB182 interact with 
pre-RC subunits MCM2, MCM7 and ORC3. This association seems to be essential for 
protecting replication forks as depletion of CNOT1 leads to reduced replication fork speeds. 
Cellular levels of MCM proteins 2, 3, 7 and CDC7 were similar in control and CNOT1-depleted 
cells 72 hours post siRNA depletion. These results indicate that CNOT1 may function at 
replication origins.  
The final step to assess the steady-state level of mRNA in CNOT1-depleted cells was to 
measure the overall level of deadenylase activity of HeLa cells. We showed that depletion of 
CNOT1 noticeably decreased the level of deadenylase activity of the CNOT complex compared 
to the control. We take this to indicate that depletion of CNOT1 results in a general inhibition 
of the activity of the CNOT complex, although we have no evidence of effects on the ubiquitin 
E3 ligase activity. 
All in all, we have shown that the steady-state level of mRNA is disrupted when the CNOT 
complex loses control of transcription and mRNA stability in HeLa cells, after CNOT1 
depletion. Moreover, we have shown that the increase in transcription synthesis in CNOT1-
depleted cells promotes transcription-induced replication stress through R-loop formation. 
We also showed that another source of replication stress in CNOT1-depleted is increased 
rNTP mis-incorporation into gDNA.  
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5 CNOT1 AND DNA DAMAGE RESPONSE 
 
 
5.1 INTRODUCTION 
The Ccr4-Not complex has been reported to be involved in DNA repair in yeast. Many IR 
resistance genes involved in DDR pathways have been shown by Westmoreland et al. (2004)  
to have an interconnection with Ccr4 (hCNOT6/hCNOT6L), a major catalytic subunit of the 
Ccr4-Not and RNA polymerase-associated factor 1 (PAF1)-CDC73 transcription complexes 
(Westmoreland, Marks et al. 2004). A systematic interaction has been observed between the 
CCR4-CAF1 subunits with the cell cycle checkpoint genes DUN1, MRC1, RAD9, 
and RAD17 following treatment with hydroxyurea or methylmethane sulfonate (MMS). Yeast 
cells lacking NOT2, NOT4, NOT5 and CCR4 or CAF1 genes were shown to be sensitive to HU 
(Westmoreland, Marks et al. 2004). In the response to replication stress the RING-finger-
dependent ubiquitin-protein ligase Not4 modulates the Ubc4p/Ubc5p-mediated stress 
responses (Mulder, Inagaki et al. 2007). In mammalian cells depletion of CNOT6 in HEK293 T 
cells resulted in remarkable resistance to cisplatin-mediated apoptosis following induction of 
Chk2T68 phosphorylation, while overexpression of CNOT6, increased the sensitivity of cells, 
not only to cisplatin but to bleomycin (Sanchez-Perez, Manguan-Garcia et al. 2009).  
In addition, deficiency in transcription-coupled repair (TC-NER), a sub-pathway of NER , is 
associated with mutations in the Ccr4-Not complex in yeast, suggesting additional functions 
in DNA repair during transcription elongation (Gaillard, Tous et al. 2009). Zou et al. (2015) 
have shown that TAB182 contributes to radiation-induced DNA double-strand break repair 
through facilitating the interaction between DNA-PKcs and PARP1. The PARP1-mediated 
PARylation of DNA-PKcs leads to activation of DNA-PKcs auto-phosphorylation during DNA 
DSB repair (Zou, Shang et al. 2015). Moreover, in the mammalian system TAB182 was 
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identified in a screen of proteins which are highly phosphorylated at SQ/TQ sites by ATM or 
ATR in response to ionising radiation-induced DNA damage  (Matsuoka, Ballif et al. 2007). 
In this chapter, we show that depletion of CNOT1 in HeLa cell increases induction of 
spontaneous genome instability and this has been confirmed by several different methods.   
 We also show that two CNOT complex subunits, CNOT1 and Tab182, associate with ATR; in 
addition, a lack of CNOT1 appears to be associated with reduced level of ATR.  
 
 
5.2 RESULTS 
5.2.1 Increased spontaneous genome instability in CNOT1-depleted cells 
Here we have assessed the extent of DNA damage generated after CNOT1 depletion over 
several days using different assays. Firstly, we have shown that CNOT1 protein is present in 
the nucleus but does not localise to DNA damage foci following IR (3Gy) treatment (Figure 
5.1.A).   
The level of DSBs in control and CNOT1-depleted HeLa cells was measured using neutral 
comet assays. An increase in tail moment was observed in CNOT1-depleted HeLa cells, 
confirming increased DSB formation 120 hours post siRNA transfection (Figure 5.1.B). In a 
second set of experiments the number of cells with more than 5 micronuclei was found to be 
significantly elevated in CNOT1-depleted HeLa cells at later time points (5 days) post siRNA 
transfection (Figure 5.1.C and D). In addition, a significant increase in 53BP1 foci formation 
was observed in G1 positive CNOT1-depleted HeLa cells, 72 hours post siRNA transfection 
(Figure 5.1.E and F).  
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Figure 5.1 Increased genome instability in CNOT1-depleted cells 
A) HeLa cells were mock-exposed or irradiated to 3 Gy IR. 5 hours post irradiation the cells 
were permeabilised twice in CSK buffer including 0.3 mg/ml RNAse A for 3 minutes per each 
time. Cells were washed twice with PBS and fixed with 2% PFA for 15 minutes followed by one 
PBS wash. Cells were then stained with antibodies against yH2AX and CNOT1. The 
immunofluorescence images are representative of 3 independent experiments. B) DNA 
damage was evaluated using the Olive tail moment in control and CNOT1-depleted HeLa cells. 
Neutral comet assay was performed 120 hours post siRNA transfection. Dot plot of Olive tail 
moments was performed by RStudio statistical software and shown (n=3 independent 
experiments; >100 cells analysed per repeat, mean ± SD, *p < 0.05, **p < 0.01 and ***p < 
0.001). C & D) Quantification of cells with micronuclei classified in three categories; (=1 
micronuclei per cell), (2- 5 micronuclei per cell) and (> 5 micronuclei per cell). Scale bars, 10μm. 
(n=3 independent experiments; >100 cells counted per repeat, mean ± SD, *p < 0.05, **p < 
0.01 and ***p < 0.001).E & F) Quantification of cells with >5 53BP1 foci in G1 positive control 
and CNOT1-depleted HeLa cells as judged by co-staining of with Cyclin A. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CNOT1 & DNA DAMAGE RESPONSE 
204 
 
5.2.2 Downregulation of ATR signalling in CNOT1-depleted cells 
Co-immunoprecipitation (CIP) assays were conducted using HeLa cell lysates with CNOT1 and 
Tab182 antibodies. A western blot showed that ATR associated with CNOT1 and Tab182, 
possibly indicating an interaction with the intact CNOT complex (Figure 5.2.A). The difference 
between the amounts of target protein immunoprecipitated with the Tab182 and CNOT1 
antibodies is probably a reflection of a much higher titre in the former compared to the latter. 
These interactions were not supressed in the presence of the ATR kinase inhibitor AZD6738 
(Figure 5.2.B). We have also shown that the expression of ATR and its binding partner ATRIP 
were both down regulated in CNOT1-depleted cells, 72 hours post siRNA transfection (Figure 
5.2.C). However, no difference was observed in level of the ATR activator protein TopBP1 
between control and CNOT1-depleted cells. It also appears that ATR loading onto chromatin 
was reduced in the absence of CNOT1 (Figure 5.2.D). A further experiment was performed to 
examine the activation of ATR substrates, between control and CNOT1-depleted HeLa cells 
up to 4 days post siRNA depletion. As expected, following downregulation of ATR, the 
phosphorylation of both Chk1 (S345) and RPA (S4/S8) was decreased in CNOT1-depleted HeLa 
cells (Figure 5.2.E). Finally, RPA foci formation was shown to be reduced in S-G2/M positive 
CNOT1-depleted HeLa cells compared to control cells (Figure 5.1.F and G).  
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Figure 5.2 Downregulation of ATR signalling in CNOT1-depleted cells 
A) The CIP assays were conducted using HeLa cell lysates incubated with either CNOT1 or 
Tab182 or irrelevant antibody (control) overnight. Antibody-bound protein complexes were 
collected on protein G-agarose beads. The immune-complexes were then fractionated by SDS-
PAGE, and western blotting was performed using an ATR antibody. B) The CIP assays were 
conducted using HeLa cell lysates treated with and without ATR inhibitor AZD6738 (2 µM) for 
2 hours and incubated with either CNOT1 or Tab182 or irrelevant antibody (control) overnight. 
C) Total levels of the indicated ATR, ATRIP and TOPBP1 proteins were determined by 
immunoblotting of total HeLa cell extracts 72 h post transfection with control or CNOT1 siRNA. 
CDK2 was used as a loading control. D) Representative immunoblot shows the expression level 
of total ATR in different fractions (whole cell fraction (WCF), cytoplasm (Cyt), nucleoplasm (N) 
and chromatin (Chr)) in control and CNOT1-depleted cells 72 hours post siRNA transfection 
after sub -cellular fractionation. Lamin B1 was used as a positive loading control. E) Expression 
of total ATR, ATRIP, pChk1, Chk1, RPA and pRPA were analysed between control and CNOT1-
depleted HeLa cells up to 4 days post siRNA transfection. β-actin was used as a loading control. 
The longer time points were used to let the CNOT1-mediated DSBs become detectable and 
trigger the threshold damage response. F) RPA foci in S and G2/M positive (positive CENPF 
staining) HeLa cells 72 hours post siRNA transfection. G) Quantification of cells with >5 Rad51 
F) G) 
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and RPA foci (n=3 independent experiments; >100 cells counted per repeat, Statistical analyses 
were performed using a two-tailed and unpaired Student t test, *P <0.05; **, P<0.01. Error 
bars represent the SEM. Scale bars, 10μm. 
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5.2.3 Reduced homologous recombination (HR) repair in CNOT1-depleted HeLa cells 
Since CNOT1-depleted cells showed the G1-cell cycle arrest phenotype, we assumed that the 
HR repair should be also inactive in those cells. To confirm this, the efficiency of HR repair in 
CNOT1-depelted cells was assessed using the recombinant I-SceI-GFP plasmid assay. BRAC2-
depleted cells were used as a positive control for the assay. As we expected, the same level 
of deficiency was observed in BRAC2 and CNOT1- depleted cells compared to control cells 
(Figure 5.3.A, B, C and D). In addition, the Rad51 foci formation was significantly reduced in 
S/G2 positive CNOT1-depleted HeLa cells compared to control cells (Figure 5.3 E and F).  
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Figure 5.3 Reduced homologous recombination (HR) repair in CNOT1-depleted HeLa cells 
 
A, B, and C) HR repair of the I-SceI-induced DSB in control, BRAC2 and CNOT1 siRNA 
transfected U2OS cells. % Parent for sub-population of P3 (GFP positive cells) was obtained for 
each experimental condition using a BD LSRFortessa™ flow cytometer. D) Representative bar 
graph shows % GFP positive cells in each sample 72 h post siRNA transfection. (n=3 
independent experiments, Statistical analyses were performed using a two-tailed and 
unpaired Student t test, *, P<0.05; ***, P<0.001. Error bars represent the SEM). E) Rad51 foci 
in S/G2 positive (positive cyclin A staining) HeLa cells 72 hours post siRNA transfection. F) 
Quantification of cells with >5 Rad51 foci (n=3 independent experiments; >100 cells counted 
per repeat, statistical analyses were performed using a two-tailed and unpaired Student t test, 
*, P<0.05; ***, P<0.001. Error bars represent the SEM. Scale bars, 10μm. 
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5.2.4 CNOT1-depleted HeLa cells show resistance to MMC treatment 
Use of the CRISPR-Cas9-mediated knockout HAP1 cell line with individual mutations in five FA 
genes has shown that CNOT1 was among those genes whose inactivation can reduce the 
chromosomal instability following MMC treatment (Velimezi, Robinson-Garcia et al. 2018). 
Besides, knowing that progression through S phase is required for efficient induction of MMC-
mediated DNA damage and CNOT1-depleted cells exhibit the G1-cell cycle arrest phenotype 
we speculated that depletion of CNOT1 allows HeLa cells to tolerate MMC-induced replication 
stress. As expected, the results from the colony survival assay showed that the control HeLa 
cells formed fewer colonies than CNOT1-depleted cells 14 days post treatment with MMC, 
indicating that the absence of an active CNOT complex is advantageous to HeLa cells to 
tolerate MMC-dependent DNA intra-crosslinking damage (Figure 5.4.A and B).  
In western blotting studies, it was seen that cells lacking CNOT1 exhibited delayed or defective 
activation of ATR signalling in response to MMC treatment, suggesting that sensing and 
repairing DNA double-strand breaks was delayed (Figure 5.4.C). However, by 24 hours the 
level of phosphorylation was comparable in control and CNOT1-depleted cells. Mono-
ubiquitination of FA core complex FANCD2 was also delayed in CNOT1-depleted HeLa cells. 
Since, in G1, ICL bypass repair is carried out by nucleotide excision repair (NER) we also 
assessed the expression of NER factors STEX, CSB, XPC, XPG and XPF and all were upregulated 
in CNOT1-depleted cells (Figure5.3.D). 
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Figure 5.4 CNOT1-depleted HeLa cells show resistance to MMC treatment 
A) Cells were plated at appropriate concentration 72 hours post siRNA transfection and then 
exposed to different concentrations of MMC (ng/mL). At day 14, large colonies were stained 
with crystal violet and counted. B) Clonogenic survival was expressed as a surviving fraction 
of non-treated controls for each condition and was plotted on a semi-logarithmic scale. The 
graph shown was plotted from 3 independent experiments, mean ± SD, *p < 0.05, **p < 0.01 
and ***p < 0.001. C) Western blot analysis of activation of ATR substrates performed after 
treatment of HeLa cells with MMC (1 µm) 72 post siRNA transfection. Samples were processed 
at the indicated time points and blotted using the antibodies shown. β-Actin was used as a 
loading control. D) Western blot analysis of NER proteins in HeLa cell lysate 72 hours post 
siRNA transfection in in control and CNOT1-depleted HeLa cells.  
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5.3 DISCUSSION 
 
 
The maintenance of genome integrity during DNA replication is crucial for cell proliferation 
and survival. The sensor kinase ATR acts as a safeguard to detect replication blocks and 
subsequent generation of double-strand breaks. We have shown that the CNOT complex may 
associate with ATR. A recent CRISPR screen revealed that CNOT complex deficiency is 
synthetically lethal with ATR both in vitro and in vivo (Wang, Wang et al. 2018). The CIP assays 
showed that ATR associates with CNOT1 and Tab182, possibly indicating an interaction with 
the intact CNOT complex. Interestingly, the ATR kinase inhibitor AZD6738 only reduced the 
interactions between CNOT1 or Tab182 and ATR slightly. Noteworthy, the ATR inhibitor can 
block the kinase activity of ATR by interacting with, and inhibiting, its kinase domains. This 
changes the configuration of ATR and inhibits its interaction with binding proteins, such as 
Chk1 and RPA.  It seems likely, therefore, that the binding site on ATR for CNOT is located well 
away from the kinase domain. We have also shown that phosphorylation of effector kinase 
Chk1 at serines-345 and 317 and RPA at serines 4/8 were reduced following CNOT1 depletion 
in HeLa cells. These are considered usual ATR substrates. Furthermore, depletion of CNOT1 
also results in reduced NBS1 and KAP1 phosphorylation, possibly indicating an effect on DNA-
PK and/or ATM. These data suggest the existence of truncated ATR and perhaps other PIKK 
signalling pathways in response to DNA damage in CNOT1-depleted cells. 
Induction of DSBs in CNOT1-depleted HeLa cells was confirmed by increased Olive Tail 
Moment, micronuclei formation and 53BP1 foci formation (in G1 positive cells). In contrast, 
phosphorylation of H2AX and its recruitment to the site of DNA damage were delayed in 
CNOT1-depleted HeLa cells (data is not presented). This may be due to reduced expression of 
histone proteins which take place in S phase.   
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 We also assessed the DDR response in CNOT1-depleted HeLa cells in combination with DNA 
damaging agent MMC, which can block DNA replication during S phase. Colony survival assays 
confirmed that the G1-arrested HeLa cells, following depletion of CNOT1, displayed reduced 
MMC sensitivity compared to control cells. In all likelihood, CNOT1-depleted cells were able 
to tolerate the deleterious effect of MMC-dependent replication stress by staying in G1 phase. 
Initial phosphorylation of DDR proteins H2AX, Chk1, KAP1, RPA1, and NBS1 was delayed after 
MMC treatment in CNOT1-depleted cells, suggesting that sensing and repairing DNA double-
strand breaks was delayed.  
Knowing that in G1, ICL bypass repair is carried out by nucleotide excision repair (NER) and 
translesion DNA synthesis (TLS) (Deans and West 2011) we analysed the expression of 
proteins involved in NER repair in CNOT1-depleted cells. The results showed upregulation of 
STEX, CSB, XPC, XPG and XPF in CNOT1-depleted cells compared to control. 
All in all, it seems that two main factors contribute to CNOT1-depleted HeLa cells’ ability to 
tolerate the MMC-mediated DNA damage compared to control cells: G1-cell cycle arrest and 
activation of NER repair.  
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6 CONCLUSIONS 
 
 
 
6.1 Proposed Model 
 
We have shown that depletion of CNOT1, a scaffold to the CNOT complex, disrupts cellular 
transcription buffering. On the one hand, by increasing the level of transcription synthesis, 
and on the other, by decreasing the mRNA decay rates. In this study, the first result of CNOT1 
depletion was disruption of cell cycle progression and G1 arrest. It seems two factors 
contribute to the G1-cell cycle arrest phenotype in HeLa cells. Firstly, the role of CNOT1 in 
transcription and mRNA stability of genes involved in cell cycle transition through different 
phases as suggested by various studies in yeast (Johnston, Eberly et al. 1990, Kadyrova, 
Habara et al. 2007, Dronamraju, Hepperla et al. 2018). Secondly, upregulation of CDK 
inhibitors p21 and p27, independently of p53 following induction of DNA damage in CNOT1-
depleted cells.  
It seems that phosphorylation of Chk2 (T68) correlated with the increased expression of p21 
in CNOT1-depleted cells. In case of p27, Morita et al. (2007) has shown that depletion of 
CNOT6L elevates the expression level of p27 protein due to increased stability of its mRNA 
poly (A) tail (Morita, Suzuki et al. 2007). Since, increased p27 protein levels did not result from 
an increase in p27 gene expression in CNOT1-depleted cells we assume disruption of 
deadenylase activity of CNOT complex is responsible for p27 upregulation. It is also possible 
that increased half-life contributes to the additional p27 protein observed following 
downregulation of E3 ubiquitin ligase (CNOT4) activity of CNOT complex. 
 
 
CONCLUSIONS 
219 
 
“Why are p21 and p27 levels increased in CNOT1 depleted cells?” 
We propose two possible scenarios below; 
1) Increased transcription-induced replication stress through R-loops formation 
2) Increased mis-incorporation of rNTPs into gDNA following depletion of dNTP pool 
resulting from: 
a) Reduction in activity of the RNR complex following downregulation of RRM2 and 
p53R2  
and/or 
b) Increased level of origin firing following overexpression of cyclin E. 
 
Either of these scenarios or a combination of them leads to increased DSB formation (judged 
by increased level of micronuclei, 53BP1 bodies and an increase in comet tail moment) in 
CNOT1-depleted cells and activation of Chk2-dependent G1/S cell cycle arrest. Irreversible 
accumulation of DNA damage drives mitotic cells either to adapt to stress through autophagy 
and/or senescence or to be eliminated through programmed cell death. In fact, CNOT1-
depleted cells showed induction of autophagy, senescence and apoptosis (independent of 
Caspase-3), perhaps with some overlapping with one other. The following cartoon shows a 
summary of pathways dysregulated during CNOT1 depletion that may lead to genomic 
instability and cell death in HeLa cells (Figure 6.1). 
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Figure 6.1 Model for the action of CNOT1 in mammalian cells  
The cartoon shows a summary of pathways dysregulated during CNOT1 depletion that may 
lead to genomic instability and cell death in HeLa cells. Pathway (1) shows Transcription-
induced replication stress in CNOT1-depleted HeLa cells. Pathway (2) shows increased level of 
rNTP mis-corporation into gDNA following reduction of RNR activity (a) and overexpression of 
cyclin E (b) in CNOT1-depleted HeLa cells. 
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6.2 Unanswered questions and future work 
The findings presented in this thesis raise several interesting questions for possible future 
investigation. Firstly, because some of the effects we have observed as a result of CNOT1 
siRNA-mediated depletion could be due to 'off-target' effects, we will carry out a range of 
complementation experiments to examine this. A cell line will be generated containing an 
inducible siRNA resistant form of CNOT1 under the control of tetracycline-inducible 
promoter. For this we will make use of U2OS 'flip-in' cells. 
Secondly, as the results from RNA-Seq did not show an upregulation of CCNE1 gene 
expression in CNOT1-depleted cells, we will look at its mRNA stability by measuring the mRNA 
half-life at different time points after treatment with a transcription inhibitor such as 
actinomycin D or DRB. In addition, we will determine the half-life of the cyclin E protein after 
CNOT1 depletion. Given that the dysregulation of the oncogene cyclin E has been shown to 
increase transcription and replication interference (Jones, Mortusewicz et al. 2013), we will 
investigate the cyclin E-dependent replication stress in CNOT1-depleted HeLa cells in more 
detail. 
Thirdly, we will also measure the nuclear intensity of pRNA poII (S5) by IF microscopy to 
support our pRNA poII (S5) western blot data.  
As separate projects, we will investigate in more detail the ATR-CNOT complex-RNase H2 
complex and ATR-CNOT complex-RNR complex axes.  
Finally, we will investigate the other phosphorylation sites in ATR and ATM substrates in 
CNOT1-dependent DDR and the involvement of DNA-PK in the DDR in CNOT1-depleted cells.  
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